Exhibit 10.1


 


EXECUTION VERSION


 


 




AGREEMENT AND PLAN OF MERGER


 


by and among


 


ADAPTHEALTH CORP.,


 


AH APOLLO MERGER SUB INC.,


 


AH APOLLO MERGER SUB II INC.,


 


AEROCARE HOLDINGS, INC.,


 


and


 


PELOTON EQUITY, LLC,


 


as Stockholder Representative


 


December
1, 2020


 


 











     


     


    

 


TABLE OF CONTENTS

 (continued)


 


	ARTICLE I DEFINITIONS	12
	 	1.1	Definitions	12
	 	1.2	Construction	12
	ARTICLE II PURCHASE AND SALE; CLOSING; CLOSING DELIVERIES	13
	 	2.1	The Mergers	13
	 	2.2	Closing	14
	 	2.3	Deliveries at Closing	15
	 	2.4	First Merger Conversion of Securities	17
	 	2.5	Payment for Securities	19
	 	2.6	Dissenting Shares	21
	 	2.7	Treatment of Company Options	21
	 	2.8	Excess Capital Equipment Adjustment; Estimated Aggregate Merger Consideration; Parent Stock	23
	 	2.9	Closing Date Estimates and Post-Closing Reconciliation	24
	 	2.10	Withholding	29
	 	2.11	[INTENTIONALLY OMITTED]	29
	 	2.12	Second Merger Conversion of Securities	29
	 	2.13	Equitable Adjustments	29
	ARTICLE III ESCROW AND REPRESENTATIVE EXPENSE AMOUNT	30
	 	3.1	Escrow Deposit; Disbursements	30
	 	3.2	Deposit of Representative Expense Amount	30
	ARTICLE IV REPRESENTATIONS AND WARRANTIES OF COMPANY	31
	 	4.1	Organization; Existence and Good Standing	31
	 	4.2	Authority; Enforceability	31
	 	4.3	No Violations	32
	 	4.4	Consents	32
	 	4.5	Capitalization; Subsidiaries	32
	 	4.6	Legal Requirements and Permits	34
	 	4.7	Legal Proceedings	38
	 	4.8	Tax Matters	38
	 	4.9	Financial Statements and Other Financial Matters	40
	 	4.10	Absence of Certain Changes	42
	 	4.11	Employee Benefit Plans	42
	 	4.12	Employment and Labor	45
	 	4.13	Contracts	47
	 	4.14	Real Property	49
	 	4.15	Personal Property	50
	 	4.16	Intellectual Property	50
	 	4.17	Insurance	52
	 	4.18	Related Party Transactions	52
	 	4.19	Material Customers, Suppliers, Payors and Referral Sources	52
	 	4.20	Privacy	53



 






    ii 


     


    

 


TABLE OF CONTENTS

 (continued)


 


	 	4.21	Brokers’ Fees	55
	 	4.22	Sufficiency of Assets	55
	 	4.23	[RESERVED]	55
	 	4.24	Environmental Matters	55
	 	4.25	Product Liability	56
	 	4.26	COVID-19 Laws	56
	 	4.27	No Other Representations and Warranties	56
	ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT, Merger Sub and merger sub ii	57
	 	5.1	Organization; Existence and Good Standing	57
	 	5.2	Authority; Enforceability	57
	 	5.3	No Violations	58
	 	5.4	Consents	58
	 	5.5	Legal Proceedings	58
	 	5.6	Brokers’ Fees	59
	 	5.7	Financing	59
	 	5.8	[RESERVED]	60
	 	5.9	Capitalization	60
	 	5.10	Shares	61
	 	5.11	SEC Reports; Financial Statements	61
	 	5.12	Compliance with Legal Requirements	63
	 	5.13 	Listing and Maintenance Requirements	63
	 	5.14	No Disqualification Events	63
	 	5.15	Solvency	63
	 	5.16	Tax Matters	63
	 	5.17	No Other Representations and Warranties	64
	ARTICLE VI COVENANTS AND OTHER AGREEMENTS	64
	 	6.1	Interim Operation of Business	64
	 	6.2	Public Announcements	68
	 	6.3	Indemnification and Insurance	69
	 	6.4	Pre-Closing Access	70
	 	6.5	Regulatory and Other Approvals	71
	 	6.6	Efforts to Consummate	73
	 	6.7	Preservation of Records; Post-Closing Access	73
	 	6.8	Post-Closing Employee Matters	74
	 	6.9	Section 280G	75
	 	6.10	401(k) Plan	76
	 	6.11	Parent’s Financing	76
	 	6.12	Exclusivity	80
	 	6.13	Transfer Restrictions	80
	 	6.14	Parent Stockholder Approval	82
	 	6.15	Company Written Consent; Company Voting and Support Agreements; Stockholder Notice	83



 






    iii 


     


    

 


TABLE OF CONTENTS

 (continued)


 


	 	6.16	Accredited Investor Certifications	83
	 	6.17	Board Rights	84
	 	6.18	Information Rights	86
	 	6.19	Tax Matters	87
	 	6.20	VDR	88
	 	6.21	Listing	88
	 	6.22	[INTENTIONALLY OMITTED]	88
	 	6.23	Form S-8	88
	 	6.24	Excess Capital Equipment	88
	 	6.25	Section 16 Matters	89
	 	6.26	Related Party Transactions	89
	ARTICLE VII CONDITIONS TO CLOSING	89
	 	7.1	Conditions Precedent to Obligations of Parent, Merger Sub and Merger Sub II	89
	 	7.2	Conditions Precedent to Obligations of the Company	90
	ARTICLE VIII INDEMNIFICATION	92
	 	8.1	Representation and Warranty Insurance	92
	 	8.2	Indemnification by Company Equityholders	92
	 	8.3	Survival	92
	 	8.4	Limitations on Indemnification; Procedures	92
	 	8.5	Defense of the Special Matter	93
	 	8.6	Sole and Exclusive Recourse	93
	 	8.7	[INTENTIONALLY OMITTED]	93
	 	8.8	Treatment for Tax Purposes	93
	 	8.9	Acknowledgement; Waiver	94
	 	8.10	No Reliance	95
	 	8.11	Non-Recourse	95
	ARTICLE IX TERMINATION	96
	 	9.1	Termination of Agreement	96
	 	9.2	Effect of Termination	98
	ARTICLE X GENERAL	100
	 	10.1	Entire Agreement	100
	 	10.2	Successor and Assigns; Third-Party Beneficiaries	100
	 	10.3	Amendments	101
	 	10.4	Notices	101
	 	10.5	Governing Law; Venue; Service of Process; Waiver of Jury Trial	103
	 	10.6	Severability	104
	 	10.7	Transaction Costs and Expenses	104
	 	10.8	Specific Enforcement	105
	 	10.9	Disclosure Schedule	106
	 	10.10	Appointment of the Stockholder Representative	107



 






    iv 


     


    

 


TABLE OF CONTENTS

 (continued)


 


	 	10.11	Counterparts	110
	 	10.12	Further Assurance	110
	 	10.13	Legal Representation	110



 






    v 


     


    

 


TABLE OF CONTENTS

 (continued)


 


EXHIBITS


	 
	Page
	Exhibit A	Definitions
	Exhibit B	[Intentionally
    Omitted]
	Exhibit C	[Intentionally
    Omitted]
	Exhibit D	[Intentionally
    Omitted]
	Exhibit E	[Intentionally
    Omitted]
	Exhibit F	Form of Stock Letter of Transmittal
	Exhibit G	[Intentionally
    Omitted]
	Exhibit H	Form of Stockholder Consent
	Exhibit I	Form of Company Voting and Support Agreement
	Exhibit J	Form of Accredited Investor Questionnaire
	Exhibit K	[Intentionally
    Omitted]
	Exhibit L	Form of Certificate of Designations
	Exhibit M	[Intentionally
    Omitted]
	Exhibit N	Preparation Methodology
	Exhibit O	Form of Parent Voting and Support Agreement
	Exhibit P	Schedule of Competitors




 






    vi 


     


    

  


GLOSSARY OF DEFINED TERMS


 


The location of the definition of each
capitalized term used in this Agreement is set forth in this Glossary:




	401(k) Plans	76
	Accredited Investor	116
	Accredited Investor Questionnaire	85
	Accredited Investor Questionnaire Deadline	85
	Acquisition Proposal	81
	Adjustment Escrow Account	116
	Adjustment Escrow Deposit	116
	Affiliate	116
	Affordable Care Act	116
	Aggregate Exercise Amount	116
	Aggregate Merger Consideration	116
	Aggregate Parent Stock Value	116
	Aggregate Shares	116
	Aggregate Stimulus Funds	117
	Agreement	11
	AI Aggregate Shares	117
	Amended and Restated Registration Rights Agreement	117
	AML Laws	37
	Anti-Corruption Laws	117
	Antitrust Division	71
	Antitrust Laws	72
	Board Representatives	85
	Borrowed Money Debt	117
	Business	117
	Business Day	117
	Business IP	50
	Capitalization Date	60
	CARES Act	117
	Cash on Hand	117
	Cash Option Consideration	117
	Certificate	19
	Certificate of Designations	117
	Certificates	19
	Change in Control Payment	118
	Charter Documents	118
	Claim	118
	Class A Common Stock	60
	Class B Common Stock	60
	Closing	14
	Closing Cash	118
	Closing Consideration Schedule	24
	Closing Date	15
	Closing Indebtedness	118
	Closing Statement	25
	Code	118
	Collection Costs	99
	Common Per Share Amount	118
	Common Per Share Cash Amount	118
	Common Per Share Stock Issuance Amount	118
	Common Stock	60
	Common Stock Share Consideration	119
	Common Stockholder	119
	Company	11
	Company Burdensome Condition	73
	Company Capital Stock	119
	Company Common Stock	119
	Company Equity Plan	119
	Company Equityholders	119
	Company Financial Statements	40
	Company Option	119
	Company Optionholder	119
	Company Real Property	49
	Company Related Party	52
	Company Releasing Related Parties	100
	Company Series C Preferred Stock	119
	Company Systems	119
	Company Voting and Support Agreements	84
	Company Written Consent	84
	Company’s Counsel	89
	Company’s Replacement Counsel	92
	Compliant	119
	Confidentiality Agreement	120
	Consent	120
	Continuation Period	74
	Continuing Employee	74
	Contract	120



 






    7


     


    

 


	Conversion Rate	120
	Covered Person	120
	COVID-19	120
	COVID-19 Measures	120
	Data Treatment	120
	date hereof	11
	date of this Agreement	11
	Deal Communications	112
	Debt Financing	59
	Debt Financing Commitment	59
	Debt Financing Sources	120
	Derivative Instruments	120
	DGCL	121
	Disclosure Schedule	30
	Dissenting Shares	21
	Dividend Recapitalization	68
	DMEPOS	35
	Employee Option	121
	Employee Plan	121
	Enforceability Exceptions	31
	Environmental Laws	121
	Equity Securities	121
	ERISA	121
	ERISA Affiliate	122
	Escrow Agent	122
	Escrow Agreement	122
	Estimated Aggregate Merger Consideration	122
	Estimated Closing Cash	23
	Estimated Closing Indebtedness	23
	Estimated Closing Statement	23
	Estimated M&A Adjustment	23
	Estimated Net Working Capital Adjustment Amount	23
	Estimated Selling Expenses	23
	Excess Capital Equipment	122
	Excess Capital Equipment Adjustment	23
	Exchange Act	57
	Exchange Ratio	22
	Excluded Information	122
	Ex-Im Laws	122
	Financing Parties	123
	First Certificate of Merger	14
	First Effective Time	14
	First Merger	11
	First Surviving Company	13
	Fraud	123
	FTC	71
	Fundamental Representations	123
	GAAP	123
	Goodwin	111
	Governmental Entity	123
	Grant Date	33
	Hazardous Substances	123
	Health Care Laws	123
	HIPAA Laws	55
	Holdings Stock Options	60
	HSR Act	124
	Indebtedness	124
	Indemnification Agreement	87
	Indemnified Parties	93
	Independent Accounting Firm	27
	Information Rights Holder	125
	Intellectual Property	125
	Interim Company Financial Statements	41
	IRS	125
	Joint Instruction Letter	30
	Knowledge	125
	Latest Audited Balance Sheet	40
	Latest Balance Sheet	41
	Latest Balance Sheet Date	41
	Leased Real Property	49
	Legal Proceeding	125
	Legal Requirement	125
	Liabilities	125
	Licenses for Generally Commercially Available Software	125
	Lien	126
	Losses	126
	M&A Adjustment	126
	M&A Costs	126
	M&A Purchase	126
	M&A Target	126
	Marketing Period	126
	Material Adverse Effect	127
	Material Contract	47
	Material Payor	53
	Material Permits	34
	Material Referral Source	53
	Material Suppliers	52
	Measurement Time	128
	Merger Sub	11



 






    8


     


    

 











	Merger Sub II	11
	Mergers	11
	Multiemployer Plan	128
	NASDAQ	128
	Net Working Capital	128
	Net Working Capital Adjustment Amount	129
	Net Working Capital Target	129
	Nomination Right Board Representative	85
	Nomination Rights Holders	85
	Non-Employee Option	129
	Non-Party Affiliates	97
	Notices	102
	Objection Notice	26
	Observer Rights Holder	86
	Option Cash Amount	22
	Option Consideration	129
	Order	129
	Ordinary Course of Business	129
	Ordinary Rep	129
	Other Board Representative	85
	Outside Date	97
	Owned Intellectual Property	50
	Parachute Payment Waivers	75
	Parent	11
	Parent Board of Directors	85
	Parent Burdensome Condition	73
	Parent Indemnitees	93
	Parent Material Adverse Effect	129
	Parent Option	22
	Parent Plans	74
	Parent Related Parties	99
	Parent Stock Awards	60
	Parent Stock Value	129
	Parent Stockholder Approval	57
	Parent Stockholders’ Meeting	84
	Parent’s Counsel	89
	Parent’s Replacement Counsel	91
	Parties	11
	Party	11
	Paying Agent	19
	Payoff Amount	15
	Payoff Letter	15
	Per Share Cash Consideration	129
	Per Share Mixed Consideration	129
	Permit	34
	Permitted Liens	129
	Permitted Transfer	82
	Person	130
	Personal Data	130
	PHI	55
	Post-Closing Covenants	93
	Post-Closing Tax Period	130
	Pre-Closing Covenants	93
	Preferred Stock	60
	Preferred Stock Share Consideration	130
	Preparation Methodology	130
	Previously Owned Real Property	49
	Privacy Laws and Requirements	54
	Privileged Deal Communications	112
	Prohibited Shares	81
	Proprietary Software	50
	Provider Relief Adjustment	131
	Proxy Statement	58
	Purchasing Expenses	131
	Real Property Leases	131
	Referral Source	37
	Rental Equipment	131
	Representative Expense Amount	131
	Representative Losses	110
	Required Financial Information	131
	Restricted Cash	132
	Restricted Period Termination Date	82
	SEC	61
	SEC Reports	61
	Second Certificate of Merger	14
	Second Effective Time	14
	Second Merger	11
	Second Surviving Company	13
	Section 280G Approval	76
	Securities	132
	Securities Act	57
	Security Breach	132
	Selling Expenses	132
	Series C Preferred Stock	133
	Series C Preferred Stockholders	133
	Share Consideration	133
	Share Consideration Amount	133
	Shortfall Amount	28
	Special Escrow Account	133
	Special Escrow Deposit	133
	Special Matter	133



 






    9


     


    

 


	Special Matter Termination Date	93
	Special Policy	93
	Stock Letter of Transmittal	19
	Stock Plan	60
	Stockholder	133
	Stockholder Notice	84
	Stockholder Representative	11
	Straddle Period	133
	Subsidiaries	133
	Subsidiary	133
	Substitute Financing	77
	Substitute Option Consideration	134
	Surviving Companies	134
	Tail Policy	69
	Tangible Personal Property	50
	Tax	134
	Tax Representation Letters	89
	Tax Return	134
	Taxes	134
	Taxing Authority	134
	Termination Fee	99
	Third Party Payor Programs	134
	Third Party Payors	134
	Trade Secrets	125
	Trading Day	134
	Transaction Documents	134, 135
	Transfer	135
	Transfer Taxes	88
	Unaffiliated Shareholders	135
	Value of the Common Per Share Stock Issuance Amount	135
	VDR	13
	Vested Cash-Out Options	135
	Vested Company Option	135
	Vested Substitute Options	136
	Voting Debt	60
	Waived 280G Benefits	75
	Waiving Party	95



 






    10


     


    

 


AGREEMENT AND PLAN OF MERGER


 


This AGREEMENT AND
PLAN OF MERGER (including the exhibits and schedules hereto, each as amended or restated from time to time in accordance with Section
 ‎10.3, this “Agreement”), dated as of December 1, 2020 (the “date hereof” or the
 “date of this Agreement”), is by and among (i) AdaptHealth Corp., a Delaware corporation (“Parent”);
(ii) AH Apollo Merger Sub Inc., a Delaware corporation and a wholly-owned direct Subsidiary of Parent (“Merger Sub”);
(iii) AH Apollo Merger Sub II Inc., a Delaware corporation and wholly-owned direct Subsidiary of Parent (“Merger Sub II”);
(iv) AeroCare Holdings, Inc., a Delaware corporation (the “Company”); and (v) Peloton Equity, LLC, a Delaware
limited liability company, solely in its capacity as the representative, agent and attorney-in-fact of the Company Equityholders
(the “Stockholder Representative”). The foregoing parties are collectively referred to as the “Parties”
and each individually is a “Party.”


 


RECITALS


 


WHEREAS, each
of Parent, Merger Sub, Merger Sub II and the Company desire to effect the acquisition of the Company by Parent through (a) the
merger of Merger Sub with and into the Company, with the Company continuing as the surviving corporation of such merger (the “First
Merger”), immediately followed by (b) the merger of the Company, as the surviving corporation of the First Merger, with
and into Merger Sub II, with Merger Sub II continuing as the surviving company of such merger (the “Second Merger”,
and together with the First Merger, the “Mergers”), in each case, upon the terms and subject to the conditions
set forth in this Agreement and in accordance with the applicable provisions of the DGCL. Upon consummation of the Mergers, the
Company and Merger Sub will cease to exist and Merger Sub II will continue as a wholly-owned Subsidiary of Parent;


 


WHEREAS, the
board of directors of the Company has (a) determined that it is in the best interests of the Company and the Stockholders, and
declared it advisable, to enter into this Agreement, (b) approved the execution, delivery and performance of this Agreement and
the consummation of the First Merger and the other transactions contemplated hereby to which the Company is a party, and (c) recommended
that the Stockholders adopt this Agreement and approve the First Merger;


 


WHEREAS, promptly
following the execution and delivery of this Agreement, it is anticipated that Stockholders holding sufficient type and number
of shares of Company Capital Stock to adopt this Agreement and approve the First Merger in accordance with the DGCL and the Company’s
Charter Documents will execute and deliver to the Company, and the Company shall deliver to Parent, the Company Written Consent;


 


WHEREAS,
the board of directors of Parent has (a) determined that it is in the best interests of Parent and its stockholders, and
declared it advisable, to enter into this Agreement, and (b) approved the execution, delivery and performance of this
Agreement and the consummation of the Mergers and the other transactions contemplated hereby;


 






    11


     


    

 


WHEREAS, the
board of directors of Merger Sub has (a) determined that it is in the best interests of Merger Sub and its stockholder, and declared
it advisable, to enter into this Agreement, (b) approved the execution, delivery and performance of this Agreement and the consummation
of the First Merger and the other transactions contemplated hereby, and (c) recommended its stockholder (in its capacity as its
stockholder) adopt this Agreement and approve the First Merger;


 


WHEREAS, the
board of directors of Merger Sub II has (a) determined that it is in the best interests of Merger Sub II and its stockholder, and
declared it advisable, to enter into this Agreement, (b) approved the execution, delivery and performance of this Agreement and
the consummation of the Second Merger and the other transactions contemplated hereby, and (c) recommended its stockholder (in its
capacity as its stockholder) adopt this Agreement and approve the Second Merger;


 


WHEREAS, for
U.S. federal income Tax purposes, Parent, Merger Sub, Merger Sub II and the Company intend that the Mergers will be treated as
an integrated plan that will qualify as a “reorganization” within the meaning of Section 368(a) of the Code and the
Treasury Regulations, and this Agreement is intended to be and is adopted as a “plan of reorganization” within the
meaning of Sections 354 and 361 of the Code; and


 


WHEREAS, contemporaneously
with the execution hereof, Parent has delivered to the Company Voting and Support Agreements by and between Parent and certain
of its stockholders (the “Parent Voting and Support Agreements”).


 


NOW, THEREFORE,
in consideration of the foregoing and the mutual covenants and agreements herein contained and intending to be legally bound hereby,
the Parties agree as follows:


 


AGREEMENTS


 


ARTICLE
I

DEFINITIONS


 


1.1           
Definitions. In addition to the terms defined in the body of this Agreement, capitalized terms used herein will have
the meanings given to them in Exhibit A. The Glossary of Defined Terms, which follows the Table of Contents, sets forth the
location in this Agreement of the definition for each capitalized term used herein.


 


1.2            Construction.
All article, section, subsection, schedule and exhibit references used in this Agreement are to this Agreement unless
otherwise specified. All schedules and exhibits attached to this Agreement constitute a part of this Agreement and are
incorporated herein. Unless the context of this Agreement clearly requires otherwise: (a) the singular includes the
plural and the plural includes the singular wherever and as often as may be appropriate, (b) the words
 “includes” or “including” mean “including without limitation,” (c) the word
 “or” is not exclusive, (d) the words “this Agreement,” “hereof,”
 “herein,” “hereunder” and similar terms in this Agreement refer to this Agreement as a whole and not
any particular section or article in which such words appear and (e) the words “as amended” mean “as
amended from time to time.” All references to Dollars or “$” are to United States dollars. All references
to “days” are to calendar days. Any reference to a particular Legal Requirement means such Legal Requirement as
amended, modified or supplemented (including all rules and regulations promulgated thereunder) and, unless otherwise
provided, as in effect from time to time. For purposes of Article ‎IV,
with respect to any document, the words “provided”, “delivered”, “made available”,
 “furnished” or similar phrase shall mean that the referenced document was posted and accessible to Parent and its
representatives in the Company’s electronic data room hosted and maintained by Datasite for “Project
Apollo” no less than one (1) Business Day prior to the date of this Agreement and remained so posted and accessible
through the date hereof (the “VDR”). When calculating the period of time before which, within which or
following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in
calculating such period shall be excluded. If the last day of such period is a non-Business Day, the period in question shall
end on the next succeeding Business Day.


 






    12


     


    

 



 


 


ARTICLE
II

PURCHASE AND SALE; CLOSING; CLOSING DELIVERIES


 


2.1           
The Mergers.


 


(a)              
Pursuant to the terms and subject to the conditions set forth in this Agreement, and in accordance with the DGCL, at the
First Effective Time, Merger Sub shall be merged with and into the Company. As a result of the First Merger, the separate corporate
existence of Merger Sub shall cease, and the Company shall continue as the surviving corporation of the First Merger (the “First
Surviving Company”). Pursuant to the terms and subject to the conditions set forth in this Agreement, and in accordance
with the DGCL, at the Second Effective Time, the First Surviving Company shall be merged with and into Merger Sub II. As a result
of the Second Merger, the separate corporate existence of the First Surviving Company shall cease, and Merger Sub II shall continue
as the surviving corporation of the Second Merger (the “Second Surviving Company”). The Mergers shall be effected
pursuant to the DGCL and shall have the effects set forth in this Agreement and the applicable provisions of the DGCL. Without
limiting the generality of the foregoing: (i) at the First Effective Time, all of the property, rights, privileges, immunities,
powers and franchises of Merger Sub and the Company shall vest in the First Surviving Company, and all of the debts, liabilities
and duties of Merger Sub and the Company shall become the debts, liabilities and duties of the First Surviving Company; and (ii) at
the Second Effective Time, all of the property, rights, privileges, immunities, powers and franchises of the First Surviving Company
and Merger Sub II shall vest in the Second Surviving Company, and all of the debts, liabilities and duties of the First Surviving
Company and Merger Sub II shall become the debts, liabilities and duties of the Second Surviving Company.


 


(b)               At
the First Effective Time, by virtue of the First Merger and without the necessity of further action by the Company or any
other Person but subject to Section ‎6.3, (i) the certificate of incorporation of the First Surviving Company
shall be amended so as to be in customary form as reasonably agreed by the Parties, and as so amended shall be the
certificate of incorporation of the First Surviving Company until thereafter changed or amended as provided therein or by
applicable Legal Requirement and (ii) the bylaws of the First Surviving Company shall be amended so as to be in customary
form as reasonably agreed by the Parties, and as so amended shall be the bylaws of the First Surviving Company until
thereafter changed or amended as provided therein or by applicable Legal Requirement. At the Second Effective Time, by virtue
of the Second Merger and without the necessity of further action by the First Surviving Company or any other Person but
subject to Section ‎6.3, (i) the certificate of incorporation of Merger Sub II as of immediately prior to the
Second Effective Time shall be the certificate of incorporation of the Second Surviving Company until thereafter changed or
amended as provided therein or by applicable Legal Requirement and (ii) the bylaws of Merger Sub II as of immediately prior
to the Second Effective Time shall be the bylaws of the Second Surviving Company until thereafter changed or amended as
provided therein or by applicable Legal Requirement.


 






    13


     


    

 


(c)              
The Company shall take all appropriate action such that, at the First Effective Time, by virtue of the First Merger and
without the necessity of further action by the Company or any other Person, the officers and directors of Merger Sub immediately
prior to the First Effective Time shall become the officers of the First Surviving Company. At the Second Effective Time, by virtue
of the Second Merger and without the necessity of further action by Merger Sub II or any other Person, the officers of Merger Sub
II immediately prior to the Second Effective Time shall be the officers of the Second Surviving Company, each to hold office, from
and after the Second Effective Time, in accordance with the certificate of incorporation and bylaws of the Second Surviving Company
until their respective successors shall have been duly elected, designated or qualified, or until their earlier death, resignation
or removal in accordance with the certificate of incorporation and bylaws of the Second Surviving Company.


 


(d)              
At the Closing, the Company and Merger Sub shall cause a certificate of merger in customary form as reasonably agreed by
the Parties (the “First Certificate of Merger”), to be filed with the Secretary of State of the State of Delaware
in accordance with the DGCL and shall make all other filings required under the DGCL. The First Merger shall become effective at
the time the First Certificate of Merger shall have been duly filed with the Secretary of State of the State of Delaware or such
later time as may be specified in the First Certificate of Merger as mutually agreed by Parent and the Stockholder Representative
(such date and time hereinafter referred to as the “First Effective Time”). Immediately following the First
Effective Time, the First Surviving Company and Merger Sub II shall cause a certificate of merger in customary form as reasonably
agreed by the Parties (the “Second Certificate of Merger”), to be filed with the Secretary of State of the State
of Delaware in accordance with the relevant provisions of the DGCL and shall make all other filings required under the DGCL. The
Second Merger shall become effective at the time the Second Certificate of Merger shall have been duly filed with the Secretary
of State of the State of Delaware or such later time as may be specified in the Second Certificate of Merger as mutually agreed
by Parent and the Stockholder Representative (such date and time hereinafter referred to as the “Second Effective Time”).


 


2.2            Closing.
Subject to the satisfaction of the conditions set forth in this Agreement (or the waiver thereof by the Party entitled to
waive any such condition), the closing of the transactions contemplated by this Agreement (the “Closing”)
will take place at 10:00 a.m., New York City time, by the electronic exchange of executed documents or, if mutually agreed by
the Parties, at the offices of Willkie Farr & Gallagher LLP, 787 Seventh Avenue, New York, New York 10019, in either case
on the second (2nd) Business Day after the satisfaction or waiver of each condition to the Closing set forth in Article
VII (other than conditions that by their nature are to be satisfied by actions taken at the Closing, but subject to the
satisfaction or waiver of such conditions), unless another time or date, or both, is agreed to in writing by the Parent and
Company; provided, however, that without the consent of Parent, the Closing shall not occur prior to January
31, 2021.  Notwithstanding the foregoing, if the Marketing Period has not ended at the time of the satisfaction or
waiver of the conditions set forth in Article VII (other than conditions that by their nature are to be satisfied by
actions taken at the Closing, but subject to the satisfaction or waiver of such conditions), then the Closing shall occur
instead on the date following the satisfaction or waiver of such conditions that is the earlier to occur of (a) any Business
Day during the Marketing Period as may be specified by Parent on no less than two (2) Business Days’ prior written
notice to the Company and (b) the second (2nd) Business Day following the final day of the Marketing Period. The
date on which the Closing will occur is referred to in this Agreement as the “Closing Date.”


 






    14


     


    

 


2.3           
Deliveries at Closing.


 


(a)          
By Company. Subject to the terms and conditions of this Agreement, at the Closing, Company shall execute and deliver,
or cause to be executed and delivered, each of the following documents (where the execution or delivery of the documents is contemplated),
deliver, or cause to be delivered, each of the following items (where the delivery of the items is contemplated), and will take
or cause to be taken, each of the following actions (where the taking of action is contemplated), in each case, to the Parent (unless
otherwise specified):


 


(i)                    
a customary payoff letter (each, a “Payoff Letter”), in form and substance reasonably satisfactory to
Parent, and related release and/or termination documents from each financial institution or other lender (or the agents representing
the foregoing) to which the Company or any of its Subsidiaries is obligated with respect to the repayment of Borrowed Money Debt
confirming (x) the total payment required to be made as of the Closing Date to repay in full all Borrowed Money Debt, including
all principal, interest, fees, prepayment premiums and penalties, if any (the aggregate of all such amounts being referred to as
the “Payoff Amount”), together with pay-off instructions for making such repayment on the Closing Date, and
(y) that upon payoff of such amounts, all obligations and all Liens securing such Borrowed Money Debt will be satisfied, discharged
and terminated and/or released;


 


(ii)                   
final invoices or estimates with respect to the Selling Expenses (described in clause (a) of the definition thereof) and
the instructions for paying the same;


 


(iii)                   
a certificate, dated as of the Closing Date, executed by an authorized officer of Company (in his or her capacity as such
and not individually) certifying that the conditions set forth in Section ‎7.1(a), Section ‎7.1(b)
and Section ‎7.1(e) have been satisfied;


 


(iv)                  
the First Certificate of Merger, duly executed by the Company;


 


(v)                    
a properly executed statement, dated as of the Closing Date, that satisfies the requirements of Treasury Regulations Section
1.1445-2(c)(3), together with the required notice to the IRS pursuant to Treasury Regulations Section 1.897-2(h) and written authorization
for Parent to deliver such notice and a copy of such statement to the IRS on behalf of the Company upon the Closing;


 


(vi)                  
a certificate, dated the Closing Date, duly executed by an authorized executive officer of the Company, certifying that
true and complete copies of resolutions of the Company’s board of directors authorizing the execution and delivery of this
Agreement and the performance by the Company of its obligations hereunder as in effect on the Closing Date, are attached to such
certificate;


 


(vii)                 
evidence with respect to the resignation or removal of the directors and officers of the Company and its Subsidiaries if
and to the extent identified in writing by the Parent at least two (2) Business Days prior to the Closing Date;


 






    15


     


    

 


(viii)                
[INTENTIONALLY OMITTED];


 


(ix)                   
evidence of the valid termination of each of the Contracts listed on Section‎ 2.3(a)(ix) of the Disclosure
Schedule;


 


(x)                    
a certificate of good standing of the Company, dated no more than thirty (30) days prior to the Closing, issued by the Secretary
of State of the State of Delaware (or the equivalent entity); and


 


(xi)                  
the Escrow Agreement, duly executed by the Stockholder Representative.


 


(b)          
By Parent. Subject to the terms and conditions of this Agreement, at the Closing, Parent shall execute and deliver,
or cause to be executed and delivered, each of the following documents (where the execution or delivery of the documents is contemplated),
deliver, or cause to be delivered, each of the following items (where the delivery of other items is contemplated) and take, or
cause to be taken, each of the following actions (where the taking of action is contemplated), in each case, to the Stockholder
Representative (unless otherwise specified):


 


(i)                     
a certificate, dated as of the Closing Date, executed by an authorized officer of Parent (in his or her capacity as such
and not individually) certifying that the conditions set forth in Section ‎7.2(a), Section ‎7.2(b)
and Section ‎7.2(e) have been satisfied;


 


(ii)                     Parent
or Merger Sub shall (i) deposit, or cause to be deposited, with the Paying Agent an amount of cash sufficient to pay the sum
of (A) the aggregate Per Share Cash Consideration to be paid to the holders of Company Capital Stock who are not Accredited
Investors pursuant to Section ‎2.4(a), plus (B) the aggregate Common Per Share Cash Amount payable
to holders of Company Capital Stock who are Accredited Investors, plus (C) cash to be paid in lieu of fractional
shares of Share Consideration pursuant to Section ‎2.8(c), less (D) the portion of the Adjustment
Escrow Deposit attributable to holders of Company Capital Stock based on all such holders’ Pro Rata Shares, less
(E) the portion of the Special Escrow Deposit attributable to holders of Company Capital Stock based on all such
holders’ Pro Rata Shares, less (F) the portion of the Representative Expense Amount attributable to holders of
Company Capital Stock based on all such holders’ Pro Rata Shares, (ii) deposit with, cause to be deposited with or
otherwise cause the Second Surviving Company to have, an amount of cash sufficient to pay the Option Cash Amount and (iii)
instruct Parent’s transfer agent to deliver to the Paying Agent a number of shares of Share Consideration equal to the
aggregate Common Per Share Stock Issuance Amount payable to holders of Company Capital Stock who are Accredited Investors to
pay the aggregate consideration to which holders of Company Capital Stock shall be entitled at the First Effective Time
pursuant to Section ‎2.4 or Section ‎2.5 of this Agreement, as applicable;


 






    16


     


    

 


(iii)                  
Parent shall pay by wire transfer of immediately available funds pursuant to instructions given by the Escrow Agent, (A)
to the Adjustment Escrow Account, the Adjustment Escrow Deposit and (B) to the Special Escrow Account, the Special Escrow Deposit;


 


(iv)                   Parent
shall pay by wire transfer of immediately available funds to the Stockholder Representative, pursuant to instructions given by
the Stockholder Representative, the Representative Expense Amount;


 


(v)                    Parent
shall pay by wire transfer of immediately available funds, on behalf of Company, the Selling Expenses according to instructions
furnished by Company in writing by Company in the Estimated Closing Statement;


 


(vi)                  
Parent shall pay by wire transfer of immediately available funds, pursuant to instructions in the Payoff Letters, the Payoff
Amount;


 


(vii)                 
a counterpart to a joinder to the Amended and Restated Registration Rights Agreement executed by Parent in favor of each
Accredited Investor that has delivered an executed joinder to the Amended and Restated Registration Rights Agreement to Parent;
and


 


(viii)                 
the Escrow Agreement, duly executed by Parent.


 


Notwithstanding anything
to the contrary in the foregoing, Parent may, in lieu of certain of the payments required to be paid by Parent under this Section
 ‎2.3(b), cause the Company to pay such amounts using the Cash on Hand of the Company.


 


(c)           
By Escrow Agent. The Parties will request that the Escrow Agent execute and deliver the Escrow Agreement to Parent
and Company at the Closing.


 


2.4          
First Merger Conversion of Securities. At the First Effective Time, by virtue of the First Merger and without any
action on the part of Parent, Merger Sub, Merger Sub II, the Company, the holders of any of the following securities or any other
Person:


 


(a)           Conversion
of Company Common Stock. Each share of Company Common Stock issued and outstanding immediately prior to the First
Effective Time but excluding any shares of Company Common Stock issuable to holders of Company Options that is held by a
Person who is an Accredited Investor, other than shares of Company Common Stock to be cancelled pursuant to Section
 ‎2.4(c) or Dissenting Shares, shall be converted solely into the right to receive the Per Share Mixed Consideration
(including, for the avoidance of doubt, amounts distributable to such Company Stockholder in respect of such Company Common
Stock pursuant to Sections 2.9, 8.4(a) and 10.10(g)) upon surrender of such shares of Company Common
Stock in accordance with Section ‎2.5. Each share of Company Common Stock issued and outstanding immediately
prior to the First Effective Time (but excluding any shares of Company Common Stock issuable to holders of Company Options)
that is held by a Person who is not an Accredited Investor, other than shares of Company Common Stock to be cancelled
pursuant to Section ‎2.4(c) or Dissenting Shares, shall be converted solely into the right to receive the Per
Share Cash Consideration (including, for the avoidance of doubt, amounts distributable to such Company Stockholder in respect
of such Company Common Stock pursuant to Sections 2.9, 8.4(a) and 10.10(g)) upon surrender of such
shares of Company Common Stock in accordance with Section ‎2.5. As of the First Effective Time, all shares of
Company Common Stock but excluding any shares of Company Common Stock issuable to holders of Company Options shall no longer
be outstanding and shall automatically be cancelled and shall cease to exist, and shall thereafter represent only the right
to receive the Per Share Mixed Consideration or the Per Share Cash Consideration, as applicable, to be paid in accordance
with Section ‎2.5 (other than Dissenting Shares which shall be entitled only to those rights set forth in Section
 ‎2.6(a)).


 






    17


     


    

 


(b)          
Conversion of Company Series C Preferred Stock. Each share of Company Series C Preferred Stock issued and outstanding
immediately prior to the First Effective Time that is held by an Accredited Investor, other than shares of Company Series C Preferred
Stock to be cancelled pursuant to Section ‎2.4(c) or Dissenting Shares, shall be converted solely into the right to
receive an amount equal to the product of (A) multiplied by (B), where (A) is the aggregate number of shares of Company
Common Stock issuable upon the conversion of such share of Company Series C Preferred Stock outstanding as of immediately prior
to the First Effective Time, and (B) is the Per Share Mixed Consideration (including, for the avoidance of doubt, amounts distributable
to such Company Stockholder in respect of such Company Common Stock pursuant to Sections 2.9, 8.4(a) and 10.10(g)),
in each case, upon surrender of such share of Company Series C Preferred Stock in accordance with Section ‎2.5. As
of the First Effective Time, all shares of Company Series C Preferred Stock and all shares of Company Common Stock into which such
shares of Company Series C Preferred Stock are convertible as described in the immediately preceding sentence shall no longer be
outstanding and shall automatically be cancelled and shall cease to exist, and shall thereafter represent only the right to receive
the foregoing consideration to be paid in accordance with Section ‎2.5 (other than Dissenting Shares which shall be
entitled only to those rights set forth in Section ‎2.6(a)).


 


(c)           
Cancellation of Certain Company Capital Stock. Each issued and outstanding share of Company Capital Stock held by
the Company as treasury stock immediately prior to the First Effective Time shall automatically be cancelled and shall cease to
exist, and no consideration or payment shall be delivered in exchange therefor or in respect thereof.


 


(d)          
Effect on Merger Sub Equity. Each share of common stock of Merger Sub issued and outstanding immediately prior to
the First Effective Time shall automatically be converted into and become one fully paid and nonassessable share of common stock,
par value $0.01 per share, of the First Surviving Company and shall constitute the only outstanding shares of capital stock of
the First Surviving Company.


 


(e)           Reduction
of Consideration. Notwithstanding the foregoing, a portion of the cash consideration payable to each Stockholder pursuant
to Section ‎2.4(a) or Section ‎2.4(b) shall be reduced pursuant to the escrow provisions of Section
 ‎2.7 hereof and shall be subject to adjustment as provided herein.


 


(f)           
No Interest. No interest will be paid or accrued, and no Stockholder shall be entitled to receive, any interest upon
surrender of any Company Capital Stock.


 






    18


     


    

 


(g)          
Allocation. The parties acknowledge and agree that the purpose and intent of this Section ‎2.4 is to
allocate the consideration payable hereunder in accordance with the terms of the Company’s Charter Documents.


 


2.5           
Payment for Securities.


 


(a)          
Paying Agent. Promptly following the date hereof, Parent and the Company shall engage a reputable bank, trust or
administrator company reasonably acceptable to the Parent and the Company, or Parent’s transfer agent, to act as the paying
agent for purposes of effecting the payment of the cash consideration in connection with the First Merger (other than with respect
to compensatory payments for Tax purposes) (the “Paying Agent”). Parent and the Company shall each be responsible
for one-half of the fees and expenses of the Paying Agent.


 


(b)           Procedures
for Surrender of Certificates. As soon as practicable after the First Effective Time, to the extent not previously
delivered, Parent shall cause the Paying Agent to mail to each Person that was, immediately prior to the First Effective
Time, a holder of record of Company Capital Stock, which shares of Company Capital Stock were converted into the right to
receive the consideration set forth in Section ‎2.4 at the First Effective Time, and who has not returned a
Stock Letter of Transmittal and the physical certificates or instruments that immediately prior to the First Effective Time
represented issued and outstanding Company Capital Stock (the “Certificates” and each, a
 “Certificate”) to the Paying Agent prior to the Closing Date: (A) a letter of transmittal substantially in
the form attached hereto as Exhibit F (a “Stock Letter of Transmittal”); and (B) instructions for
effecting the surrender of such holder’s Certificates (or affidavits of loss in lieu of Certificates as provided in Section ‎2.5(e))
in exchange for payment of the cash consideration set forth in Section ‎2.4. Upon surrender of a Certificate (or
affidavit of loss in lieu of the Certificate as provided in Section‎ 2.5(e)) to the Paying Agent, and upon
delivery of a Stock Letter of Transmittal, in accordance with the terms of such Stock Letter of Transmittal, duly executed
and in proper form, with respect to such Certificates, the holder of such Certificate shall be entitled to receive in
exchange therefor the consideration set forth in Section ‎2.4 for each share of Company Capital Stock formerly
represented by such Certificate, and any Certificate so surrendered shall forthwith be cancelled. If payment of such
consideration is to be made to a Person other than the Person in whose name any surrendered Certificate is registered, it
shall be a condition precedent of payment that the Certificate so surrendered shall be properly endorsed or shall be
otherwise in proper form for transfer, and the Person requesting such payment shall have paid any transfer and other similar
Taxes required by reason of the payment of the consideration to a Person other than the registered holder of the Certificate
so surrendered and shall have established to the reasonable satisfaction of Parent that such Taxes either have been paid or
are not required to be paid. Until surrendered or cancelled as contemplated hereby, each Certificate shall be deemed at any
time after the First Effective Time to represent only the right to receive the consideration set forth in Section
 ‎2.4, except for Certificates representing shares of Company Capital Stock held by holders of Dissenting Shares,
which shall be deemed to represent the right to receive payment of the fair value of such shares of Company Capital Stock in
accordance with and to the extent provided by Section 262 of the DGCL.


 


(c)          
Transfer Books; No Further Ownership Rights in Company Capital Stock. At the First Effective Time, the stock transfer
books of the Company shall be closed and no transfer of shares of Company Capital Stock shall thereafter be made. If, after the
First Effective Time, Certificates are presented to Parent or any Surviving Company for any reason, they shall be cancelled and
exchanged as provided in this Agreement. From and after the First Effective Time, each holder of shares of Company Capital Stock
outstanding immediately prior to the First Effective Time shall cease to have any rights as a stockholder of the Company, except
for, in the case of a holder of Company Capital Stock (other than shares to be cancelled pursuant to Section ‎2.4(c)
or Dissenting Shares), the right to surrender such holder’s shares of Company Capital Stock in accordance with this Section
 ‎2.5 in exchange for the consideration set forth in Section ‎2.4, or in the case of a holder of Dissenting
Shares, the right to perfect such holder’s right to receive payment pursuant to Section 262 of the DGCL.


 






    19


     


    

 


(d)          
Termination of Fund; Abandoned Property; No Liability. Any portion of the funds (including any interest received
with respect thereto) and Share Consideration made available to the Paying Agent at the Closing that remains unclaimed by the holders
of Certificates on the first anniversary of the First Effective Time will be returned to Parent or an Affiliate thereof designated
by Parent, upon demand, and any such holder who has not prior to such time provided a duly executed Stock Letter of Transmittal
to Parent and/or has not tendered its Certificates for the consideration set forth in Section ‎2.4, in each case in
accordance with Section ‎2.5(b), shall thereafter look only to Parent (subject to abandoned property, escheat or other
similar Legal Requirements) for delivery of such consideration, without interest, in respect of such holder’s surrender of
such holder’s Certificates in compliance with the procedures in Section ‎2.5(b). Any consideration remaining
unclaimed by the holders of Certificates immediately prior to such time as such amounts would otherwise escheat to, or become property
of, any Governmental Entity will, to the extent permitted by applicable Legal Requirements, become the property of Parent or an
Affiliate thereof designated by Parent, free and clear of any claim or interest of any Person previously entitled thereto. Notwithstanding
the foregoing, none of Parent, Merger Sub, Merger Sub II, the Surviving Companies, the Paying Agent or their respective Affiliates
will be liable to any holder of Certificates for consideration delivered to a public official pursuant to any applicable abandoned
property, escheat or similar Legal Requirements. Any portion of the consideration made available to the Paying Agent to pay for
shares of Company Capital Stock for which appraisal rights have been perfected shall be returned to Parent or an Affiliate thereof
designated by Parent upon demand.


 


(e)           
Lost, Stolen or Destroyed Certificates. In the event that any Certificates shall have been lost, stolen or destroyed,
the Paying Agent shall issue in exchange for such lost, stolen or destroyed Certificates, upon the making of a customary affidavit
(containing customary indemnification obligations) of that fact by the holder thereof, the consideration payable in respect thereof
pursuant to Section ‎2.4 (subject to the delivery of a Stock Letter of Transmittal in accordance with Section
2.5(b)).


 






    20


     


    

 


2.6           
 Dissenting Shares.


 


(a)           
Notwithstanding anything in this Agreement to the contrary (but subject to the provisions of this Section ‎2.6),
shares of Company Capital Stock outstanding immediately prior to the First Effective Time and held by a holder who is entitled
to demand and has properly demanded appraisal for such shares of Company Capital Stock in accordance with, and who complies in
all respects with, Section 262 of the DGCL (such shares of Company Capital Stock, the “Dissenting Shares”)
shall not be converted into the right to receive the consideration set forth in Section ‎2.4. At the First Effective
Time, all Dissenting Shares shall be cancelled and cease to exist, and the holders of Dissenting Shares shall only be entitled
to the rights granted to them under Section 262 of the DGCL, subject to the immediately following sentence. If any such holder
fails to perfect or otherwise waives, withdraws or loses such holder’s right to appraisal under Section 262 of the DGCL,
then such Dissenting Shares shall be deemed to have been converted, as of the First Effective Time, into, and shall represent only,
the right to receive (upon surrender in accordance with Section ‎2.5) the consideration set forth in Section ‎2.4,
without interest.


 


(b)          
Prior to the Closing Date, the Company shall give Parent (i) prompt notice of any written demand for appraisal received
by the Company pursuant to the applicable provisions of the DGCL (and of any similar demand purportedly made under other applicable
Legal Requirements) and (ii) the opportunity to participate in all negotiations and proceedings with respect to such demands. Prior
to the Closing Date, the Company shall not, except with the prior written consent of Parent (not to be unreasonably withheld, delayed
or conditioned), make any payment with respect to any such demands or offer to settle or settle any such demands other than as
required by Legal Requirements or pursuant to a final court order. Prior to the Closing Date, any written communication to be made
by the Company to any holder of Company Capital Stock with respect to such demands shall be submitted to Parent in advance and
the Company shall consider in good faith any input from Parent with regards to such written communication.


 


2.7           
Treatment of Company Options.


 


(a)           
At the First Effective Time, by virtue of the First Merger and without any action on the part of Parent, Merger Sub, Merger
Sub II, the Company, the Company Optionholders or any other Person, each Vested Company Option shall be converted into the right
to receive the Option Consideration (as further described in Sections ‎2.7(b) and ‎2.7(c)) with respect
to each such Vested Company Option (including, for the avoidance of doubt, if applicable, amounts distributable to such Company
Optionholder in respect of such Vested Company Option pursuant to Sections 2.9, 8.4(a) and 10.10(g)). Each
Company Option that is not a Vested Company Option shall be cancelled as of immediately prior to the First Effective Time and shall
cease to exist (including for all computations required by this Agreement), and no consideration shall be delivered in exchange
therefor. For the avoidance of doubt, each Company Option shall, as of the First Effective Time, cease to be outstanding and shall
automatically be canceled and retired and shall cease to exist, whether or not the holder of such Company Option is entitled to
any consideration under this Section ‎‎2.7.


 


(b)           At
the First Effective Time, by virtue of the First Merger and without any action on the part of Parent, Merger Sub, Merger Sub
II, the Company, the Company Optionholders or any other Person, each Vested Company Option that is a Vested Substitute Option
shall be assumed by Parent and automatically substituted with a non-qualified stock option (each, a “Parent
Option”) to purchase a number of shares of Class A Common Stock equal to, rounded down to the nearest whole
share of Class A Common Stock, (i) the total number of shares of Company Common Stock underlying such Vested
Substitute Option, multiplied by (ii) a ratio, the numerator of which is the Common Per Share Amount and the
denominator of which is the Parent Stock Value (such ratio, the “Exchange Ratio”), with each Parent
Option having a per share exercise price equal to, rounded up to the nearest cent, (A) the exercise price per share of
Company Common Stock underlying such Vested Substitute Option, divided by (B) the Exchange Ratio. The conversion
and substitution of the Vested Substitute Options hereunder is intended to comply with Section 409A of the Code and the
applicable regulations thereunder (including Treas. Reg. Section 1.409A-1(b)(5)(v)(D)) and, for the avoidance of doubt, each
Parent Option shall otherwise continue to have and be subject to substantially the same terms and conditions as were
applicable to such Vested Substitute Option immediately before the First Effective Time (including, but not limited to,
expiration date and exercise provisions). The shares of Class A Common Stock subject to the Parent Options will be
granted pursuant to the Stock Plan and are intended to be exempt from shareholder approval in accordance with Nasdaq listing
rule 5635(c)(3) and shall not count against the share reserve under the Stock Plan.


 






    21


     


    

 


(c)          
The Cash Option Consideration payable to the holders of Vested Cash-Out Options pursuant to Section ‎2.7(a)
(less (x) the amount, with respect to the applicable holder, equal to such holder’s Pro Rata Share of the Adjustment Escrow
Deposit, (y) the amount, with respect to the applicable holder, equal to such holder’s Pro Rata Share of the Special Escrow
Deposit and (z) the amount, with respect to the applicable holder, equal to such holder’s Pro Rata Share of the Representative
Expense Amount, in each case, pursuant to Section‎ 3.1) (in the aggregate, the “Option Cash Amount”)
shall be paid (i) in respect of each Vested Cash-Out Option that is an Employee Option, through the Second Surviving Company’s
payroll system (or the payroll system of Parent or a Subsidiary of Parent), less any required withholding Taxes in accordance with
Section‎ 2.10, no later than the first regularly scheduled payroll date of the Company that is at least five (5) Business
Days following the Second Effective Time, and (ii) in respect of each Vested Cash-Out Option that is a Non-Employee Option, directly
by the Second Surviving Company (or Parent or a Subsidiary of Parent) within five (5) Business Days following the Second Effective
Time.


 


(d)          
Prior to the First Effective Time, the board of directors of the Company (or, if appropriate, any committee thereof) shall
adopt appropriate resolutions and the Company shall take, or cause to be taken, all other actions reasonably necessary or appropriate,
including obtaining any required consents and providing any required notices (whether under the Company Equity Plan or otherwise)
to effect the transactions described in this Section ‎2.7, and to ensure that no holder of Company Options shall have
any rights from and after the First Effective Time with respect to any Company Options to acquire any Company Capital Stock or
to receive any payment, right or benefit with respect to any award previously granted under the Company Equity Plan, except the
right to receive a payment with respect thereto as provided in this Section ‎2.7 and Section‎ 2.9, as
applicable.


 






    22


     


    

 


2.8           
 Excess Capital Equipment Adjustment; Estimated Aggregate Merger Consideration; Parent Stock.


 


(a)          
Excess Capital Equipment Adjustment. The Company shall engage a nationally-recognized or regionally-recognized independent
accounting firm to conduct a physical count of all of the Excess Capital Equipment within ten (10) days prior to the Closing, which
physical count may be observed by Parent and its accounting advisors if in compliance with applicable Legal Requirements (including,
if applicable, by allowing the Parent and its accounting advisors to observe by electronic video means). The parties acknowledge
and agree that the Excess Capital Equipment will be valued in accordance with GAAP, using a lower of cost or market methodology,
which value shall be the “Excess Capital Equipment Adjustment”; provided, that in no event shall the
Excess Capital Equipment Adjustment exceed $9,639,062. The Excess Capital Equipment Adjustment shall be deemed to be final and
binding on the Parties and shall not be subject to adjustment pursuant to Section ‎2.9.


 


(b)           Estimated
Aggregate Merger Consideration. At least five (5) Business Days prior to the Closing Date, the Company shall deliver to
Parent a statement (the “Estimated Closing Statement”) setting forth (i) the Company’s good faith
estimate of (A) the Selling Expenses (the “Estimated Selling Expenses”), (B) the Closing Indebtedness (the
 “Estimated Closing Indebtedness”), (C) the Closing Cash (the “Estimated Closing Cash”),
(D) the Net Working Capital as of the Measurement Time, (E) the Net Working Capital Adjustment Amount as of the Measurement
Time (the “Estimated Net Working Capital Adjustment Amount”), (F) the M&A Costs and the M&A
Adjustment (the “Estimated M&A Adjustment”), (G) the Excess Capital Equipment Adjustment determined
pursuant to Section ‎ 2.8(a)and (H) the Provider Relief Adjustment, and based thereon the calculation of the
Estimated Aggregate Merger Consideration, and (ii) wire instructions for repayment of the Estimated Selling Expenses
described in clause (a) of the definition of Selling Expenses. The Estimated Closing Statement shall be accompanied by a
schedule showing the Company’s reasonably detailed calculation of the items set forth thereon. The Company shall
provide Parent with supporting documentation reasonably requested and shall afford Parent and its representatives reasonable
access during normal business hours to the financials, books, and records pertaining to the Company and its Subsidiaries and
to the Company’s and its Subsidiaries’ accountants (subject to the execution of any access letters that such
accountants may reasonably require in connection with the review of such work papers) and employees, in each case to the
extent reasonably necessary, for Parent to evaluate the Estimated Closing Statement and the calculations set forth therein; provided,
that neither the Company nor any of its Subsidiaries shall have any obligation to provide information or access to
information, materials or persons if doing so would reasonably be expected to (i) interfere unreasonably with the conduct of
the Business, (ii) result in the waiver of any attorney-client privilege or (iii) violate any applicable Legal Requirement.
The Company shall consider in good faith and update the Estimated Closing Statement to reflect any mutually agreed comments
by Parent on such Estimated Closing Statement with which it agrees (acting in good faith); provided, that the Closing
shall not be delayed if Parent and the Company are unable to agree on any such comments, and in the case of any such
disagreement, the estimated numbers and calculations proposed by the Company shall be used for purposes of determining the
Estimated Aggregate Merger Consideration (without limiting any of the provisions of this Agreement, including Section
2.9).


 


(c)           
Share Consideration. To determine the type of Share Consideration received hereunder, the following priority shall
be used: first (A) the holders of Vested Substitute Options shall receive Parent Options to purchase Class A Common Stock, then
(B) each Company Stockholder that is an Accredited Investor shall be allocated the remaining Common Stock Share Consideration pro
rata based on the number of shares of shares of Company Common Stock held by each such Company Stockholder (rounded down to the
nearest whole number of shares of Class A Common Stock resulting therefrom for each such Company Stockholder), then (C) each Company
Stockholder shall receive its remaining Share Consideration (including the incremental portion that was rounded down in clause
(B) hereof) as Series C Preferred Stock (rounded down to the nearest whole number of Class A Common Stock into which such Series
C Preferred Stock is convertible (without taking into account the Share Cap (as defined in the Certificate of Designations)) for
each such Company Stockholder (i.e. rounded down to the nearest one-hundredth of a share of Series C Preferred Stock)), and (D)
any amounts rounded down in clause (C) shall be paid in cash in an amount equal to (x) the fraction of a share of Series C Preferred
Stock that was rounded down, multiplied by (y) the Conversion Rate, multiplied by (z) the Parent Stock Value.


 






    23


     


    

 


2.9           
Closing Date Estimates and Post-Closing Reconciliation.


 


(a)          
At least five (5) Business Days prior to the Closing Date, the Company shall deliver to Parent a schedule (the “Closing
Consideration Schedule”), which schedule shall be certified as complete and correct by an officer of the Company and
which shall accurately set forth as of such date and based upon the Estimated Closing Statement:


 


(i)                     
the Common Per Share Amount;


 


(ii)                   
all Common Stockholders and their respective email and physical addresses (to the extent known to the Company), the number
of shares of Company Common Stock held by each Common Stockholder, including their respective Certificate numbers, whether each
such Common Stockholder is an Accredited Investor and the aggregate consideration to be paid to each Common Stockholder pursuant
to Section ‎2.4 at the Closing, including the cash amount and number of shares of Share Consideration (as allocated
in accordance with Section 2.8(c), together with the amount of cash to be paid in lieu of any fractional shares in accordance
with Section 2.8(c)) to be delivered to each Common Stockholder who is an Accredited Investor or the cash amount to be delivered
to each Common Stockholder who is not an Accredited Investor, as applicable;


 


(iii)                   all
Series C Preferred Stockholders and their respective email and physical addresses (to the extent known to the Company), the
number of shares of Company Series C Preferred Stock held by each Series C Preferred Stockholder (including their respective
Certificate numbers) and the aggregate consideration to be paid to each Series C Preferred Stockholder pursuant to Section ‎2.4
at the Closing, including the cash amount and number of shares of Share Consideration (as allocated in accordance with Section
2.8(c), together with the amount of cash to be paid in lieu of any fractional shares in accordance with Section
2.8(c)) to be delivered to each Series C Preferred Stockholder;


 


(iv)                  
all Company Optionholders and their respective email and physical addresses (to the extent known to the Company), along
with (A) the number of shares of Company Common Stock underlying each Company Option held by such Company Optionholder as
of the Closing (including, as applicable, whether each such Company Option is a Vested Company Option (and, if so, whether such
Vested Company Option is a Vested Cash-Out Option or Vested Substitute Option) or an Employee Options or Non-Employee Option),
(B) the exercise price per share of Company Common Stock underlying each such Company Option, (C) whether each such Company Optionholder
is an Accredited Investor, and (D) the Company’s calculation of the applicable Option Consideration payable at the Closing,
if any, to be delivered to such Company Optionholder, including the number of Parent Options to be granted to such Company Optionholder
(if any) and the exchange ratio applicable to such Parent Options;


 






    24


     


    

 


(v)                    the
percentage of the Adjustment Escrow Deposit contributed by each Company Equityholder based on their Pro Rata Share;


 


(vi)                   the
percentage of the Special Escrow Deposit contributed by each Company Equityholder based on their Pro Rata Share;


 


(vii)                 
the percentage of the Representative Expense Amount contributed by each Company Equityholder based on their Pro Rata Share;
and


 


(viii)               
the percentage of any amount to be paid by Parent pursuant to Section‎ 2.9(b)(v) payable to each Company
Equityholder based on their Pro Rata Share.


 


Parent shall be entitled
to rely conclusively on the Closing Consideration Schedule, and, as between the Common Stockholders, Series C Preferred Stockholders,
and Company Optionholders, on the one hand, and Parent, the First Surviving Company and the Second Surviving Company, on the other
hand, any amounts delivered by Parent, the First Surviving Company or the Second Surviving Company to any Common Stockholders,
Series C Preferred Stockholders, Company Optionholders or delivered by Parent to the Paying Agent for delivery in accordance with
the Closing Consideration Schedule in effect from time to time shall be deemed for all purposes to have been delivered to the applicable
Common Stockholders, Series C Preferred Stockholders, Company Optionholders in full satisfaction of Parent’s obligations
under this Article ‎II.


 


(b)          
Post-Closing Reconciliation.


 


(i)                     As
promptly as practicable, but no later than ninety (90) days following the Closing Date, Parent will prepare and deliver to
the Stockholder Representative a statement (the “Closing Statement”) setting forth Parent’s good
faith calculation of: (i) the Selling Expenses; (ii) the Closing Indebtedness; (iii) the Closing Cash; (iv) the Net
Working Capital (as of the Measurement Time); (v) the Net Working Capital Adjustment Amount (as of the Measurement Time, in a
manner consistent with and using only those specific line items set forth in the Preparation Methodology); (vi) the M&A
Costs and the M&A Adjustment; (vii) the Final Provider Relief Adjustment and (viii) the Excess Capital Equipment
Adjustment determined pursuant Section ‎ 2.8(a), and based thereon a
calculation of the Aggregate Merger Consideration.


 






    25


     


    

 


The Closing Statement
and the components thereof (and all calculations of Net Working Capital, the Net Working Capital Adjustment Amount, Closing Cash,
Closing Indebtedness, Selling Expenses, M&A Costs, the M&A Adjustment, Final Provider Relief Adjustment and Aggregate Merger
Consideration) shall be prepared and calculated in accordance with GAAP, the Preparation Methodology, and the definitions herein,
except that the Closing Statement and the components thereof (and all calculations of Net Working Capital, the Net Working Capital
Adjustment Amount, Closing Cash, Closing Indebtedness, Selling Expenses, M&A Costs, the M&A Adjustment, Final Provider
Relief Adjustment and Aggregate Merger Consideration) shall: (A) not include any purchase accounting or other adjustment arising
out of the consummation of the transactions contemplated by this Agreement; be based on facts and circumstances as they exist immediately
prior to the Closing and shall exclude the effect of any act, decision or event occurring on or after the Closing except to the
extent such act, decision or event provides information about circumstances that existed immediately prior to Closing; and (B)
not reflect, directly or indirectly, any additional reserve or accrual that is not reflected on the Latest Balance Sheet, except
those that (1) result from material developments occurring after the date of the Latest Balance Sheet but prior to the Closing
or (2) would be required to be reflected on the face of a balance sheet prepared in accordance with GAAP, the Preparation Methodology,
and the definitions herein. The Parties agree that the purpose of preparing the Closing Statement and components thereof (and all
calculations of Net Working Capital, the Net Working Capital Adjustment Amount, Closing Cash, Closing Indebtedness, Selling Expenses,
M&A Costs, the M&A Adjustment, Final Provider Relief Adjustment and Aggregate Merger Consideration) is solely to assess
the accuracy of the amounts depicted in the Closing Statement and the calculation of the Aggregate Merger Consideration derived
therefrom, and such processes are not intended to permit the introduction of different accounting methods, policies, practices,
procedures, conventions, categorizations, definitions, principles, judgments, assumptions, techniques or estimation methods with
respect to financial statements, their classification or presentation or otherwise (including with respect to the nature of accounts,
level of reserves or level of accruals) from those used to calculate the amounts set forth in the Preparation Methodology.


 


(ii)                     During
the thirty (30) days after delivery of the Closing Statement, Parent will provide the Stockholder Representative and its
accountants with reasonable supporting documentation and reasonable access, during normal business hours and upon reasonable
notice, to (x) review the financial books and records of the Second Surviving Company, any of Parent’s
accountants’ work papers related to the calculation of amounts related to the Closing Statement (subject to the
execution of any access letters that such accountants may reasonably require in connection with the review of such work
papers), and (y) the employees and other representatives of Parent who were responsible for the preparation of the Closing
Statement to respond to questions relating to the preparation of the Closing Statement and the calculation of the items
thereon, in each case solely to allow the Stockholder Representative to determine the accuracy of Parent’s calculation
of the items set forth on the Closing Statement. Neither Parent nor any of its Subsidiaries shall have any obligation to
provide information or access to information, materials or persons if doing so would reasonably be expected to (i) interfere
unreasonably with the conduct of the Business, (ii) result in the waiver of any attorney-client privilege or the disclosure
of any trade secrets or (iii) violate any applicable Legal Requirement. If the Stockholder Representative disagrees with any
of Parent’s calculations set forth in the Closing Statement, the Stockholder Representative may, within thirty (30)
days after delivery of the Closing Statement, deliver a written notice (the “Objection Notice”) to Parent
disagreeing with such calculations. Any Objection Notice shall specify those items or amounts with which the Stockholder
Representative disagrees, together with a reasonably detailed written explanation of the reasons for disagreement with each
such item or amount, and shall set forth the Stockholder Representative’s calculation, based on such objections, of the
Selling Expenses, the Closing Indebtedness, the Closing Cash, the Net Working Capital as of the Measurement Time and the Net
Working Capital Adjustment Amount as of the Measurement Time, the M&A Costs and the M&A Adjustments, the Excess
Capital Adjustment determined pursuant to Section ‎ 2.8(a), the
Final Provider Relief Adjustment, and based thereon a calculation of the Aggregate Merger Consideration. To the extent not
set forth in the Objection Notice, the Stockholder Representative shall be deemed to have agreed with Parent’s
calculation of all other items and amounts contained in the Closing Statement and such amounts shall be final and binding on
the parties. If the Stockholder Representative does not deliver an Objection Notice within such thirty-day period, then the
amounts set forth in the Closing Statement shall be deemed to be final and binding on the parties.


 






    26


     


    

 


(iii)                    If
an Objection Notice is timely delivered pursuant to Section ‎ 2.9(b)(ii), the Stockholder
Representative and Parent shall, during the thirty (30) days following such delivery, use their reasonable best efforts to
reach agreement on the value of the disputed items or amounts. If, during such period, the Stockholder Representative and
Parent are unable to reach agreement on all disputed items, they shall promptly thereafter mutually engage and submit such
dispute to a nationally-recognized or regionally-recognized independent accounting firm as is mutually agreed to by Parent
and the Stockholder Representative (the “Independent Accounting Firm”) for final and binding resolution.
The Independent Accounting Firm (i) shall consider only those items or amounts disputed by the Stockholder Representative in
the Objection Notice which remain in dispute; (ii) shall not assign a value to any item or amount in dispute greater than the
greatest value for such item or amount assigned by the Stockholder Representative, on the one hand, or Parent, on the other
hand, or less than the smallest value for such item or amount assigned by the Stockholder Representative, on the one hand, or
Parent, on the other hand; and (iii) shall act as an expert and not as an arbitrator. The Independent Accounting Firm’s
determination will be based solely on presentations by the Stockholder Representative and Parent which are in accordance with
the guidelines and procedures set forth in this Agreement (i.e., not on the basis of independent review) and the Stockholder
Representative and Parent shall cause the Independent Accounting Firm to deliver to the Stockholder Representative and Parent
as promptly as practicable (but in any event within thirty (30) days of its retention) a written report setting forth its
determination of the amounts in dispute. Such report shall be final and binding on the parties. The cost of such review and
report shall be borne (and paid) by the Stockholder Representative (solely on behalf of the Company Equityholders, in
accordance with the percentages contributed to the Adjustment Escrow Amount set forth on the Closing Consideration Schedule
(which may for convenience be paid by the Stockholder Representative out of the Representative Expense Amount)), on the one
hand, and Parent, on the other hand, based on the percentage which the portion of the contested amount not awarded to each
party bears to the amount actually contested by such party. For example, if closing accounts receivable is the only disputed
item, and Parent claims that closing accounts receivable is $1,000 less than the amount determined by the Stockholder
Representative, and the Stockholder Representative contests only $500 of the amount claimed by Parent, and if the independent
accountant ultimately resolves the dispute by awarding Parent $300 of the $500 contested, then the cost of such review and
report will be allocated 60% (i.e., 300 divided by 500) to the Stockholder Representative (solely on behalf of the Company
Equityholders) and 40% (i.e., 200 divided by 500) to Parent.


 






    27


     


    

 



 


(iv)                  
If the Aggregate Merger Consideration, as finally determined pursuant to this Section‎ 2.9, is less
than the Estimated Aggregate Merger Consideration, then, within five (5) Business Days of the final determination of the Aggregate
Merger Consideration, Parent and the Stockholder Representative shall jointly instruct the Escrow Agent to deliver to Parent the
amount of such difference (the “Shortfall Amount”) from the Adjustment Escrow Account. In the event that the
funds available in the Adjustment Escrow Account are in excess of the Shortfall Amount (such excess, the “Escrow Excess
Amount”), Parent and the Stockholder Representative shall, in the same joint written instruction described in the preceding
sentence, instruct the Escrow Agent to pay the Escrow Excess Amount (i) to the Paying Agent, for further distribution to the Company
Equityholders (other than holders of Vested Company Options that are Employee Options) and (ii) to the Parent for further distribution
to the holders of Vested Company Options that are Employee Options on the next regularly scheduled payment date, through the payroll
system of Parent or a Subsidiary of Parent subject to applicable Tax withholding, in each case based on percentages specified on
the Closing Consideration Schedule. The Company Equityholders shall not have any liability for any amount due pursuant to this
Section‎ 2.9(b)(v) except to the extent of the funds available in the Adjustment Escrow Account.


 


(v)                    
If the Aggregate Merger Consideration, as finally determined pursuant to this Section‎ 2.9, is greater
than the Estimated Aggregate Merger Consideration, then (A) the amount of such excess shall be paid in cash by Parent (1) within
five (5) Business Days of the final determination of the Aggregate Merger Consideration to the Paying Agent, for further distribution
to the Company Equityholders (other than holders of Vested Company Options that are Employee Options) and (2) on the next regularly
scheduled payment date to the holders of Vested Company Options that are Employee Options, through the payroll system of Parent
or a Subsidiary of Parent subject to applicable Tax withholding, in each case, based on the Pro Rata Share of each such Company
Equityholder, and (B) Parent and the Stockholder Representative shall, within five (5) Business Days of the final determination
of the Aggregate Merger Consideration, instruct the Escrow Agent to pay the amount in the Adjustment Escrow Account (1) to the
Paying Agent, for further distribution to the Company Equityholders (other than holders of Vested Company Options that are Employee
Options) and (2) to the Parent for further distribution to the holders of Vested Company Options that are Employee Options on the
next regularly scheduled payment date, through the payroll system of Parent or a Subsidiary of Parent subject to applicable Tax
withholding, in each case, based on the Pro Rata Share of each such Company Equityholder. Parent shall not have any liability for
any amount due pursuant to this Section‎ 2.9(b)(v) in excess of an amount equal to the Adjustment Escrow Deposit.


 


(vi)                  
Any payment(s) made pursuant to this Section‎ 2.9 shall be deemed, for Tax purposes, to be an adjustment
to the cash consideration payable to the Company Equityholders in consideration for the First Merger.


 






    28


     


    

 


2.10       
 Withholding. Merger Sub, Parent, the First Surviving Company, the Second Surviving Company and the Paying Agent,
as the case may be, shall be entitled to deduct and withhold from any amounts otherwise payable pursuant to this Agreement such
amounts as are required to be deducted and withheld with respect to the making of such payment under the Code and the Treasury
Regulations or under any applicable Tax Legal Requirement; provided, however, assuming the Company complies with
its obligations under Section‎ 2.3(a)(v), if either
the Merger Sub, Parent, the First Surviving Company, the Second Surviving Company or the Paying Agent, as applicable, determines
that it is obligated to deduct or withhold any amounts from any non-compensatory consideration payable or otherwise deliverable
pursuant to this Agreement (other than in respect of backup withholding), such Person shall (i) provide such payee with prior written
notice of its intent to deduct and withhold (together with information setting forth the amount and reason for such deduction or
withholding), and (ii) afford such payee a reasonable opportunity to reduce or eliminate such deduction or withholding. To the
extent that amounts are so withheld and timely paid over to the appropriate Governmental Entity by Merger Sub, Parent, the First
Surviving Company, the Second Surviving Company or the Paying Agent, such amounts shall be treated for all purposes of this Agreement
as having been paid to the Person in respect of which such deduction or withholding was made. Notwithstanding anything to the contrary,
any compensatory payments for Tax purposes payable pursuant to or as contemplated by this Agreement shall be paid through the Second
Surviving Company’s payroll system (or a payroll system of Parent or a Subsidiary of Parent) subject to applicable Tax withholding.
For the avoidance of doubt, any such amount withheld shall reduce the cash consideration payable to such Company Equityholder regardless
of whether the withholding is in respect of cash or equity consideration payable hereunder.


 


2.11       
[INTENTIONALLY OMITTED]


 


2.12       
Second Merger Conversion of Securities. At the Second Effective Time, by virtue of the Second Merger and without
any action on the part of Parent, the First Surviving Company or Merger Sub II:


 


(a)              
Each share of common stock of Merger Sub II issued and outstanding immediately prior to the Second Effective Time shall
be cancelled and retired and shall cease to exist.


 


(b)              
Each share of common stock of the First Surviving Company issued and outstanding immediately prior to the Second Effective
Time shall be converted into one share of common stock of the Second Surviving Company.


 


2.13        Equitable
Adjustments. If at any time after the date of this Agreement and prior to the Closing Date any change in the outstanding
shares of Class A Common Stock or Preferred Stock shall occur by reason of any reclassification, recapitalization, stock
split or combination, exchange or readjustment of shares, or any stock dividend thereon with a record date during such
period, any number or amount contained in this Agreement which is based on the price or the number of shares of Class A
Common Stock or Preferred Stock of Parent shall be equitably adjusted to the extent necessary to provide the Parties the same
economic effect with respect to such shares of capital stock as contemplated by this Agreement prior to such
reclassification, recapitalization, stock split or combination, exchange or readjustment of shares, or stock dividend
thereon.


 






    29


     


    

 


ARTICLE
III

ESCROW AND REPRESENTATIVE EXPENSE AMOUNT


 


3.1           
Escrow Deposit; Disbursements.


 


(a)              
At the Closing, pursuant to Section‎ 2.3(b)(iii), Parent shall deliver the Adjustment Escrow Deposit and the
Special Escrow Deposit to the Escrow Agent to be, in separate and segregated accounts, held, safeguarded, invested and released
pursuant to the terms of this Agreement and the Escrow Agreement. Parent and the Company (as a Selling Expense) shall each be responsible
for one-half of the fees and expenses of the Escrow Agent. Parent shall be deemed to have contributed the percentages of the Adjustment
Escrow Deposit and the Special Escrow Deposit with respect to each Company Equityholder (including with respect to any Vested Cash-Out
Options held thereby immediately prior to the Closing) as set forth on the Closing Consideration Schedule and the cash consideration
payable to each Company Equityholder pursuant to Section ‎2.4, Section ‎2.5, or Section ‎2.7,
as applicable, shall be reduced by such amounts based on each such Company Equityholder’s Pro Rata Share.


 


(b)              
The Escrow Agreement will provide that disbursements from the Adjustment Escrow Account and the Special Escrow Account shall
only be made in accordance with written instructions jointly signed by Parent and the Stockholder Representative in such form reasonably
acceptable to the Escrow Agent, Parent and the Stockholder Representative (each, a “Joint Instruction Letter”)
or pursuant to a final judgment rendered pursuant to Section‎ 10.5 of this Agreement.


 


(c)              
If either Parent or the Stockholder Representative fails to timely execute and deliver a Joint Instruction Letter when required
under this Agreement, Parent or Company, as applicable, shall be entitled to seek an order (in accordance with Section ‎10.8)
that will enable the Escrow Agent to distribute to the Paying Agent and the Company, on behalf of the Company Equityholders or
the Parent, as applicable, the funds to which it is entitled.


 


(d)              
Amounts released from the Adjustment Escrow Account and/or the Special Escrow Account to the Company Equityholders will
be treated, for Tax and all other purposes, as additional consideration for the First Merger.


 


3.2           
Deposit of Representative Expense Amount.


 


(a)              
At the Closing, pursuant to Section ‎2.3(b)(iv), Parent shall deliver the Representative Expense Amount to
the Stockholder Representative. Parent shall be deemed to have contributed the percentage of the Representative Expense Amount
with respect to each Company Equityholder (including with respect to any Vested Cash-Out Options held thereby immediately prior
to the Closing) as set forth on the Closing Consideration Schedule and the cash consideration payable to each Company Equityholder
pursuant to Section ‎2.4, Section ‎2.5, or Section ‎2.7, as applicable, shall be reduced
by such amount based on each such Company Equityholder’s Pro Rata Share.


 


(b)              
 Any portion of the Representative Expense Amount released to the Company Equityholders will be treated, for Tax and all
other purposes, as additional consideration for the First Merger.


 






    30


     


    

 


ARTICLE
IV

REPRESENTATIONS AND WARRANTIES OF COMPANY


 


Except as set forth
in the disclosure schedule delivered by the Company to Parent in connection with this Agreement (the “Disclosure Schedule”),
the Company hereby represents and warrants, as of the date hereof and as of the Closing Date, to Parent as follows in this ‎ARTICLE
IV.


 


4.1           
Organization; Existence and Good Standing. Each of the Company and each of its Material Subsidiaries (i) is a corporation
or other entity duly organized, validly existing and in good standing under the laws of its state or other jurisdiction of incorporation
or organization, (ii) has full corporate or other power and authority to carry on its business as it is now being conducted and
to own and lease the properties and assets it now owns and leases (other than with respect to any inaccuracies that are corrected
by the Company at no cost and without liability to any of Parent, Merger Sub or Merger Sub II prior to the Closing); and (iii)
is in good standing and is duly qualified or licensed to do business as a foreign corporation or other entity in each jurisdiction
wherein the character of the properties owned by it, or the nature of its business makes such licensing or qualification necessary,
except with respect to clause (i) (in the case of the Material Subsidiaries) and with respect to clause (iii) (in the case of the
Company and its Material Subsidiaries), where the failure to so qualify or be in good standing or of clause (iii) would not, individually
or in the aggregate, have a Material Adverse Effect.


 


4.2           
Authority; Enforceability.


 


(a)               The
Company has the full corporate power and authority to execute this Agreement and the other Transaction Documents to which it
is or will be a party, and, subject to receipt of the Company Written Consent, to perform its obligations under this
Agreement and the other Transaction Documents to which it is a party. The execution and delivery of, and the performance of
the Company’s obligations under, this Agreement and the other Transaction Documents to which the Company is a party
have been duly and validly authorized by the Company’s board of directors and, except for (i) receipt of the Company
Written Consent and (ii) the filing of the First Certificate of Merger and the Second Certificate of Merger with the Delaware
Secretary of State, no other corporate proceedings on the part of the Company are necessary to authorize the consummation of
the transactions contemplated by this Agreement or the Transaction Documents to which it is a party. On or prior to the date
hereof, the Company’s board of directors has unanimously (x) resolved that this Agreement and the Transaction Documents
to which it is a party and the consummation of the First Merger and the other transactions contemplated hereby and thereby
are fair to and in the best interests of the Company and the Stockholders, (y) approved and declared advisable this
Agreement, the Transaction Documents and the First Merger and the other transactions contemplated hereby and thereby on the
terms and subject to the conditions set forth herein, in accordance with the requirements of the DGCL, and (z) has
recommended that the Company’s Stockholders adopt this Agreement and approve the First Merger. Assuming the due
authorization, execution and delivery by the other Parties to this Agreement and the other Transaction Documents, this
Agreement and the other Transaction Documents to which the Company is a party, as the case may be, constitute the valid and
binding obligations of the Company, enforceable against the Company in accordance with each of their respective terms and
conditions, except as enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other Legal
Requirements relating to or affecting creditors’ rights generally or by equitable principles (regardless of whether
enforcement is sought at law or in equity) (together, the “Enforceability Exceptions”).


 






    31


     


    

 


(b)              
The Company Written Consent is the only action of the Stockholders in their capacity as such required to approve (i) this
Agreement and the Transaction Documents to which the Company or its equityholders are a party, (ii) the First Merger Agreement
and (iii) the other transactions contemplated hereby and thereby.


 


4.3           
No Violations. The execution and delivery of this Agreement by the Company and the execution and delivery of the
other Transaction Documents to which the Company is a party does not and will not, and the performance and compliance with the
terms and conditions hereof and thereof by the Company and the consummation of the transactions contemplated hereby and thereby
by the Company will not (with or without notice or passage of time, or both), except, with respect to clause (c), as would not
be material to the Company:


 


(a)              
violate, conflict with, result in a breach of or constitute a default under any of the provisions of the Charter Documents
of the Company, or any of its Subsidiaries;


 


(b)              
violate or conflict with any provision of, or cause a default under, any Legal Requirement applicable to the Company or
any of its Subsidiaries; or


 


(c)              
except as set forth on Section‎ 4.3(c) of the Disclosure Schedule, require any notice or filing with respect
to, result in a violation or breach of, or cause acceleration of any right or obligation under, or require any notice or constitute
a default, or give rise to any right of termination, amendment, modification, cancellation, loss of benefit or acceleration under,
any of the terms, conditions or provisions of or result in a Lien on any of the assets of the Company or its Subsidiaries pursuant
to, any Material Contract or Material Permit to which the Company or any of its Subsidiaries is a party.


 


4.4           
Consents. No material approval, consent, waiver, authorization or other order of, and no declaration, notice, filing,
registration, qualification or recording with, any Governmental Entity is or will be required to be obtained or made by or on behalf
of the Company or any of its Subsidiaries in connection with the execution, delivery or performance of this Agreement and the consummation
of the Closing hereunder, except for those (a) set forth in Section‎
4.4 of the Disclosure Schedule and (b) under the HSR Act.


 


4.5           
Capitalization; Subsidiaries.


 


(a)               As
of the date of this Agreement, the total number of shares of all classes of capital stock which the Company is authorized to
issue is 90,087,434 shares, which consists of (i) 72,000,000 shares of Company Common Stock and (ii) 18,087,434 shares of
Company Series C Preferred Stock. As of the date of this Agreement, there are 42,384,693 shares of Company Common Stock
outstanding, and 18,087,434 shares of Company Series C Preferred Stock outstanding, in each case, held by the Stockholders as
set forth in the attached “Capitalization Schedule.” As of the date of this Agreement, (i) 2,271,035 shares of
Company Common Stock remained available for issuance pursuant to the Company Equity Plans and (ii) Company Options to
purchase 8,853,750 shares of Company Common Stock pursuant to the Company Equity Plan were outstanding and held by the
Company Optionholders as set forth on the Capitalization Schedule, including, with respect to each Company Option, the holder
of such Company Option, the date such Company Option was granted, the expiration date, the number of shares of Company Common
Stock subject to such Company Option and the applicable exercise price. All of the issued and outstanding shares of Company
Common Stock and Company Series C Preferred Stock have been duly authorized and validly issued and are fully paid,
nonassessable and free of preemptive or similar rights. The Company has made available to Parent an accurate and complete
copy of the Charter Documents of the Company.


 






    32


     


    

 


(b)              
The attached “Capitalization Schedule” accurately sets forth the authorized and outstanding equity interests
of each of the Company’s Subsidiaries and the name and number of equity interests held by each stockholder or member. All
of such issued and outstanding equity interests have been duly authorized and validly issued and are fully paid non-assessable
(to the extent such concepts are applicable) and free of preemptive or similar rights. No Subsidiary of the Company has outstanding
stockholder purchase rights or “poison pill” or any similar arrangement in effect.


 


(c)              
Except as may be set forth on the attached Capitalization Schedule, there are no outstanding or authorized options, warrants,
rights, contracts, pledges, calls, puts, rights to subscribe, conversion rights or other agreements or commitments to which any
of the Company or any of its Subsidiaries is a party or which is binding upon the Company or any of its Subsidiaries that provides
for the issuance, disposition or acquisition of any of its equity, income appreciation or any rights or interests exercisable therefor
or obligating the Company or any of its Subsidiaries to provide funds to or make any investment (in the form of a loan, capital
contribution, subscription or otherwise) in any other Person. Except as set forth in the Capitalization Schedule, there are no
outstanding or authorized equity appreciation, profit, phantom stock or similar rights with respect to the Company or any of its
Subsidiaries. Except as may be set forth on the attached Capitalization Schedule or as accrued (but not declared) on the Company
Series C Preferred Stock, there are no declared or accrued and unpaid dividends on any of the equity interests in the Company or
commitments to issue additional shares of capital stock. Except as set forth on Section 4.5(c) of the Disclosure Schedule,
there are no outstanding equityholder or other agreements or obligations (contingent or otherwise) with respect to the voting (including
voting trusts and proxies) or sale, redemption, acquisition or transfer of any equity interests of the Company or any of its Subsidiaries,
other than such rights as are in favor of the Company or one of its Subsidiaries.


 


(d)               With
respect to each Company Option and each other equity award granted by the Company or any of its Subsidiaries, (i) each such
grant was duly authorized no later than the date on which the grant of such grant was by its terms effective (the
 “Grant Date”) by all necessary corporate action, and the award agreement governing such grant was duly
executed and delivered by each party thereto within a reasonable time following the Grant Date, (ii) each grant was made in
compliance in all material respects with all applicable Legal Requirements (including all applicable federal, state and local
securities laws) and all of the terms and conditions of the applicable Employee Plan and, each Company Option has an exercise
price that is equal or greater than the fair market value of the underlying shares of Company Common Stock on the applicable
Grant Date, (iii) each such grant was properly accounted for in all material respects in accordance with GAAP in the
financial statements (including the related notes) of the Company, and (iv) no modifications have been made to any Company
Options following the Grant Date. No offer letter or other agreement with a current or former employee or other service
provider of the Company or any of its Subsidiaries contemplates a grant of, or right to purchase or receive (i) options
or other equity awards with respect to the equity of the Company (or any of its Subsidiaries), or (ii) other securities
of the Company or any of its Subsidiaries, that in each case, have not been issued or granted as of the date of this
Agreement. The treatment of Company Options under this Agreement, complies in all respects with applicable Legal Requirements
and with the terms and conditions of the applicable Employee Plans and the applicable Company Option agreements.


 






    33


     


    

 


(e)              
Each of the Subsidiaries of the Company are set forth on Section 4.5(e) of the Disclosure Schedule. Except as set
forth on Section‎ 4.5(e) of the Disclosure Schedule, the Company holds direct or indirect legal and beneficial title
to all of the issued and outstanding equity interests of its Subsidiaries, free and clear of all Liens (other than Permitted Liens
and any transfer restrictions imposed by federal and state securities laws). Except as set forth on the Capitalization Schedule,
neither the Company nor any of its Subsidiaries owns, directly or indirectly, any capital stock or equity interests of any Person.


 


(f)               
Each of the Company’s Subsidiaries (other than the Material Subsidiaries) (i) is a corporation or other entity duly
organized, validly existing and in good standing under the laws of its state or other jurisdiction of incorporation or organization,
(ii) has full corporate or other power and authority to carry on its business as it is now being conducted and to own and lease
the properties and assets it now owns and leases; and (iii) is in good standing and is duly qualified or licensed to do business
as a foreign corporation or other entity in each jurisdiction wherein the character of the properties owned by it, or the nature
of its business makes such licensing or qualification necessary, except with respect to clause (i) and clause (iii), where the
failure to so qualify or be in good standing would not, individually or in the aggregate, have a Material Adverse Effect.


 


4.6           
Legal Requirements and Permits.


 


(a)               Except
as set forth on Section‎ 4.6(a) of the Disclosure Schedule, the Company and each of its Subsidiaries is, and
since December 31, 2016 has been, in compliance in all material respects with all applicable Legal Requirements, including
Health Care Laws, and neither the Company nor any of its Subsidiaries has received written notice of any investigation with
respect to any alleged material violation of any applicable Legal Requirements including Health Care Laws. To the Knowledge
of the Company, no investigation or review by any Governmental Entity concerning any material violation of a Health Care Law
by the Company, any of its Subsidiaries or any of their respective directors, limited liability company managers (or
equivalent governing authority), officers, employees, or independent contractors is currently pending or threatened. Neither
the Company nor any of its Subsidiaries nor, to the Knowledge of the Company, any of their respective officers, directors or
employees, nor to the Company’s Knowledge, any agent or other third party representative acting on behalf of the
Company, is currently, or has been since December 31, 2016, in violation of any Anti-Corruption Laws or Trade Control Laws in
any material respect.


 


(b)              
The Company and each of its Subsidiaries has been granted all material licenses, permits, consents, registrations, accreditations,
certificates, approvals, franchises and other authorizations under any Legal Requirement (each, a “Permit”)
necessary for the conduct of the Business as currently conducted (collectively, the “Material Permits”). The
Material Permits held by the Company and its Subsidiaries are valid and in full force and effect and neither the Company nor any
of its Subsidiaries is in material default under any such Material Permit. Except as set forth on Section‎ 4.6(b)
of the Disclosure Schedule, no Governmental Entity has given notice of or, to the Company’s Knowledge, threatened any revocation,
suspension or restriction of any Material Permit issued to the Company or any of its Subsidiaries, except as would not be material
to the Company and its Subsidiaries, taken as a whole. The Company and its Subsidiaries have made, since December 31, 2016, all
material declarations and filings with applicable Governmental Entities, in each case that are necessary to enable them to lawfully
carry on their respect operations as then or as currently conducted (as applicable). Except as set forth in Section 4.6(c)
of the Disclosure Schedule, since December 31, 2016, there has been no suspension or restriction of any Material Permit issued
to the Company or any of its Subsidiaries.


 






    34


     


    

 


(c)              
Except as set forth in Section‎ 4.6(c) of the Disclosure Schedule, neither the Company, nor any Subsidiary
of the Company, nor, to the Knowledge of the Company, any officer, director, employee, independent contractor, agent or Person
with a “direct or indirect ownership interest” (as that phrase is defined in 42 C.F.R. § 420.201) in the Company
or any Subsidiaries: (i) has been excluded by the Office of Inspector General for the Department of Health and Human Services,
the System for Award Management or the General Services Administration from participation in any “Federal Health Care Program”
or “State Health Care Program” (each as defined in 42 U.S.C. § 1320a-7a(f) and 42 U.S.C. § 1320a-7(h)), including
Medicare or Medicaid; (ii) has been charged with or convicted of a criminal offense related to any Health Care Law or been charged
with or convicted of a criminal offense relating to fraud, theft, embezzlement, breach of fiduciary responsibility, or other financial
misconduct in connection with the delivery of a health care item or service, or in connection with a program operated by or financed
in whole or in part by a Federal Health Care Program or State Health Care Program; (iii) has been assessed a civil monetary penalty
under Section 1128A of the Social Security Act (42 U.S.C. § 1320a-7a) or any regulations promulgated thereunder; (iv) is currently
listed on the System for Award Management published list of parties excluded from federal procurement programs and non-procurement
programs; (v) is the target or subject of any current or potential investigation relating to any offense related to Medicare, Medicaid
or any other state or federal healthcare program; or (vi) has a continuing obligation in respect of any order, individual integrity
agreement, corporate integrity agreement or other formal or informal agreement (e.g., deferred prosecution agreement) with
any Governmental Entity concerning compliance with any Health Care Law.


 


(d)              
Except as set forth in Section‎ 4.6(d) of the Disclosure Schedule, no Person has filed, or, has threatened
in writing to file, against the Company or any of its Subsidiaries an action under any Health Care Law, including any federal or
state whistleblower statute, including under the False Claims Act of 1863 (31 U.S.C. Section 3729 et seq.).


 


(e)              
 The Company and each of its Subsidiaries are, and have at all relevant times since December 31, 2016 been duly accredited,
certified, enrolled, and in good standing to participate in and receive reimbursement under all Third Party Payor Programs in which
the Company or any of its Subsidiaries have participated and/or to which the Company or any of its Subsidiaries have provided services
or products and (i) are not subject to any suspension, revocation proceedings, or other limitation on such participation status;
(ii) are in compliance in all material respects with the conditions of participation and all applicable conditions of payment for
such Third Party Payor Programs; and (iii) are in compliance in all material respects with the Medicare Durable Medical Equipment,
Prosthetics, Orthotics and Supplies (“DMEPOS”) Supplier Standards listed in 42 C.F.R. 424.56(c) and the DMEPOS
Quality Standards established by Center for Medicare and Medicaid Services under the Medicare Modernization Act of 2003. Except
as set forth in Section‎ 4.6(e) of the Disclosure Schedule, neither the Company nor any of its Subsidiaries has received
written notice since December 31, 2016 of any actual or alleged material violation of, or failure to be in material compliance
with any Third Party Payor Program.


 






    35


     


    

 


(f)               
The billing practices of the Company and its Subsidiaries with respect to all Third Party Payors and Third Party Payor Programs
are currently and have since the Latest Balance Sheet Date been in material compliance with all applicable Health Care Laws as
well as the provisions of any other Third Party Payor Program agreement to which it is bound. Neither the Company nor any of its
Subsidiaries has billed, received and retained any payment or reimbursement in excess of amounts allowed by (a) applicable Health
Care Laws, (b) the applicable reimbursement rates established from time to time by Third Party Payor Programs, or (c) the terms
of each participating provider agreement or similar contract or arrangements between the Company or its Subsidiaries, on one hand,
and Third Party Payor Programs, on the other, except for routine, billing errors that would not, in the aggregate, require a repayment
of $50,000 (Fifty Thousand Dollars) or more.


 


(g)              
Except as set forth on Section‎ 4.6(g) of the Disclosure Schedule, the Company and each of its Subsidiaries
does and has at all times since December 31, 2016 (i) filed all reports and billings required to be filed with respect to each
Third Party Payor in compliance in all material respects with applicable Legal Requirement and applicable Third Party Payor requirements,
and (ii) paid all material known and undisputed refunds, overpayments, discounts and adjustments due with respect to any such report
or billing. There are no material pending or, to the Company’s Knowledge, threatened audits, investigations, appeals, adjustments
or Legal Proceedings relating to such claims. All claims submitted by the Company and its Subsidiaries were for medically necessary
goods actually sold or services actually performed by the billing Company or Subsidiary to eligible patients. The Company and each
of its Subsidiaries maintains sufficient documentation that is required by Legal Requirement or the applicable Third Party Payor
to support all of the Company’s and each Subsidiary’s billings to Third Party Payors. Since December 31, 2016, to the
extent that the Company or any of its Subsidiaries has identified any material overpayments from any Federal Health Care Program,
the Company or such Subsidiary has notified the applicable agency and returned such overpayments in accordance in all material
respects with the requirements under the Patient Protection and Affordable Care Act of 2010, as amended, and the Health Care and
Education Reconciliation Act of 2010, as amended.


 


(h)              
 Except as set forth on Section‎ 4.6(h) of the Disclosure Schedule, neither the Company nor any of its Subsidiaries
has any outstanding material liabilities as of the date hereof, except for routine recoupments, refunds, set-offs, and adjustments
subject to reconciliation in the ordinary course of the Business; (i) to any Third Party Payor or Third Party Payor Program or
(ii) to any third party contractor administering claims for any Third Party Payor or Third Party Payor Program, for the recoupment
of any material amounts previously paid to the Company or its Subsidiaries by any such Third Party Payor, Third Party Payor Program,
or third party contractor administering claims for any Third Party Payor or Third Party Payor Program, nor to the Knowledge of
the Company, is there a basis for any such recoupments, except as recorded as a contingent or actual liability, as applicable.
There are no material claims, actions or appeals pending before any Governmental Entity, including the Centers for Medicare and
Medicaid Services or other Governmental Entity, with respect to any Government Program claims filed by the Company or any of its
Subsidiaries in connection with any Third Party Payor Program, nor have there been any disallowances by any commission, board or
agency in connection with any audit inquiry or review of such claims which are not recorded on the Company Financial Statements.
To the Knowledge of the Company, no event has occurred which would provide the basis for termination of (a) the Company’s
or any Subsidiary’s Medicare or Medicaid provider agreement; or (b) any participating provider agreement or similar contract
or arrangements between the Company or any of its Subsidiaries on one hand, and Third Party Payors on the other.


 






    36


     


    

 


(i)                
The Company and its Subsidiaries maintain, and have at all times since December 31, 2016 maintained, a compliance program
in conformance in all material respects with the elements of a corporate compliance and ethics program identified in U.S.S.G. §
8B2.1 and the criteria established by the Office of Inspector General of the Department of Health and Human Services (OIG). The
Company and its Subsidiaries have provided to Parent complete and accurate copies of all current compliance program materials.


 


(j)                
Except as set forth on Section‎ 4.6(j) of the Disclosure Schedule, the Company and its Subsidiaries and, to
the Company’s Knowledge, their respective directors, limited liability company managers (or equivalent governing authority),
officers, personnel (whether employed or engaged as independent contractors) and authorized representatives, are operating and
since December 31, 2016 have operated in compliance in all material respects with all applicable federal and state Health Care
Laws with respect to direct and indirect compensation arrangements, ownership interests or other relationships between such person
and any past, present or potential patient, physician, supplier, contractor, customer, Third Party Payor or other person in a position
to refer, recommend or arrange for the referral of patients or other health care business (each a “Referral Source”)
or to whom such person refers, recommends or arranges for the referral of patients or other health care business.


 


(k)               The
proceeds of any loans or funds received by the Company and its Subsidiaries under the Medicare Advanced Payment Program or
Health and Human Services Provider Relief Fund under the CARES Act have in all material respects either (i) been used for
purposes permitted under such program or fund under the CARES Act, or (ii) otherwise remain deposited in a segregated account
owned by the Company and its Subsidiaries. No material breach has occurred in respect of any attestation or the Terms and
Conditions associated with the Medicare Advanced Payment Program or Health and Human Services Provider Relief Fund under the
CARES Act. No material written (or, to the Knowledge of the Company and its Subsidiaries, oral) notices or communications
with the Department of Health and Human Services related to non-compliance with the terms of the Medicare Advanced Payment
Program or Health and Human Services Provider Relief Fund under the CARES Act, or non-eligibility for receipt of funds in
connection with the Medicare Advanced Payment Program or Health and Human Services Provider Relief Fund under the CARES Act,
have been received by the Company and its Subsidiaries, and there are, to the Knowledge of the Company and its Subsidiaries,
no facts upon which any such material claim of non-compliance or non-eligibility might reasonably be justified.


 






    37


     


    

 


(l)                
The Company and its Subsidiaries are in compliance in all material respects with all anti-money laundering laws, rules,
regulations and orders of jurisdictions applicable to the Company and its Subsidiaries (collectively, “AML Laws”),
including the USA PATRIOT Act. No proceeding involving the Company, with respect to AML Laws, is currently pending or, to the Knowledge
of the Company, threatened which in each case would reasonably be expected to result in a material violation of this representation.
Neither the Company nor its Subsidiaries are required to be registered with the U.S. Department of the Treasury as a money services
business, as such term is defined by federal law or regulation, and neither the Company nor its Subsidiaries are required to be
registered or licensed as a money services business, money transmitter, or equivalent enterprise under the applicable Legal Requirements
of any other jurisdiction.


 


4.7           
Legal Proceedings. Except as set forth in Section‎
4.7 of the Disclosure Schedule, there are no, and since December 31, 2016 there have not been any, material Legal Proceedings
pending or, to the Knowledge of the Company, threatened against or relating to (a) the Company or any of its Subsidiaries (or the
Company or any of its Affiliates relating to the Business), including, without limitation, any Legal Proceeding (i) seeking equitable
or injunctive relief as its principal remedy, (ii) alleging criminal wrongdoing by the Company or any of its Subsidiaries or (iii)
related to the transactions contemplated hereby, or (b) any director, officer or, to the Knowledge of the Company, employee of
the Company or any of its Subsidiaries in such Person’s capacity as such. Neither the Company nor any of its Subsidiaries
is, or since December 31, 2016 has been, subject to, or bound by, any Order. As of the date hereof, neither the Company nor or
any of its Subsidiaries are engaged in any Legal Proceeding to recover damages sustained by it.


 


4.8           
Tax Matters.


 


(a)              
Each of the Company and its Subsidiaries has duly and timely filed with the appropriate Governmental Entities all income
and other material Tax Returns required to be filed by or with respect to it (taking into account any applicable extensions to
file such Tax Returns). All such Tax Returns are true, correct and complete in all material respects. All material amounts of Taxes
due and owing by or with respect to the Company and its Subsidiaries on or before the date hereof (whether or not shown on any
Tax Returns) have been timely paid in full (or adequate reserves have been established therefor in accordance with GAAP).


 


(b)              
Neither the Company nor any of its Subsidiaries has incurred any material liability for Taxes outside the ordinary course
of business or otherwise inconsistent with past custom and practice, in each case, except to the extent contemplated by this Agreement.


 


(c)              
 No material deficiencies for any Taxes with respect to the Company or its Subsidiaries been proposed, claimed or assessed,
in each case, in writing, by any Governmental Entity. There are no pending audits, assessments, investigations, disputes, claims
or other actions for or relating to any liability in respect of the Company or its Subsidiaries nor any such audits, assessments,
investigations, disputes, claims or other actions is asserted by any Governmental Entity. No claim has ever been made in writing
by a Governmental Entity in a jurisdiction where the Company or its Subsidiaries does not file Tax Returns that the applicable
Person is or may be subject to taxation by, or required to file Tax Return in, that jurisdiction, nor is any such assertion threatened.


 


(d)              
The Company has delivered or made available to Parent complete and accurate copies of federal, state and foreign income
Tax Returns and all other material Tax Returns of the Company or its Subsidiaries and their respective predecessors for all taxable
years beginning on or after January 1, 2018, including, upon their availability, for the most recent taxable year, and complete
and accurate copies of all audit or examination reports and statements of deficiencies assessed against or agreed to by the Company
or its Subsidiaries (or any of their respective predecessors) since January 1, 2018, with respect to Taxes of any type.


 






    38


     


    

 


(e)              Neither the Company nor its Subsidiaries (nor any predecessor of any such Person) has waived any statute of limitations
in respect of Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency, other than, in each case,
with respect to routine extensions to file Tax Returns. No closing agreement, private letter ruling, technical advice memoranda
or similar agreements or ruling with respect to Taxes has been requested of any Governmental Entity by or on behalf of the Company
or its Subsidiaries.


 


(f)               There
are no Liens for Taxes upon any property or asset of the Company or its Subsidiaries (other than for current Taxes not yet delinquent
or that are being contested in good faith for which sufficient reserves have been established in accordance with GAAP).


 


(g)              Each of the Company and its Subsidiaries has deducted, withheld, collected, deposited or paid to the appropriate Governmental
Entity all material amounts of Taxes required to have been deducted, withheld, collected, deposited or paid in connection with
amounts paid or owing to any employee, former employee, independent contractor, creditor, stockholder or other third party, and
each of the Company and its Subsidiaries has complied in all material respects with all reporting and record keeping requirements.


 


(h)              Neither the Company nor its Subsidiaries has been a member of an “affiliated group” (within the meaning of Section
1504(a) of the Code) filing a consolidated, joint, unitary or combined federal income Tax Return or any similar group for federal,
state, local or foreign Tax purposes (other than a group the common parent of which is the Company). Neither the Company nor its
Subsidiaries has any liability for the Taxes of any other Person under Treasury Regulations Section 1.1502-6 (or any similar provision
of state, local or foreign law), as a transferee or successor, by contract or otherwise (other than any agreement, arrangement
or other Contract not principally related to Taxes).


 


(i)               There
are no material Tax sharing agreements, Tax allocation agreements or similar arrangements (including Tax indemnity arrangements)
with respect to or involving the Company or its Subsidiaries (other than any agreement, arrangement or other Contract not principally
related to Taxes).


 


(j)               Neither the Company nor its Subsidiaries has been a party to a transaction that is a “reportable transaction”
within the meaning of Treasury Regulations Section 1.6011-4(b) or any predecessor thereof.


 


(k)              Each
of the Company and its Subsidiaries has disclosed on its federal income Tax Returns all positions taken therein that could give
rise to a substantial understatement of federal income Tax within the meaning of Section 6662 of the Code.


 


(l)               Neither
the Company nor its Subsidiaries has constituted either a “distributing corporation” or a “controlled corporation”
(within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of stock qualifying for tax-free treatment under Section
355 of the Code (or so much of Section 356 of the Code as relates to Section 355 of the Code).


 






    39


     


    

 


(m)            
Neither the Company nor its Subsidiaries will be required to include any item of income in, or exclude any item of deduction
from, taxable income for any period (or any portion thereof) beginning after the Closing Date as a result of (i) a change in or
incorrect method of accounting occurring prior to the Closing, (ii) an installment sale or open transaction arising or entered
into in a taxable period (or portion thereof) ending on or before the Closing, (iii) a prepaid amount received or deferred revenue
realized on or prior to the Closing outside of the Ordinary Course of Business, (iv) a “closing agreement” as described
in Section 7121 of the Code (or any corresponding or similar provision of state or local income Tax Legal Requirement) executed
on or prior to the Closing, or (v) any intercompany transactions or any excess loss account described in Treasury Regulations under
Section 1502 of the Code (or any corresponding or similar provision of state or local income Tax Legal Requirement).


 


(n)              
Neither the Company nor its Subsidiaries has ever had a permanent establishment in a country other than the country of its
organization.


 


(o)              
Each of the Company and its Subsidiaries has properly (i) collected and remitted all material amounts of sales, use, valued
added and similar Taxes with respect to sales or leases made or services provided to its customers and (ii) for all sales, leases
or provision of services that are exempt from sales, use, valued added and similar Taxes and that were made without charging or
remitting sales, use, valued added or similar Taxes, received and retained any appropriate Tax exemption certificates and other
documentation qualifying such sale, lease or provision of services as exempt.


 


(p)              
Neither the Company nor its Subsidiaries has (i) claimed any Tax credit pursuant to Section 2301 of the CARES Act, (ii)
deferred any Liability for Taxes pursuant to Section 2302 of the CARES Act or any other COVID-19 related Legal Requirements, or
(iii) claimed any Tax credit pursuant to Section 7001 or 7003 of the Families First Coronavirus Response Act of 2020.


 


(q)               Neither
the Company nor its Subsidiaries has taken or agreed to take any action, or has Knowledge of the existence of any fact or
circumstance, that would reasonably be expected to impede or prevent the Mergers from qualifying as a
 “reorganization” within the meaning of Section 368(a) of the Code.


 


4.9           
Financial Statements and Other Financial Matters.


 


(a)              
Set forth in Section‎ 4.9(a) of the Disclosure Schedule are the following financial statements (collectively,
the “Company Financial Statements”):


 


(i)                      
the audited, consolidated balance sheet of the Company and its Subsidiaries as of December 31, 2019 (the “Latest
Audited Balance Sheet”), and the related consolidated statements of operations, shareholders’ equity and cash flows
for the year then ended;


 






    40


     


    

 


(ii)                   
the audited, consolidated balance sheet of the Company and its Subsidiaries as of December 31, 2018, and the related consolidated
statements of operations, shareholders’ equity and cash flows for the year then ended; and


 


(iii)                 
the unaudited, consolidated balance sheet of the Company and its Subsidiaries as of September 30, 2020 (such balance sheet,
the “Latest Balance Sheet” and such date, the “Latest Balance Sheet Date”), and the related
consolidated income statements and statement of cash flows for the nine-month period then ended (the “Interim Company
Financial Statements”).


 


(b)              
Except as set forth on Section‎ 4.9(b) of the Disclosure Schedule, the Company Financial Statements have been
prepared from the books and records of the Company in all material respects and in accordance with GAAP consistently applied throughout
the period, subject, in the case of the Interim Company Financial Statements, to the absence of explanatory footnote disclosures
and normal year-end adjustments required by GAAP (none of which are material in amount or scope) and fairly present in all material
respects the financial position and results of operations of the Company and its Subsidiaries at the respective dates and for the
respective periods described above.


 


(c)              
The Company and each of its Subsidiaries has established and maintain a system of internal accounting controls sufficient
to provide reasonable assurances for a company of its size and private ownership that transactions are recorded as necessary to
permit the preparation of financial statements in conformity with GAAP, and provide reasonable assurance regarding the prevention
or timely detection of fraud. Since December 31, 2016, no officer, director or employee of the Company or any of its Subsidiaries
has refused to execute any certification of any nature whatsoever required by Legal Requirement or requested by any accounting,
banking, financial or legal firm or entity.


 


(d)               Since
the Latest Balance Sheet Date, neither the Company nor any of its Subsidiaries has incurred any obligation or liability
(whether accrued, absolute, contingent or otherwise), other than any such liabilities or obligations (i) incurred or arising
(A) in the Ordinary Course of Business (including pursuant to any Contract to which the Company or any of its Subsidiaries is
party but excluding any obligation or Liability arising out of any breach thereof), or (B) in connection with this Agreement
or the transactions contemplated hereby; (ii) disclosed, reflected or reserved against in the Latest Balance Sheet or in the
notes thereto; (iii) taken into account in the calculation of Selling Expenses, Closing Indebtedness or Net Working Capital,
each as finally determined pursuant to Section‎ 2.9; (iv) that are described in Section‎ 4.9(c) of
the Disclosure Schedule; and (v) which would not, individually or in the aggregate, be material to the Company and its
Subsidiaries, taken as a whole.


 


(e)              
Neither the Company nor any of its Subsidiaries is a party to any off-balance sheet joint venture, off-balance sheet partnership
or any similar off-balance sheet arrangement.


 


(f)               
Inventory. The Company or a Subsidiary thereof, as applicable, owns all of its material inventory, whether or not
reflected in the Company Financial Statements, free and clear of all Liens, other than Permitted Liens. All material inventory
of the Company and its Subsidiaries consists of a quality and quantity usable and salable in the Ordinary Course of Business, except
for obsolete items and items of below-standard quality, all of which have been written off or written down to net realizable value. 
The quantities of each item of inventory (whether raw materials, work-in-process, or finished goods) are reasonable in the present
circumstances of the Company and its Subsidiaries. Neither the Company nor any of its Subsidiaries holds any inventory or other
goods pursuant to any consignment arrangement and has no liabilities relating to consigned inventory or other goods.


 






    41


     


    

 


4.10       
Absence of Certain Changes. Since the Latest Audited Balance Sheet Date, except as would not be material to the Companies
or its Subsidiaries, taken as a whole, and except as contemplated or permitted by this Agreement, or as reasonably taken in good
faith as a result of or in connection with any COVID-19 Measure, (i) there has not occurred any Material Adverse Effect, (ii) the
Company and its Subsidiaries have conducted business in the Ordinary Course of Business and in substantially the same manner as
conducted during the period covered by the Company Financial Statements, and (iii) the Company and its Subsidiaries have not taken
or omitted to take any action that, if taken after the date hereof, would require the consent of Parent under Section ‎6.1.


 


4.11       
Employee Benefit Plans.


 


(a)               Section‎
4.11(a) of the Disclosure Schedule sets forth a true and complete list of each material Employee Plan (excluding
employment agreements and offer letters that (x) do not materially differ from a form agreement provided,
(y) provide for employment “at-will” and do not include for any severance or other company-paid
post-termination obligations, and (z) provide for annual base salary in the aggregate of less than $150,000). With
respect to each Employee Plan required to be scheduled on Section‎ 4.11(a) of the Disclosure Schedule, the
Company has delivered a true and complete copy, to the extent applicable, of: (i) each current writing constituting a part of
such Employee Plan and all amendments thereto, and if unwritten, a written description of such Employee Plan; (ii) the most
recent annual report and accompanying schedules; (iii) the current summary plan description and any summaries of material
modifications; (iv) the most recent annual financial and actuarial reports; (v) the most recent determination or opinion
letter received by the Company or any of its Subsidiaries from the IRS regarding the tax-qualified status of such Employee
Plan; (vi) the most recent written results of all required compliance testing; and (vii) copies of any material,
correspondence with the IRS, Department of Labor or other Governmental Entity since December 31, 2016. There has been no
amendment to, announcement by the Company or any of its Subsidiaries relating to, or change in employee participation or
coverage under, any Employee Plan which would increase materially the expense of maintaining such plan above the level of the
expense incurred therefor for the most recent fiscal year.


 


(b)              
Each Employee Plan (and each related trust, insurance contract or fund) has been established, administered and funded in
accordance in all material respects with its express terms, and in compliance in all material respects with all applicable Legal
Requirements, including ERISA and the Code. There are no pending or, to the Knowledge of the Company, threatened actions, claims
or lawsuits against or relating to the Employee Plans, the assets of any of the trusts under such plans or the plan sponsor or
the plan administrator, or against any fiduciary of the Employee Plans with respect to the operation of such plans (other than
routine benefits claims). Neither the Company, its Subsidiaries nor, to the Knowledge of the Company, any “party in interest”
or “disqualified person” with respect to an Employee Plan has engaged in a non-exempt “prohibited transaction”
within the meaning of Section 4975 of the Code or Section 406 of ERISA. To the Knowledge of the Company, no fiduciary (within the
meaning of Section 3(21) of ERISA) has breached any fiduciary duty with respect to an Employee Plan or otherwise has any liability
in connection with acts taken (or the failure to act) with respect to the administration or investment of the assets of any Employee
Plan. To the Knowledge of the Company no Employee Plan is presently under audit or examination (nor has written notice been received
of a potential audit or examination) by any Governmental Entity. All payments required to be made by the Company or any of its
Subsidiaries under, or with respect to, any Employee Plan (including all contributions, distributions, reimbursements, premium
payments or intercompany charges) with respect to all prior periods since December 31, 2016 have been timely made or, for any such
payments that are not yet due, properly accrued and reflected in the most recent consolidated balance sheet prior to the date hereof,
in each case in accordance with the provisions of each of the Employee Plans, applicable Legal Requirements and GAAP. There is
not now, nor do any circumstances exist that could give rise to, any requirement for the posting of security with respect to an
Employee Plan or the imposition of any lien on the assets of the Company or any of its Subsidiaries under ERISA or the Code.


 






    42


     


    

 



 


(c)              
With respect to each Employee Plan that is intended to qualify under Section 401(a) of the Code, such plan, and its related
trust, has at all times since its adoption been so qualified and has received a current determination letter (or is the subject
of a current opinion or advisory letter in the case of any prototype plan) from the IRS on which the Company and its Subsidiaries
can rely that it is so qualified and that its trust is exempt from tax under Section 501(a) of the Code, and nothing has occurred
with respect to the operation of any such plan which would cause the loss of such qualification or exemption or the imposition
of any material liability, penalty or tax under ERISA or the Code. No stock or other securities issued by the Company or any of
its Subsidiaries forms or has formed any part of the assets of any Employee Plan that is intended to qualify under Section 401(a)
of the Code.


 


(d)               No
Employee Plan is, and none of the Company, its Subsidiaries or any ERISA Affiliate of the Company or its Subsidiaries have
ever sponsored, established, maintained, contributed to or been required to contribute to, or in any way has any liability
(whether on account of an ERISA Affiliate or otherwise), directly or indirectly, with respect to any plan that is,
(i) subject to Title IV or Section 302 of ERISA or Section 412, 430 or 4971 of the Code or a “defined
benefit” plan within the meaning of Section 414(j) of the Code or Section 3(35) of ERISA (whether or not subject
thereto), (ii) a Multiemployer Plan, (iii) a plan that has two or more contributing sponsors at least two of whom are not
under common control, within the meaning of Section 4063 of ERISA, (iv) a “multiple employer welfare arrangement”
(as defined in Section 3(40) of ERISA), or (v) a plan maintained in connection with any trust described in Section 501(c)(9)
of the Code. None of the Company or its Subsidiaries has withdrawn at any time within the preceding six years from any
Multiemployer Plan, or incurred any withdrawal liability which remains unsatisfied, and no events have occurred and no
circumstances exist that could reasonably be expected to result in any such liability to the Company or any of its
Subsidiaries.


 


(e)              
No event has occurred and no condition exists that would subject the Company or any of its Subsidiaries by reason of their
affiliation with any ERISA Affiliate to any (i) Tax, penalty, fine, (ii) lien, or (iii) other liability imposed by ERISA, the Code
or other applicable Legal Requirements, in each case, in respect of any employee benefit plan maintained, sponsored, contributed
to, or required to be contributed to by any ERISA Affiliate (other than the Company or its Subsidiaries).


 






    43


     


    

 


(f)               
Each Employee Plan that is subject to Affordable Care Act has been established, maintained and administered in compliance
in all material respects with the requirements of the Affordable Care Act, including all notice and coverage requirements, and
the Company, its Subsidiaries and each ERISA Affiliate offer minimum essential health coverage, satisfying the affordability and
minimum value requirements, to their full time employees (as defined by the Affordable Care Act) sufficient to prevent liability
for assessable payments under Section 4980H of the Code. None of the Company or its Subsidiaries has attempted to maintain the
grandfathered heath plan status under the Affordable Care Act of any Employee Plan. None of the Employee Plans provide medical,
health, life or other welfare benefits for former employees or for present employees after termination of employment, except as
may be required by Section 4980B of the Code and Section 601 of ERISA, any other applicable Legal Requirement or at the sole expense
of the participant or the participant’s beneficiary. No Employee Plan is a self-insured arrangement by the Company or any
of its Subsidiaries or funded through a trust and no event has occurred and no condition exists that could reasonably be expected
to result in a material increase in the premium costs of any Employee Plans that are fully-insured. None of the Company or its
Subsidiaries has incurred (whether or not assessed), or is reasonably expected to incur or to be subject to, any Tax or other penalty
with respect to the reporting requirements under Sections 6055 and 6056 of the Code, as applicable, or under Section 4980B, 4980D
or 4980H of the Code.


 


(g)               Except
as set forth on Schedule 4.14(g), neither the execution and delivery of this Agreement nor the consummation of the
transactions contemplated hereby will (either alone or in combination with another event) (i) result in any payment becoming
due, or increase the amount of any compensation or benefits due, to any current or former employee, officer, director or
other individual service provider of the Company or any of its Subsidiaries or with respect to any Employee Plan; (ii)
increase any benefits otherwise payable under any Employee Plan; (iii) result in the acceleration of the time of payment or
vesting of (other than Company Options) any such compensation or benefits, or the forgiveness of indebtedness of any current
or former employee, officer, director or other individual service provider of the Company or any of its Subsidiaries; or (iv)
result in an obligation to fund or otherwise set aside assets to secure to any extent any of the obligations under any
Employee Plan. No person is entitled to receive any additional payment (including any tax gross-up or other payment) from the
Company or any of its Subsidiaries as a result of the imposition of the excise taxes required by Section 4999 of the Code or
any taxes required by Section 409A of the Code.


 


(h)              
After giving effect to the Section 280G Approval pursuant to Section 6.9 below, neither the execution and delivery
of this Agreement nor the consummation of the transactions contemplated hereby will (either alone or in combination with another
event) result in any payment or benefit (whether in cash or property or the vesting of property) to any “disqualified individual”
(as such term is defined in Treasury Regulation Section 1.280G-1) that would, individually or in combination with any other
such payment, constitute an “excess parachute payment” (as defined in Section 280G(b)(1) of the Code).


 






    44


     


    

 


(i)                
Each Employee Plan which constitutes a “nonqualified deferred compensation plan” within the meaning of Section
409A of the Code complies, and has at all relevant times complied, with the operational and documentary requirements of Section
409A in all material respects.


 


(j)                
No Employee Plan covers any employees, officers, directors or other individual service providers of the Company or any of
its Subsidiaries residing or working outside of the United States.


 


4.12       
Employment and Labor.


 


(a)              
The Company and its Subsidiaries are, and since December 31, 2016 have been, in compliance in all material respects with
all applicable Legal Requirements relating to the hiring of employees and employment of labor, including all applicable Legal Requirements
relating to wages, hours, overtime, collective bargaining, employment discrimination, civil rights, safety and health, workers’
compensation, pay equity, classification of employees and independent contractors, and the collection and payment of withholding
and/or social security Taxes. Each of the Company and its Subsidiaries has met in all material respects all Legal Requirements
relating to the employment of foreign citizens, and none of the Company or its Subsidiaries currently employs, or, since December
31, 2016, has employed, any Person who was not authorized to work in the jurisdiction in which such Person was employed. The Company
and its Subsidiaries have complied since December 31, 2016 in all material respects with all applicable Legal Requirements that
require overtime to be paid to any current or former employee of the Company or its Subsidiaries, and no Person, since December
31, 2016, has brought a claim, and no claim brought is a prior period is still outstanding, for unpaid compensation or employee
benefits, including overtime amounts and, to the Knowledge of the Company, no current or former employee of the Company or its
Subsidiaries has threatened to bring any such claim.


 


(b)               None
of the Company or its Subsidiaries is delinquent in payment to any of its current or former employees, officers, directors or
other individual service providers for any wages, fees, salaries, commissions, bonuses, or other direct compensation for
service performed by them or amounts required to be reimbursed to such employees, officers, directors or other individual
service providers or in payments owed upon any termination of such person’s employment or service in any material
respect.


 


(c)              
None of the Company or its Subsidiaries is a party to or otherwise bound by any collective bargaining agreement or other
agreement with a labor union, works council or similar organization applicable to employees of the Company or its Subsidiaries
(in their capacity as such) and, to the Knowledge of the Company, there are no activities or proceedings of any labor union, works
council or similar organization to organize any such employees as of the date hereof. Additionally, (i) there is no unfair labor
practice charge or complaint pending before any applicable Governmental Entity relating to the Company, any of its Subsidiaries
or any employee or other individual service provider thereof; (ii) there is no labor strike, material slowdown, material dispute,
or material work stoppage or lockout pending or, to the Knowledge of the Company, threatened against or affecting the Company or
any of its Subsidiaries, and none of the Company or its Subsidiaries has, since December 31, 2016, experienced any strike, material
slowdown or material work stoppage, lockout or other collective labor action by or with respect to its employees; (iii) there is
no representation claim or petition pending before any applicable Governmental Entity; and (iv) there are no charges with respect
to or relating to the Company or any of its Subsidiaries pending before any applicable Governmental Entity responsible for the
prevention of unlawful employment practices.


 






    45


     


    

 


(d)              
To the Knowledge of the Company, no employee or other individual service provider of the Company or its Subsidiaries is
bound by any contract (including licenses, covenants or commitments of any nature) or subject to any judgment, decree or order
of any Governmental Entity that would materially interfere with the Person’s ability to provide services to the Company and
its Subsidiaries or that would materially conflict with the business of the Company and its Subsidiaries as currently conducted.
To the Knowledge of the Company, as of the date hereof, (i) no officer or key employee, or group of key employees, intends
to terminate their employment with the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has
a present intention to terminate the employment of any of the foregoing, and (ii) no officer or key employee has received an offer
to join a business that is competitive with the business activities of the Company and its Subsidiaries.


 


(e)              
Any individual who performs or, since December 31, 2016, had performed services for the Company or its Subsidiaries and
who is not treated as an employee for federal income tax purposes by the Company or its Subsidiaries is not an employee under applicable
Legal Requirements or for any purpose, including, without limitation, for Tax withholding purposes or Employee Plan purposes, and
none of the Company or its Subsidiaries has any liability by reason of any individual who performs or performed services for Company
or its Subsidiaries, in any capacity, being improperly excluded from participating in any Employee Plan. Each current and former
employee of Company and its Subsidiaries is, and at all relevant times since December 31, 2016, has been, properly classified by
the Company as “exempt” or “non-exempt” under applicable Legal Requirements.


 


(f)                To
the Knowledge of the Company, since December 31, 2016, (i) no allegations of sexual harassment or sexual misconduct have been
made against any director, officer or other managerial employee of the Company or its Subsidiaries, and (ii) neither the
Company nor any of its Subsidiaries has entered into any settlement agreement related to allegations of sexual harassment or
sexual misconduct by any managerial employee, officer or director of the Company or any of its Subsidiaries.


 


(g)              
The Company and each of its Subsidiaries has (i) taken commercially reasonable steps consistent with market practice to
minimize potential workplace exposure in light of COVID-19 and (ii) delivered accurate and complete copies of all applicable (A) workplace
communications from the Company and its Subsidiaries to employees regarding actions or changes in workplace schedules or employee
hours, employee travel, remote work practices, onsite meetings, implementation and enforcement of health and safety, social distancing
and return-to-work practices and protocols or other changes that have been implemented in response to COVID-19; (B) contingency
plans for workplace cessation in light of COVID-19; and (C) policies implemented in relation to COVID-19.


 






    46


     


    

 


4.13       
Contracts.


 


(a)              
Section‎ 4.13(a) of the Disclosure Schedule sets forth a correct and complete list of the following Contracts
(including any amendment, supplement or modification (whether written or verbal) thereto) (other than Employee Plans) to which
the Company or any of its Subsidiaries is a party or bound, in each case pursuant to which the Company, its applicable Subsidiary
or any other party thereto has any continuing obligation (each, as amended, supplemented or modified to date, a “Material
Contract”):


 


(i)                    each
Real Property Lease and each other Contract pursuant to which the Company or its applicable Subsidiary currently leases or subleases
real or personal property to or from any Person, in each case, for rent amounts of more than $250,000 per annum;


 


(ii)                   each
Contract (A) for employment of any officer or individual employee of the Company or any of its Subsidiaries on a full-time or
part-time basis providing annual cash compensation in excess of $150,000 (other than offer letters that are not required to be
disclosed on Section‎ 4.11(a) of the Disclosure Schedule), or (B) for
the engagement of any consultant or other service provider of the Company or any of its Subsidiaries which (I) provides for annual
cash compensation in excess of $150,000 or (II) is not terminable on thirty (30) days’ notice or less without material liability;


 


(iii)                 
[INTENTIONALLY OMITTED];


 


(iv)                  each collective bargaining agreement, labor contract or other written agreement or arrangement with any labor union or any
employee organization or contract, agreement or arrangement with a professional employer organization, co-employer organization,
human resources or benefits outsourcing entity, or similar vendor or provider;


 


(v)                   each
Contract providing for severance or other post-termination compensation payment in excess of $150,000 to any officer, individual
employee, or other Person on a full-time, part-time, consulting or other basis which has any outstanding payment obligation or
which is not terminable on less than thirty (30) days’ notice;


 


(vi)                  each Contract (other than purchase orders and invoices entered into by the Company or its applicable Subsidiary in the
Ordinary Course of Business) that involves future payments, performance of services or delivery of goods or materials to or by
the Company or its applicable Subsidiary of any amount or value reasonably expected to exceed $250,000 in the current fiscal year
or the next fiscal year;


 


(vii)                 each
Contract related to material Intellectual Property owned or licensed by the Company or any of its Subsidiaries, including (A)
Contracts by which any material Intellectual Property is licensed by or to the Company or any of its Subsidiaries or that involves
annual individual license or maintenance fees in excess of $500,000 and (B) co-existence, concurrent use, and consent to
use Contracts (excluding Licenses for Generally Commercially Available Software and non-exclusive licenses granted to customers,
contractors or service providers of the Company or any of its Subsidiaries in the Ordinary Course of Business);


 






    47


     


    

 


(viii)               each
joint venture or partnership with a third party, including any Contract involving the sharing of the Company’s and/or its
Subsidiaries’ profits with such third party;


 


(ix)                  each Contract that prohibits the Company or any of its Subsidiaries from competing in any line of business or in any geographic
area or with any Person or that restricts the Company’s or one of its Subsidiary’s ability to (A) purchase or deliver
any products or services, (B) solicit or hire any person as an employee (excluding any agreements relating primarily to confidentiality
or nondisclosure which are entered into by the Company or such Subsidiary in the Ordinary Course of Business) or (C) charge certain
prices pursuant to a “most-favored nation” or similar clause;


 


(x)                   each
Contract set forth or required to be set forth on Section ‎ 4.18 of the Disclosure Schedule;


 


(xi)                  any
Contract pursuant to which the Company or any of its Subsidiaries has granted or otherwise permitted to exist a Lien (other than
any Permitted Lien) on any material asset or group of assets of the Company;


 


(xii)                 each
settlement, conciliation or similar Contract (A) with any Governmental Entity or (B) pursuant to which the Company or any of its
Subsidiaries has any outstanding obligation after the date of this Agreement in excess of $100,000;


 


(xiii)                each
Contract with a Third Party Payor from which the Company has received reimbursement in excess of $250,000 in any twelve (12) month
period;


 


(xiv)                each
Contract with a Referral Source involving payment in excess of $250,000;


 


(xv)                 each
Contract with any Material Customer or Material Supplier (other than purchase orders entered into by the Company or its applicable
Subsidiary in the Ordinary Course of Business);


 


(xvi)                involving acquisitions or dispositions (in each case whether by merger, purchase or sale of assets or stock or otherwise)
by the Company or any of its Subsidiaries of any company (or a material portion of its assets), business or line of business,
(A) entered into since December 31, 2016 or (B) as to which the Company or any of its Subsidiaries has any continuing payment
obligations or any material indemnification or other material obligations;


 


(xvii)               each Contract under which the Company or any of its Subsidiaries has made advances or loans to another Person in excess
of $100,000; and


 


(xviii)              each
Contract relating to the voting or control of equity securities, preemptive rights, registration rights, transfer restrictions,
information rights, preferential purchase rights, tag-along rights, or drag-along obligations, in each case, relating to securities
of the Company or any of its Subsidiaries (other than wholly-owned Subsidiaries) or the holders of any such securities;


 






    48


     


    

 


(xix)              
each Contract governing the terms of any Indebtedness or any guaranty in respect thereof.


 


(b)              
The Company has provided Parent with a true and complete copy of each Material Contract, together with all amendments, waivers
or other changes thereto, and in the case of any oral contract that is also a Material Contract, a true and complete written description
of the terms thereof. With respect to each Material Contract, (i) such Material Contract is the legal and valid obligation of the
Company or its applicable Subsidiary party thereto, enforceable against such Person in accordance with its terms, except as enforceability
may be limited by the Enforceability Exceptions, (ii) to the Knowledge of the Company, such Material Contract is the legal and
valid obligation of each other party thereto, enforceable against such Person in accordance with its terms, except as enforceability
may be limited by the Enforceability Exceptions, and (iii) such Material Contract is in full force and effect, and neither the
Company nor its applicable Subsidiary party thereto, nor, to the Knowledge of the Company, any other party thereto, is in material
breach or default thereunder and no event has occurred or circumstance exists which, with the delivery of notice, the passage of
time or both, would constitute such a breach or default or permit the termination or acceleration of any payment under any such
Material Contract.


 


(c)              
The ability of the Company to perform all obligations required to be performed by it under the Material Contracts has not
been materially limited or adversely affected by or as a result of COVID 19 or any COVID 19 Measure in any material respect. To
the Knowledge of the Company, the ability of each other party to each Material Contract to perform all obligations required to
be performed by it under the applicable Material Contracts has not been materially limited or adversely affected by or as a result
of COVID-19 or any COVID 19 Measure in any material respect.


 


4.14       
Real Property.


 


(a)               Neither
the Company nor any of its Subsidiaries owns, nor has owned since December 31, 2016 (“Previously Owned Real
Property” ), any real property. Neither the Company, nor any of its Subsidiaries, has any outstanding or continuing
obligations (whether pursuant to any contract or otherwise) with respect to any Previously Owned Real Property.


 


(b)              
Section‎ 4.14(b) of the Disclosure Schedule provides the addresses of all material real property in which the
Company or one of its Subsidiaries owns a leasehold interest (the “Leased Real Property” or the “Company
Real Property”) and a complete list of the material Real Property Leases (including the date, address and name of the
parties to each such Real Property Lease document) applicable thereto. The Company’s and each of its applicable Subsidiary’s
title in and to the leasehold interests in the Leased Real Property is free and clear of Liens, except for Permitted Liens and
such Liens as registered in the land registers in the applicable jurisdiction or as would not be material.


 


(c)              
The Company Real Property constitutes all of the material real property currently used in the conduct of the Business. The
Leased Real Property is, in all material respects, in good condition and repair, and are sufficient for the operation of the Business
as currently conducted. The Company’s or its applicable Subsidiary’s possession and quiet enjoyment of the Leased Real
Property have not been disturbed. There are no leases, subleases, assignments, occupancy agreements or other agreements granting
to any Person (other than the Company or one of its Subsidiaries) the right of use or occupancy of any Company Real Property except
in connection with any co-location agreement with any customer of the Company or one of its Subsidiaries as provided in Section‎
4.14(a) of the Disclosure Schedule. There are no pending or ongoing, or, to the Company’s Knowledge, threatened, Legal
Proceedings with respect to any Real Property Lease. The Company has not collaterally assigned or granted any other security interest
in any Real Property Lease or any interest therein.


 






    49


     


    

 


4.15       
Personal Property.


 


(a)              
The Company or one of its Subsidiaries is vested with good title in and to, or valid right to use, each material item of
inventory, equipment, machinery, supply, furniture, computer hardware, raw material, inventory, car, truck, trailer and other rolling
stock and each other item of tangible personal property reflected on the Latest Balance Sheet other than the Rental Equipment and
any other goods held by the Company or its Subsidiaries pursuant to consignment arrangements, items sold, leased or otherwise disposed
of in the Ordinary Course of Business since the Latest Balance Sheet Date (the “Tangible Personal Property”).
The Tangible Personal Property is in all material respects in good working order and repair, ordinary wear and tear excepted, and,
in all material respects, is adequate and sufficient, and in satisfactory condition to support the current operations of the Company
and its Subsidiaries.


 


(b)              
Taken as a whole, the Rental Equipment has been maintained, serviced and refurbished in all material respects in accordance
with standard industry practices.


 


4.16       
Intellectual Property.


 


(a)               Section‎
4.16(a) of the Disclosure Schedule lists all issuances, registrations and pending applications pertaining to Intellectual
Property owned by or registered to the Company or any of its Subsidiaries (together with all other Intellectual Property
owned or purported to be owned by the Company or any of its Subsidiaries, the “Owned Intellectual
Property”). All Owned Intellectual Property is subsisting, valid and enforceable in all material respects. All
necessary registration, maintenance and renewal fees in connection with Owned Intellectual Property have been paid and all
necessary documents and certificates in connection with the foregoing have been filed with the relevant authorities for the
purposes of perfecting, prosecuting and maintaining the foregoing.


 


(b)              
Section ‎ 4.16(b) of the Disclosure Schedule sets forth a true, accurate, and complete list of all material
computer software owned, or purported to be owned by, the Company (the “Proprietary Software”).


 


(c)              
(i) The Company or one of its Subsidiaries exclusively owns and possesses all right, title and interest in and to all Owned
Intellectual Property and Proprietary Software and (ii) the Company and its Subsidiaries have sufficient rights pursuant to a valid
and enforceable Contract to all other Intellectual Property used in or necessary for the current operations of the Business (together
with the Owned Intellectual Property, the “Business IP”), in each case of clause (i) and (ii), free and clear
of all Liens, other than Permitted Liens and non-exclusive licenses of Intellectual Property. The Company and its Subsidiaries
have sufficient seat, server, case or other unit licenses for all software or services licensed from a third party for the conduct
of the Business as currently conducted. The Company and its Subsidiaries have taken all reasonable steps under the circumstances
to protect, preserve and maintain all Owned Intellectual Property and any other Trade Secrets used by any of them, except for Owned
Intellectual Property that is not material to the Business and the Company or applicable Subsidiary has determined not to protect,
preserve or maintain in its reasonable business judgment. No Trade Secrets in the Owned Intellectual Property have been disclosed
or authorized to be disclosed to any Person, other than in the Ordinary Course of Business pursuant to a written confidentiality
agreement. To the Knowledge of the Company, no Person is in breach of any such obligation.


 






    50


     


    

 


(d)              
None of the Company, any of its Subsidiaries or the Business is infringing, misappropriating, diluting or otherwise violating,
or have since December 31, 2016, infringed, misappropriated, diluted or otherwise violated, any Intellectual Property of any other
Person. Neither the Company nor any of its Subsidiaries has received or sent any written or, to the Knowledge of the Company, oral
notice, claim, complaint, demand, challenge or other communication regarding any infringement, misappropriation, dilution or violation
of any Intellectual Property, or challenging the enforceability, use, ownership, scope, licensing or validity of any Intellectual
Property (other than actions received from the US Patent and Trademark Office and counterpart foreign offices in the ordinary course
of registering Intellectual Property), including of any other Person or request for indemnification in relation to Intellectual
Property. No other Person is infringing, misappropriating, diluting or otherwise violating any of the Owned Intellectual Property.


 


(e)               Each
Person who has participated in the authorship, conception, creation, reduction to practice, or development of any
Intellectual Property for, on behalf of or under the direction or supervision of the Company or any of its Subsidiaries or
any Owned Intellectual Property has executed and delivered to the Company a valid written Contract providing for (i) the
non-disclosure by such Person of all Trade Secrets of the Company or any of its Subsidiaries and (ii) the assignment by such
Person (by way of a present grant of assignment) to the Company or any of its Subsidiaries of all right, title and interest
in and to such Intellectual Property or otherwise arising out of such Person’s employment by, engagement by, or
Contract with the Company or any of its Subsidiaries. To the Knowledge of the Company, no Person is in breach of any such
Contract.


 


(f)               The
Company Systems are sufficient in all material respects for the current needs of the Company and its Subsidiaries. Since December
31, 2016, there have been no failures, crashes, Security Breaches or other similar adverse events affecting the computer software,
computer hardware, firmware, networks and related systems used by the Company or its Subsidiaries or other Company Systems which
have had a material effect on the operations of the Business. The Company and its Subsidiaries have taken reasonable precautions
to (i) protect the confidentiality, integrity and security of the Company Systems and all information stored or contained therein
or transmitted thereby from any theft, corruption, loss or unauthorized use, access, interruption or modification by any Person
and (ii) ensure that all Company Systems are (A) fully functional and operate and run in a reasonable and efficient business manner
in all material respects, and (B) free from any material bug, virus, malware or programming, design or documentation error or
corruption or defect. The Company and its Subsidiaries have implemented, maintained and tested adequate and commercially reasonable
disaster recovery procedures and facilities. The Company Systems do not contain any computer code or any other mechanisms which
may (i) to the Knowledge of the Company, maliciously disrupt, disable, erase or harm in any way the Proprietary Software’s
operation, or maliciously cause the Company Systems to damage or corrupt any data, hardware, storage media, programs, equipment
or communications, or (ii) permit any Person to access the Company Systems without authorization.


 






    51


     


    

 


4.17       
Insurance. The Company has made available to Parent all material policies of insurance (other than any Employee Plan)
owned or held by the Company as of the date of this Agreement. All such material policies are, as of the date of this Agreement,
in full force and effect and, since December 31, 2016, all premiums due and payable have been paid prior to the date hereof in
accordance with their terms. The Company has not received written notice that it is in material default (whether as to the payment
of premium or otherwise, under the terms of any such policy), and neither the Company nor any of its Subsidiaries has received
notice of cancellation or non-renewal or, to the Knowledge of the Company, threatened cancellation or non-renewal of any insurance
policy held by the Company or its applicable Subsidiary and there are no material claims pending under any such insurance policies
for which coverage has been denied or disputed by the applicable insurance carrier (other than pursuant to a customary reservation
of rights notice). Excluding insurance policies that have expired and been replaced in the ordinary course of business, no insurance
policy has been cancelled since January 1, 2018 and, to the Knowledge of the Company, no threat has been made to the Company in
writing to cancel any insurance policy insuring the Company during such period. Except as set forth in Section‎
4.17 of the Disclosure Schedule, none of such material insurance policies will terminate or lapse as a result of the consummation
of the transactions contemplated by this Agreement.


 


4.18        Related
Party Transactions. Except as set forth in Section ‎4.18 of
the Disclosure Schedule, (a) neither the Company nor any of its Subsidiaries (i) is party to any Contract with any Affiliate
of the Company or any of its Subsidiaries, any Company Equityholder or any shareholder, executive manager, officer or
director of the Company or any of its Subsidiaries or, to the Knowledge of the Company, any employee of the Company or any of
its Subsidiaries (each, a “Company Related Party”) other than Contracts governing an employee’s
services to the Company or its Subsidiaries and employee benefits (including pursuant to any Employee Plan), (ii) owes or has
outstanding any indebtedness (for monies actually borrowed or lent) in excess of $50,000 to any Company Related Party, and
(b) no Company Related Party owns any material asset used by the Company or any of its Subsidiaries in and necessary for the
operation of the business or has any right, title, license or interest in or to any material Business IP, in each case, other
than through any direct or indirect ownership interest in the Company.


 


4.19       
Material Customers, Suppliers, Payors and Referral Sources.


 


(a)              
Section‎ 4.19(a) of the Disclosure Schedule sets forth (i) the twenty (20) largest customers of the Company
and its Subsidiaries, taken as a whole, by revenue (“Material Customers”), and (ii) the twenty (20) largest
suppliers of the Company and its Subsidiaries, taken as a whole, by expense (“Material Suppliers”), in each
case for each of the current calendar year and the immediately preceding calendar year. Since January 1, 2020, no Material Customer
or Material Supplier, has (x) notified the Company or any of its Subsidiaries in writing that it intends to discontinue or materially
and adversely change its relationship with the Company or its Subsidiaries, or (y) actually discontinued or materially and adversely
changed its relationship with the Company or its Subsidiaries.


 






    52


     


    

 


(b)              
Section‎ 4.19(b) of the Disclosure Schedule sets forth the twenty (20) largest Third Party Payors of the Company
and its Subsidiaries, taken as a whole, by actual payments received by the Company and each of its Subsidiaries from such Third
Party Payors, in each case, for each of the current calendar year and the immediately preceding calendar year (each a “Material
Payor”). Since January 1, 2020, no Material Payor has (x) notified the Company or any of its Subsidiaries in writing
that it intends to discontinue or materially and adversely modify its relationship with the Company or its Subsidiaries or (y)
actually discontinued or materially and adversely changed its relation with the Company or its Subsidiaries.


 


(c)              
Section‎ 4.19(c) of the Disclosure Schedule sets forth the twenty (20) largest Referral Sources to the
Company and its Subsidiaries, taken as a whole, by actual payments received by the Company and each of its Subsidiaries in respect
of such Referral Sources during the current calendar year and the immediately preceding calendar year (each a “Material
Referral Source”). Since January 1, 2020, no Material Referral Source has (x) notified the Company or any of its Subsidiaries
in writing that it intends to discontinue or materially and adversely modify its relationship with the Company or its Subsidiaries
or (y) actually discontinued or materially and adversely changed its relation with the Company or its Subsidiaries.


 


4.20       
Privacy.


 


(a)               Other
than as set forth on Section‎ 4.20 of the Disclosure Schedule, no Security Breach materially affecting the
Business and no violation or unauthorized access to any Personal Data that is collected, used, or held for use or otherwise
subject to Data Treatment by or on behalf of by the Company or its Subsidiaries, has occurred since December 31, 2016 or, to
the Knowledge of the Company, is threatened.


 


(b)              
The Company and its Subsidiaries materially comply and have materially complied since December 31, 2016 with all (A) applicable
laws, statutes, directives, rules, and regulations concerning data protection, privacy, security or other similar laws (including
any security breach notification requirements), including, in each case, to the extent applicable, the HITECH Act, Fair Credit
Reporting Act, Fair and Accurate Credit Transaction Act, Privacy Act of 1974, CAN-SPAM Act, Telephone Consumer Protection Act,
Telemarketing and Consumer Fraud and Abuse Prevention Act, state social security number protection laws, state data breach notification
laws, and state consumer protection laws, (B) contractual obligations (including, but not limited to, those with identified customers)
relating to data privacy, security, confidentiality, breach, and/or processing for Personal Data, (C) internal and public-facing
data privacy, security, confidentiality, breach and/or processing policies of the Company or its Subsidiaries, which policies are
sufficient to comply in all material respects with all applicable laws, statutes, directives, rules and regulations, (D) rules
of applicable self-regulatory organizations relating to privacy, data handling and/or security policies or practices, (E) the Payment
Card Industry Data Security Standard, and other applicable rules and requirements of payment card brands; and (F) applicable published
industry standards, in each case, including relating to (i) the privacy of users of any web properties, products and/or services
of the Company or its Subsidiaries; (ii) the creation, receipt, transmission, collection, use, security, storage, retention, disclosure,
transfer, disposal, or any other processing or Data Treatment of any Personal Data collected or used by the Company or its Subsidiaries;
or (iii) the transmission of marketing and/or commercial messages containing or using Personal Data through any means, including,
without limitation, via email, text message and/or any other means ((A) through (F), collectively, “Privacy Laws and Requirements”).
To the extent required by any Legal Requirement, the Company has executed agreements, which require all third parties that have,
or have had, access to Personal Data collected or subject to Data Treatment by or on behalf of the Company or its subsidiaries,
to comply in a commercially reasonable manner with all applicable Privacy Laws and Requirements.


 






    53


     


    

 


(c)              
The Company and each of its Subsidiaries maintains privacy policies, procedures and rules that describe their policies with
respect to the creation, receipt, maintenance, transmission, collection, use, security, storage, retention, disclosure, transfer,
disposal or other processing or Data Treatment of Personal Data, which policies are sufficient to comply in all material respects
with all applicable Privacy Laws and Requirements. Each such privacy policy has included information and made disclosures to users
or customers in material compliance with Privacy Laws and Requirements. The Company and each of its Subsidiaries have obtained
all necessary consents from data subjects, in each case required for the operation of the Business, and abided by any privacy choices
(including opt-out preferences) of data subjects relating to Personal Data, except in each instance, as would not be material to
the Company and its Subsidiaries, taken as a whole. None of such disclosures made or contained in any such privacy policy or in
any such materials has been inaccurate, misleading or deceptive or in violation of any Privacy Laws and Requirements, except in
each instance, as would not be material to the Company and its Subsidiaries, taken as a whole.


 


(d)              
 There is not, and has not been, any complaint, notice, demand, challenge or other communication made to, or any Legal Proceeding,
audit, proceeding, investigation (formal or informal) or claim currently pending, threatened in writing, or to the Knowledge of
the Company, threatened orally against the Company by any private party, the Federal Trade Commission, the Officer for Civil Rights,
any state attorney general or similar state official, or any other Governmental Entity or other Person, with respect to the privacy,
security, creation, receipt, maintenance, transmission, collection, use, security, storage, retention, disclosure, transfer, storage,
disposal or other processing of Personal Data, Privacy Laws and Regulations, Security Breach or Data Treatment, except in each
instance, as would not be material to the Company and its Subsidiaries, taken as a whole. The Company has taken steps reasonably
necessary (including, without limitation, implementing and monitoring compliance with adequate measures, controls, procedures,
protocols, and safeguards with respect to administrative, technical and physical security) to protect Personal Data against loss,
breach, or unauthorized access, acquisition, use, modification, disclosure or other misuse, except in each instance, as would not
be material to the Company and its Subsidiaries, taken as a whole.


 


(e)              
Except as would not be material to the Company and its Subsidiaries, taken as a whole, the Company and its Subsidiaries
have established and are materially in compliance with a written information security program that: (i) includes commercially reasonable
and appropriate administrative, technical and physical safeguards designed to safeguard the availability, confidentiality, and
integrity of transactions and Personal Data; and (ii) is commercially reasonable and designed to protect against unauthorized access
to the Company Systems or Personal Data.


 






    54


     


    

 


(f)               
The Company and each of its Subsidiaries has since December 31, 2016 conducted its businesses in material compliance with
HIPAA and applicable regulations, including those regulations addressing the security of electronic Protected Health Information
(“PHI”), notification obligations in the case of breaches of unsecured PHI, and the privacy of individually
identifiable health information that are promulgated at 45 C.F.R. Parts 160 and 164 (collectively, the “HIPAA Laws”).
The Company and each of its Subsidiaries has adopted and implemented reasonable and appropriate internal policies and procedures
and safeguards to maintain privacy and security of PHI, including, without limitation, electronic PHI, in compliance in all material
respects with its obligations under the HIPAA Laws.


 


4.21       
Brokers’ Fees. Except as set forth in Section‎
4.21 of the Disclosure Schedule, neither the Company nor any of its Subsidiaries is liable for any investment banking fee,
finder’s fee, brokerage payment or other like payment in connection with the origination, negotiation or consummation of
the transactions contemplated by this Agreement.


 


4.22        Sufficiency
of Assets. Except as set forth on Section‎ 4.22
of the Disclosure Schedule, and assuming the receipt of all required third-party or governmental consents, waivers and
approvals required in connection with the consummation of the transactions contemplated by this Agreement or any of the other
Transaction Documents, the property, assets, and rights of every type and description, whether real or personal, tangible or
intangible, of the Company and its Subsidiaries, and the services and rights contemplated to be provided to Parent, any of
its Affiliates and/or the Business pursuant to the Transaction Documents, constitute all material properties, assets and
rights necessary to the conduct of the Business and in all material respects as conducted by the Company and its Subsidiaries
during the twelve (12)-month period immediately preceding the Closing Date.


 


4.23       
[RESERVED].


 


4.24       
Environmental Matters. Except as set forth on Section‎
4.24 of the Disclosure Schedule: (i) the Company and each of its Subsidiaries is currently and since December 31, 2016 has
been in material compliance with all Environmental Laws; (ii) without limiting the generality of the foregoing, the Company and
each of its Subsidiaries has obtained and complied with, and is currently in compliance with, all permits, licenses and other authorizations
that may be required pursuant to Environmental Laws; (iii) neither the Company, the Company nor any of the Company’s Subsidiaries
has received since December 31, 2016 any notice, report or other information regarding any actual or alleged violation of or liabilities
under any Environmental Laws; (iv) there are no Legal Proceedings, orders or claims pending or, to the Knowledge of the Company,
threatened against the Company or any of its Subsidiaries with respect to violations of or liabilities under Environmental Laws;
and (v) neither the Company nor any of its Subsidiaries, nor any of their respective predecessors or Affiliates, has treated, stored,
disposed of, arranged for or permitted the disposal of, transported, handled, released or exposed any person to any Hazardous Substance,
or owned or operated any property or facility contaminated by any Hazardous Substance, in each case, as has given or would give
rise to liabilities or obligations under any Environmental Laws that would be material to the Company or its Subsidiaries, taken
as a whole. The Company and its Subsidiaries have furnished to Parent all environmental and occupational safety and health related
audits, reports and other material documents relating to its past or current properties or operations which are in its possession
or under its reasonable control.


 






    55


     


    

 


4.25       
Product Liability. The Company and each of its Subsidiaries (i) have not received written notice and, to the Company’s
Knowledge, have no other notice of any statements, citations or decisions by any Governmental Entity declaring any of the goods,
products or inventory used, distributed, refurbished or produced by the Company or its Subsidiaries to be defective or unsafe;
(ii) have not received written notice and, to the Company’s Knowledge, have no other notice of any recalls ordered by any
Governmental Entity with respect to any of their goods, products or inventory; and (iii) have no liability for products engineered,
designed, manufactured, fabricated, filled, distributed, refurbished or sold prior to the date hereof, including any liability
pursuant to any applicable Contract or warranty (whether express or implied), that is reasonably likely to give rise to or result
in damages (other than any damages that would be covered by vendor warranties or insurance in effect prior to the Closing if Parent
used commercially reasonable efforts to recover under such vendor warranties or insurance) in excess of $100,000.


 


4.26       
COVID-19 Laws. Except for the Aggregate Stimulus Funds in the aggregate amount set forth on Section 4.26 of
the Disclosure Schedule, as of the date hereof, neither the Company nor any of its Subsidiaries has entered into a material Contract
in connection with, or materially participated in, or sought material relief of benefits under, any program under any COVID-19
related Legal Requirement, including in respect of the Small Business Administration Paycheck Protection Program.


 


4.27        No
Other Representations and Warranties. THE PARTIES ACKNOWLEDGE AND AGREE THAT, EXCEPT AS EXPRESSLY SET FORTH IN THIS ‎ARTICLE
IV (AS MODIFIED BY THE APPLICABLE DISCLOSURE SCHEDULE) AND IN ANY CERTIFICATE DELIVERED PURSUANT TO SECTION ‎2.3(a),
THE COMPANY IS NOT MAKING ANY OTHER REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, NOR HAS IT MADE IN ANY EVENT ANY
REPRESENTATION OR WARRANTY WITH RESPECT TO MATERIALS FURNISHED TO PARENT OR ITS REPRESENTATIVES DURING THE DILIGENCE PROCESS
OR OTHERWISE OR MATTERS THAT WERE DISCUSSED ON OR PRIOR TO THE DATE HEREOF OR OTHERWISE. NOTWITHSTANDING THE FOREGOING, THE
COMPANY MAKES AND HAS MADE NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO ANY FINANCIAL FORECASTS, PROJECTIONS,
ESTIMATES OR BUDGETS HERETOFORE DELIVERED TO OR MADE AVAILABLE TO PARENT OR ITS COUNSEL, ACCOUNTANTS OR ADVISORS OF FUTURE
REVENUES, EXPENSES OR EXPENDITURES OR FUTURE RESULTS OF OPERATIONS OF THE COMPANY, IN EACH CASE EXCEPT TO THE EXTENT THE
SUBJECT OF A REPRESENTATION OR WARRANTY SET FORTH IN ARTICLE IV. PARENT SHALL ACQUIRE THE BUSINESS OF THE COMPANY WITHOUT ANY
REPRESENTATION OR WARRANTY AS TO MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, IN AN “AS IS” CONDITION
AND ON A “WHERE IS” BASIS, EXCEPT AS OTHERWISE EXPRESSLY REPRESENTED OR WARRANTED IN THIS ‎ARTICLE
IV, AS QUALIFIED BY THE APPLICABLE DISCLOSURE SCHEDULE, OR IN ANY OTHER TRANSACTION DOCUMENT OR CERTIFICATE DELIVERED
PURSUANT TO SECTION ‎2.3(a). Notwithstanding
anything to the contrary contained in this Section‎
4.27 or otherwise, nothing in this Section‎
4.27 shall in any manner apply TO any claim of fraud.


 






    56


     


    

 


ARTICLE
V

REPRESENTATIONS AND WARRANTIES OF PARENT, Merger Sub and merger sub ii


 


Except as set forth in publicly available
SEC Reports filed by Parent with the SEC following December 31, 2019, and prior to the date hereof but excluding any disclosures
set forth in risk factors or any “forward looking statements” within the meaning of the Securities Act of 1933 (the
 “Securities Act” ) or the Securities Exchange Act of 1934, as amended, (the “Exchange Act”
), Parent hereby represents and warrants, as of the date hereof and as of the Closing Date, to the Company as follows in this ‎ARTICLE
V.


 


5.1           
Organization; Existence and Good Standing. Parent, Merger Sub and Merger Sub II are each duly organized, validly
existing and in good standing under the laws of its state of incorporation.


 


5.2            Authority;
Enforceability. Each of Parent, Merger Sub and Merger Sub II has all necessary corporate power and authority, as
applicable, to execute this Agreement and the other Transaction Documents to which it is or will be a party, and to perform
its obligations under this Agreement and the other Transaction Documents to which it is a party. The execution and delivery
of, and the performance of Parent’s obligations under, this Agreement and the other Transaction Documents to which
Parent, Merger Sub or Merger Sub II is a party have been duly and validly authorized by all required corporate action on the
part of Parent, Merger Sub and Merger Sub II, as applicable. This Agreement and the other Transaction Documents to which
Parent, Merger Sub or Merger Sub II is a party, as the case may be, constitute the valid and binding obligations of Parent,
Merger Sub or Merger Sub II, as applicable, enforceable against Parent, Merger Sub or Merger Sub II, as applicable, in
accordance with each of their respective terms and conditions, except as enforceability may be limited by any of the
applicable Enforceability Exceptions. Parent, Merger Sub and Merger Sub II have, in accordance with all Legal Requirements
and the Charter Documents of Parent, Merger Sub and Merger Sub II, obtained all approvals and taken all actions necessary for
the authorization, execution, delivery and performance of the respective obligations by each of Parent, Merger Sub and Merger
Sub II of and under this Agreement and the other Transaction Documents to which it is a party. The Parent Board of Directors,
at a meeting duly called and held or by written consent, adopted resolutions (i) directing that Parent submit to the holders
of Common Stock a proposal to approve the removal of the Conversion Restriction (as such term is defined in the Certificate
of Designations) at a meeting of the holders of Common Stock in accordance with the terms of this Agreement (ii) recommending
that the holders of the Common Stock approve the removal of the Conversion Restriction (as such term is defined in the
Certificate of Designations), which resolutions have not been subsequently rescinded, modified or withdrawn. The affirmative
vote (in person or by proxy) of the holders of a majority of the shares of Common Stock (excluding the Share Consideration)
voting at the stockholders meeting for the removal of the Conversion Restriction (as such term is defined in the Certificate
of Designations) is the only vote or approval of the holders of any class or series of capital stock of Parent or any of its
Subsidiaries that is required under the rules and regulations of the SEC, the General Corporation Law of the State of
Delaware or Nasdaq to approve the transactions contemplated by this Agreement and any other Transaction Document and the
consummation thereof and thereby, including the conversion of all the Share Consideration under Nasdaq listing rule 5635 (the
 “Parent Stockholder Approval”).


 






    57


     


    

 



 


5.3           
No Violations. The execution, delivery and performance of the obligations under this Agreement and any other Transaction
Document to which any of Parent, Merger Sub or Merger Sub II, as applicable, is a party, by Parent, Merger Sub and Merger Sub II
and the execution and delivery of other Transaction Documents to which Parent, Merger Sub or Merger Sub II, as applicable, is a
party does not and will not, and the performance and compliance with the terms and conditions hereof and thereof by Parent, Merger
Sub and Merger Sub II, as applicable, and the consummation of the transactions contemplated hereby and thereby by Parent, Merger
Sub and Merger Sub II, as applicable, will not (with or without notice or passage of time, or both), except, with respect to clause
(c), as would not have a Parent Material Adverse Effect:


 


(a)              
violate or conflict with, result in a breach of or constitute a default under any of the provisions of any of Parent’s,
Merger Sub’s or Merger Sub II’s Charter Documents;


 


(b)              
(i) violate or conflict with any provision of, (ii) cause a default under, or (iii) give rise to, or result in, or require,
any notice, filing, consent, authorization or approval under, any Legal Requirement binding upon Parent, Merger Sub or Merger Sub
II; or


 


(c)               to
the extent it would have a, require any notice or filing with respect to, result in a violation or breach of, or cause
acceleration of any right or obligation under, or require any notice or constitute a default, or give rise to any right of
termination, amendment, modification, cancellation, loss of benefit or acceleration under, any of the terms, conditions or
provisions of or result in a Lien on any of the assets of any of Parent, Merger Sub or Merger Sub II pursuant to any Contract
to which any of Parent, Merger Sub or Merger Sub II is a party or is otherwise bound or any Permit held by any of Parent,
Merger Sub or Merger Sub II.


 


5.4           
Consents. No material approval, consent, waiver, authorization or other order of, and no declaration, filing, registration,
qualification or recording with, any Governmental Entity is or will be required to be obtained or made by or on behalf of Parent,
Merger Sub or Merger Sub II, as applicable, in connection with the execution, delivery or performance of this Agreement and the
consummation of the Closing hereunder, except for (a) approval under the HSR Act, (b) the filing with the SEC of such current reports
and other documents, if any, required to be filed with the SEC under the Exchange Act or Securities Act in connection with the
transactions contemplated hereunder, including the filing with the SEC of a proxy statement relating to the Parent Stockholders’
Meeting (the “Proxy Statement”), (c) compliance with any applicable state securities or blue sky laws, (d) any
filings required by the Amended and Restated Registration Rights Agreement, as in effect at such time, and (e) the filing of the
Certificate of Designations with the Secretary of State of the State of Delaware.


 


5.5           
Legal Proceedings. There are no Legal Proceedings pending or, to the Knowledge of Parent, threatened against (a)
Parent or any of its Subsidiaries (or Parent or any of its Affiliates relating to the business of Parent and its Subsidiaries),
including, without limitation, any Legal Proceeding (i) seeking equitable or injunctive relief as its principal remedy, (ii) allege
criminal wrongdoing by Parent or any of its Subsidiaries or (iii) related to the transactions contemplated hereby, or (b) any director,
officer or, to the Knowledge of Parent, employee of Parent or any of its Subsidiaries in such Person’s capacity as such,
except, in each case, as would not be material to Parent and its Subsidiaries, taken as a whole. Neither Parent nor any of its
Subsidiaries is subject to, or bound by, any Order, except as would not be material to Parent and its Subsidiaries, taken as a
whole.


 






    58


     


    

 


5.6           
Brokers’ Fees. Neither Parent nor Merger Sub nor Merger Sub II is liable for any investment banking fee, finder’s
fee, brokerage payment or other like payment in connection with the origination, negotiation or consummation of the transactions
contemplated by this Agreement.


 


5.7            Financing.
Parent has delivered to Company a true, correct and complete copy of the fully executed debt commitment letter(s) and the fee
letter(s), dated as of the date hereof (the “Debt Financing Commitment”) (in the case of the fee
letter(s), redacted form removing commercially sensitive information therein, including the fee information and
 “flex” provisions), pursuant to which the Debt Financing Sources have committed to Parent and/or its Affiliates,
subject to the terms and conditions set forth therein, to provide or cause to be provided the debt amounts set forth therein
for the purpose, among others, of financing the transactions contemplated by this Agreement and related fees and expenses to
be incurred by Parent and/or its Affiliates in connection therewith and for the other purposes set forth therein (the
 “Debt Financing”, which may also include certain actions to be taken under and in connection with the
Existing Credit Agreement). As of the date hereof, the Debt Financing Commitment is valid and in full force and effect, has
not been amended, modified or waived, no such amendment, modification or waiver is pending or contemplated (except for
amendments to add additional financing sources thereto in accordance with the Debt Financing Commitment), and the Debt
Financing Commitment has not been withdrawn, terminated or rescinded in any respect. Parent has fully paid or caused to be
fully paid any and all commitment fees or other fees required to be paid in connection with the Debt Financing Commitment
that are payable on or prior to the date hereof. The Debt Financing Commitment, in the form so delivered, is a valid, legal,
binding and enforceable obligation of Parent and, to the knowledge of Parent, the other parties thereto, except as
enforceability may be limited by the Enforceability Exceptions. Assuming the truth and correctness in all material respects
of the Company’s representations and warranties made hereunder, as of the date hereof, no event has occurred which,
with or without notice, lapse of time or both, would constitute a default or breach on the part of Parent or to the Knowledge
of Parent, any other parties thereto, under the Debt Financing Commitment, or a failure of any condition to the Debt
Financing or otherwise result in any portion of the Debt Financing being unavailable on the Closing Date. Assuming the truth
and correctness of the Company’s representations and warranties hereunder, as of the date hereof, Parent does not have
any reason to believe that any of the conditions to the Debt Financing will fail to timely be satisfied or that the full
amount of the Debt Financing will be unavailable on the Closing Date (taking into account the Marketing Period). As of the
date of this Agreement, Parent is not aware of any fact, event or other occurrence that makes any of the representations or
warranties of Parent in the Debt Financing Commitment misleading or inaccurate in any material respect. The Debt Financing
Commitment is not subject to any conditions precedent to the obligations of the parties thereunder (including with respect to
the Debt Financing Commitment, pursuant to any “flex” provisions in the related fee letter) to make the full
amount of the Debt Financing available to Parent at the Closing other than as set forth therein (including the payment of
customary fees). The Debt Financing (both before and after giving effect to any “flex” provisions contained in
the Debt Financing Commitment), will be sufficient for Parent to pay the Aggregate Merger Consideration (less the
Aggregate Parent Stock Value and less the Aggregate Exercise Price), the Payoff Amount and the Selling Expenses.


 






    59


     


    

 


5.8           
[RESERVED]


 


5.9           
Capitalization.


 


(a)               The
total number of shares of all classes of capital stock which Parent is authorized to issue is 250,000,000 shares, which
consists of (a) 245,000,000 shares of common stock, par value $0.0001 per share (“Common Stock”), which
Common Stock consists of (i) 210,000,000 shares of Class A Common Stock (“Class A Common Stock”) and (ii)
35,000,000 shares of Class B Common Stock (“Class B Common Stock”) and (b) 5,000,000 shares of preferred
stock, par value $0.0001 per share (“Preferred Stock”), of which 185,000 shares of Preferred Stock are
authorized as Series B-1 Preferred Stock and 40,000 shares of Preferred Stock are authorized as Series A Preferred Stock. As
of the close of business on November 30, 2020 (the “Capitalization Date”), there were 66,172,024 shares of
Class A Common Stock outstanding, 23,590,620 shares of Class B Common Stock outstanding, 183,560.02 shares of Series B-1
Preferred Stock outstanding and no shares of Series A Preferred Stock or Series B-2 Preferred Stock. As of the close of
business on the Capitalization Date, (i) 1,569,978 shares of Class A Common Stock remained available for issuance pursuant to
the AdaptHealth Corp. 2019 Stock Incentive Plan (the “Stock Plan”), (ii) options to purchase 3,464,001
shares of Class A Common Stock (“Parent Stock Options”) pursuant to the Stock Plan were outstanding, (iii)
2,826,398 unvested shares of Class A Common Stock granted pursuant to the Stock Plan were outstanding (together with the
Parent Stock Options, the “Parent Stock Awards”), (iv) 993,719 shares of Class A Common Stock remained
available for issuance pursuant to the AdaptHealth Corp. 2019 Employee Stock Purchase Plan and (v) public and private
warrants to acquire 4,280,548 shares of Class A Common Stock were outstanding. All of the issued and outstanding shares of
Common Stock have been duly authorized and validly issued and are fully paid, nonassessable and free of preemptive or similar
rights. From and after the Capitalization Date through the date of this Agreement, no other shares of Common Stock or
Preferred Stock have been issued other than shares of Common Stock issued in respect of the exercise of Parent Stock Options
or grant or payment of Parent Stock Awards in the ordinary course of business. Parent does not have outstanding stockholder
purchase rights or “poison pill” or any similar arrangement in effect.


 


(b)              
No bonds, debentures, notes or other indebtedness having the right to vote (or convertible into or exchangeable for, securities
having the right to vote) on any matters on which the stockholders of Parent may vote (“Voting Debt” ) are issued
and outstanding. Except (i) pursuant to any cashless exercise provisions of any Parent Stock Options or pursuant to the surrender
of shares to Parent or the withholding of shares by Parent to cover tax withholding obligations under Parent Stock Options or Parent
Stock Awards, (ii) for the Warrants and (iii) as set forth in Section 5.9(a), Parent does not have and is not bound by any
outstanding options, preemptive rights, rights of first offer, warrants, calls, commitments or other rights or agreements calling
for the purchase, sale or issuance of, or securities or rights convertible into, or exchangeable for, any shares of Common Stock
or any other equity securities of Parent or Voting Debt or any securities representing the right to purchase or otherwise receive
any shares of capital stock of Parent (including any rights plan or agreement).


 






    60


     


    

 


5.10       
Shares; Issuance of Share Consideration.


 


(a)              
The Share Consideration to be delivered to certain of the Company Equityholders hereunder and under the Certificate of Designations
upon conversion of the Series C Preferred Stock has been duly authorized and, when issued and paid for pursuant to this Agreement
or issued pursuant to the Certificate of Designations shall be validly issued, fully paid and non-assessable and not subject to
pre-emptive or similar rights created by any applicable Legal Requirement, Parent’s Charter Documents or any Contract to
which Parent is a party or is otherwise bound. All shares of Class A Common Stock to be issued upon exercise of the Substitute
Option Consideration have been duly authorized and shall, upon issuance, be validly issued, fully paid and non-assessable.


 


(b)               Assuming
the accuracy of the Company's representations and warranties in Article III and the accuracy of the Accredited Investor
Questionnaires delivered to Parent and the accredited investor questionnaires set forth in the Company Voting Agreements, the
offer and sale of the Share Consideration is exempt from the registration and prospectus delivery requirements of the
Securities Act and the rules and regulations promulgated thereunder. Without limiting the foregoing, neither Parent nor, to
the knowledge of Parent, any other Person authorized by Parent to act on its behalf, has engaged in a general solicitation or
general advertising (within the meaning of Regulation D of the Securities Act) of investors with respect to offer or sales of
the Share Consideration and neither Parent nor, to the Knowledge of Parent, any other Person authorized by Parent to act on
its behalf, has made any offers or sales of any security or solicited any offers to buy any security, under circumstances
that would cause the offering or issuance of the Share Consideration under this Agreement to be integrated with prior
offerings by Parent for purposes of the Securities Act that would result in Regulation D or any other applicable exemption
from registration under the Securities Act not being available, nor will Parent take any action or steps that would cause the
offering or issuance of the Share Consideration under this Agreement to be integrated with other offerings.


 


5.11        
SEC Reports; Financial Statements.


 


(a)              
Parent has filed, on a timely basis, all forms, reports, prospectuses, proxy statements and documents (together with all
amendments thereof and supplements thereto) required to be filed by it with the Securities and Exchange Commission (the “SEC”)
since February 15, 2018 (together with all exhibits and schedules thereto and all information incorporated therein by reference,
the “SEC Reports”). The SEC Reports (as of the date filed with the SEC and, in the case of registration statements,
prospectuses and proxy statements, on the dates of effectiveness and the dates of mailing, respectively, and, in the case of any
SEC Reports amended or superseded by a filing prior to the date hereof, then on the date of such amending or superseding filing)
(i) have complied in all material respects in accordance with either the applicable requirements of the Securities Act or the Exchange
Act, as the case may be, and the applicable rules and regulations promulgated by the SEC thereunder and (ii) did not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading.


 


(b)              
As of the date hereof, (A) none of Parent’s Subsidiaries is required to file any documents with the SEC, (B) there
are no outstanding or unresolved comments in comment letters from the SEC staff with respect to any of the SEC Reports, and (C)
to Parent’s knowledge, none of the SEC Reports is the subject of ongoing SEC review, outstanding SEC comment or outstanding
SEC investigation. Each of the certifications and statements relating to the SEC Reports required by: (x) Rule 13a-14 or Rule 15d-14
under the Exchange Act; (y) 18 U.S.C. §1350 (Section 906 of the Sarbanes-Oxley Act); or (z) any other rule or regulation promulgated
by the SEC or applicable to the SEC Reports is accurate and complete, and complies as to form and content, in all material respects
with all applicable Legal Requirements.


 






    61


     


    

 


(c)               The
consolidated financial statements of Parent, and the related notes thereto, included or incorporated by reference in the SEC
Reports, as of the date filed with the SEC (and, in the case of registration statements, prospectuses and proxy statements,
on the dates of effectiveness and the dates of mailing, respectively, and, in the case of any SEC Report amended or
superseded by a filing prior to the date hereof, then on the date of such amending or superseding filing), have complied as
to form in all material respects with applicable accounting requirements and with the published rules and regulations of the
SEC with respect thereto, were prepared in accordance with GAAP applied on a consistent basis during the periods indicated
(except as may be indicated in the notes thereto or, in the case of unaudited statements, as permitted by Form 10-Q of the
SEC), and fairly presented, in all material respects (subject, in the case of the unaudited statements, to normal year-end
adjustments and the absence of footnote disclosure, none of which, individually or in the aggregate, are material to Parent
and its Subsidiaries taken as a whole), the consolidated financial position of Parent and its consolidated Subsidiaries as of
the dates of such financial statements and the consolidated results of their operations and cash flows for each of the
periods specified.


 


(d)              
Parent (i) has implemented and maintains disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange
Act) that are reasonably designed to provide assurance that material information relating to Parent, including its consolidated
Subsidiaries, is made known to the individuals responsible for the preparation of Parent’s filings with the SEC and (ii)
has disclosed, based on its most recent evaluation prior to the date of this Agreement, to Parent’s outside auditors and
the audit committee of Parent’s board of directors (i) any significant deficiencies and material weaknesses in the design
or operation of internal controls over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that are reasonably
likely to adversely affect Parent’s ability to record, process, summarize and report material financial information, and
(ii) any fraud involving Parent, whether or not material, by management or other employees who have a significant role in Parent’s
internal controls over financial reporting. As of the date of this Agreement, to the Knowledge of Parent, the outside auditors
and its chief executive officer and chief financial officer will be able to give the certifications and attestations required pursuant
to the rules and regulations adopted pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, without qualification, when next
due.


 


(e)              
There is no transaction, arrangement or other relationship between the Parent and/or any of its Subsidiaries and an unconsolidated
or other off-balance sheet entity that is required to be disclosed by Parent in its SEC Reports and is not so disclosed.


 


(f)               
The Proxy Statement (including any amendment or supplement thereto) will comply as to form in all material respects with
the requirements of the Exchange Act and will not, at the time it or any amendment or supplement thereto is filed with the SEC
or at the time first published, sent or given to the stockholders of Parent, or at the time of the Parent Stockholders’ Meeting,
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding
the foregoing, Parent makes no representation or warranty with respect to statements made or incorporated by reference therein
based on information supplied by or on behalf of the Company or any Affiliates thereof for inclusion or incorporation by reference
in the Proxy Statement.


 






    62


     


    

 


5.12         Compliance with Legal Requirements(a). Parent and each of its Subsidiaries is in compliance in all material respects
with all applicable Legal Requirements, including Health Care Laws, and neither Parent nor any of its Subsidiaries has received
written notice of any investigation with respect to any alleged violation of any applicable Legal Requirements including Health
Care Laws.


 


5.13         Listing
and Maintenance Requirements. The shares of Class A Common Stock are registered pursuant to Section 12(b) of the Exchange
Act and listed on Nasdaq, and the Parent has taken no action designed to, or which to the Knowledge of the Parent is
reasonably likely to, have the effect of, terminating the registration of the shares of Class A Common Stock under the
Exchange Act or delisting the Class A Common Stock from the Nasdaq nor has the Parent received as of the date of this
Agreement any notification that the SEC or the Nasdaq is contemplating terminating such registration or de-listing.


 


5.14         No Disqualification Events. With respect to the issuance of the Share Consideration, none of Parent, any of its predecessors,
any Affiliated issuer, any director, executive officer, other officer of Parent, any beneficial owner of 20% or more of Parent’s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule
405 under the Securities Act) connected with Parent in any capacity at the time of sale is subject to any of the “Bad Actor”
disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act except for items covered by Rule 506(d)(2)
or (d)(3).


 


5.15         Solvency. Assuming that the Company and its Subsidiaries are, taken as a whole, solvent as of the date hereof and
as of immediately prior to Closing, that the representations and warranties set forth in Article ‎IV
and Article ‎V are true and correct
in all respects as of the date hereof and as of the Closing, immediately after giving effect to the consummation of the transactions
contemplated by this Agreement, and assuming the satisfaction of the conditions to Closing set forth in Article VII, Parent
and its Subsidiaries (including the Surviving Company and its Subsidiaries), taken as a whole, shall (i) be able to pay their debts
as they become due; (ii) own property which has a fair saleable value greater than the amounts required to pay their debts as and
when they become due (including a reasonable estimate of the amount of all contingent liabilities); and (iii) have adequate capital
or access to adequate capital to carry on their businesses.


 


5.16         Tax
Matters. Each of Parent and its Subsidiaries has duly and timely filed with the appropriate Governmental Entities all income
and other material Tax Returns required to be filed by or with respect to it (taking into account any applicable extensions to
file such Tax Returns). All such Tax Returns are true, correct and complete in all material respects. All material amounts of
Taxes due and owing by or with respect to Parent and its Subsidiaries on or before the date hereof (whether or not shown on any
Tax Returns) have been timely paid in full (or adequate reserves have been established therefor in accordance with GAAP). Neither
Parent nor its Subsidiaries (nor any predecessor of any such Person) has waived any statute of limitations in respect of Taxes
or agreed to any extension of time with respect to a Tax assessment or deficiency, other than, in each case, with respect to routine
extensions to file Tax Returns. Neither Parent nor any Subsidiary of Parent has taken or agreed to take any action or has Knowledge
of the existence of any fact that could reasonably be expected to prevent or impede the Merger from qualifying as a “reorganization”
within the meaning of Section 368(a) of the Code.  


 






    63


     


    

 


5.17         No
Other Representations and Warranties. THE PARTIES ACKNOWLEDGE AND AGREE THAT, EXCEPT AS EXPRESSLY SET FORTH IN THIS ‎ARTICLE
V (AS MODIFIED BY THE APPLICABLE DISCLOSURE SCHEDULE) AND IN ANY CERTIFICATE DELIVERED PURSUANT TO SECTION ‎2.3(b),
PARENT IS NOT MAKING ANY OTHER REPRESENTATION OR WARRANTY, NOR HAS IT MADE IN ANY EVENT ANY REPRESENTATION OR WARRANTY WITH
RESPECT TO MATERIALS FURNISHED TO COMPANY OR ITS REPRESENTATIVES DURING THE DILIGENCE PROCESS OR OTHERWISE (INCLUDING
FINANCIAL FORECASTS, PROJECTIONS, ESTIMATES OR BUDGETS HERETOFORE DELIVERED TO OR MADE AVAILABLE TO COMPANY OR ITS COUNSEL,
ACCOUNTANTS OR ADVISORS OF FUTURE REVENUES, EXPENSES OR EXPENDITURES OR FUTURE RESULTS OF OPERATIONS OF PARENT) OR MATTERS
THAT WERE DISCUSSED ON OR PRIOR TO THE DATE HEREOF OR OTHERWISE. COMPANY SHALL ACQUIRE THE SHARE CONSIDERATION WITHOUT ANY
REPRESENTATION OR WARRANTY AS TO MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, IN AN “AS IS” CONDITION
AND ON A “WHERE IS” BASIS, EXCEPT AS OTHERWISE EXPRESSLY REPRESENTED OR WARRANTED IN THIS ARTICLE V, AS
QUALIFIED BY THE APPLICABLE DISCLOSURE SCHEDULE, OR IN ANY CERTIFICATE DELIVERED PURSUANT TO SECTION 2.3(b). Notwithstanding
anything to the contrary contained in this Section‎
5.17 or otherwise, nothing in this SECTION‎
5.17 shall in any manner APPLY TO ANY claim of fraud.


 


ARTICLE
VI

COVENANTS AND OTHER AGREEMENTS


 


6.1           
Interim Operation of Business by the Company; Parent.


 


(a)              
From the date hereof through the earlier of the date this Agreement is terminated in accordance with its terms and the Closing,
except as otherwise expressly permitted, required or contemplated by this Agreement, or pursuant to any Legal Requirement (including
COVID-19 Measures), the Company will, and will cause its Subsidiaries to, (x) use commercially reasonable efforts to conduct the
Business in the Ordinary Course of Business except for any actions outside the Ordinary Course of Business for which Parent has
given its prior written consent (not to be unreasonably withheld, conditioned or delayed), (y) use commercially reasonable efforts
to (A) maintain in all material respects the existence and all material rights, Permits, franchises, technology, Intellectual Property
and Contracts of the Company and its Subsidiaries, (B) maintain the books, accounts and records of the Company and its Subsidiaries
in all material respects in accordance with past custom and practice, (C) preserve in all material respects the Company’s
and its Subsidiaries’ goodwill and their relationships with their respective customers and suppliers and retain, in all material
respects, the services of their employees and service providers, and (D) in the event of a condemnation, casualty, loss or other
material damage to any of the assets of the Company and its Subsidiaries prior to the Closing Date, either, following consultation
with Parent, repair or replace, in all material respects, such condemned or damaged property solely through the use of the proceeds
of such condemnation or insurance, or preserve such proceeds for use by the Company and its Subsidiaries, as applicable, following
the Closing, and, (z) except as set forth on Section‎ 6.1 of the Disclosure Schedule, cause the Company and its Subsidiaries
not to, without the prior written consent of Parent (not to be unreasonably withheld, conditioned or delayed with respect to clauses
(ii), (iii), (iv), (v), (vi), (xi) and (xiv)):


 






    64


     


    

 


(i)                     enter
into any transactions with any Related Party (other than as contemplated by this Agreement, the payment of compensation in the
Ordinary Course of Business to a Related Party who is an employee of the Company or any of its Subsidiaries or on arms lengths
terms that are fair);


 


(ii)                    except
as required by any Legal Requirement, an Employee Plan made available to Parent or as explicitly contemplated hereunder,
(i)  increase the compensation or benefits of any employee or other individual independent contractor of the Company or
any of its Subsidiaries outside the Ordinary Course of Business, (ii) accelerate the vesting or payment of any compensation
or benefits of any employee or other individual independent contractor of the Company or any of its Subsidiaries,
(iii) enter into, materially amend or terminate any Employee Plan (or any plan, program, agreement or arrangement that
would be an Employee Plan if in effect on the date hereof) or grant, amend or terminate any awards thereunder, (iv) fund
any payments or benefits that are payable or to be provided under any Employee Plan, (v) terminate without
 “cause” any employee of the Company or any of its Subsidiaries with annual base salary of $150,000 or more,
(vi) Outside the Ordinary Course of Business, hire or engage any new employee or individual independent contractor with
annual base salary of $150,000 or more, (vii) make any loan to any present or former employee or other individual
independent contractor of the Company or any of its Subsidiaries (other than advancement of expenses in the Ordinary Course
of Business), or (viii) enter, amend or terminate into any collective bargaining agreement or other agreement with a
labor union, works council or similar organization;


 


(iii)                   sell,
lease or otherwise dispose of or subject to any Lien any assets except (other than with respect to Excess Capital Equipment between
the date of the physical inventory pursuant to Section 2.8(a) and the Closing) (i) for sales or other dispositions
of inventory in the Ordinary Course of Business and (ii) as may otherwise be expressly permitted or required by the terms of this
Agreement;


 


(iv)                  
make any capital expenditures with respect to the Business in excess of $15 million in the aggregate in any calendar month;


 


(v)                    except
as required by GAAP, revalue any assets of the Company or any of its Subsidiaries or make any material change in its methods or
principles of accounting or accounting practices (including changes in reserves or accrual policies);


 


(vi)                   except
as required by GAAP, (x) change or modify any existing credit and collection policies, procedures or other practices with respect
to accounts receivable or accounts payable in any material respect, (y) change, modify, or write-off as uncollectible any notes
or accounts receivable of the Company and its Subsidiaries, except write-offs in the Ordinary Course of Business and any write-off
of such notes and accounts receivable that are fully reserved for in a manner consistent with GAAP, or (z) materially alter its
practices with respect to inventory levels or the product offerings of the Company or its Subsidiaries;


 






    65


     


    

 


(vii)                  issue, sell, grant or otherwise dispose of any equity interest of the Company or any of its Subsidiaries (other than pursuant
to the exercise or settlement of any outstanding equity awards held by current or former employees of the Company or its Subsidiaries
set forth on Section 6.1(a)(vii) of the Disclosure Schedule or the issuance of equity interests of a Subsidiary to the Company
or a wholly-owned Subsidiary of the Company) or grant any option or warrant or other right to purchase or obtain any such equity
interests;


 


(viii)                 sell,
transfer, assign, dispose of, license, or sublicense to any Person (other than non-exclusive licenses and sublicenses to customers
and vendors in the Ordinary Course of Business), or lose, abandon, or let lapse or expire any material Owned Intellectual Property
other than in the Ordinary Course of Business;


 


(ix)                   split, combine, redeem or reclassify, or purchase, redeem or otherwise acquire, any shares of capital stock or other securities
of the Company or any of its Subsidiaries other than repurchases of capital stock from employees in connection with the termination
of their employment pursuant to the terms of any plan or agreements in effect on the date hereof and made available to Parent;


 


(x)                     (a) incur
any Indebtedness, other than Indebtedness that is included in the Estimated Closing Statement as Estimated Closing Indebtedness
or Indebtedness that is repaid prior to the Closing or (b) make any loans or advances to any other Person, other than in the Ordinary
Course of Business;


 


(xi)                  
enter into any Contract that would constitute a Material Contract if existing as of the date hereof, other than in the Ordinary
Course of Business consistent with past practice; or amend in any material respect or terminate any Material Contract or waive
material rights under any Material Contract, other than extensions of the term, or terminations by way of expiration of the term,
in each case, of the applicable Contract in the Ordinary Course of Business consistent with past practice;


 


(xii)                  
acquire, merge or consolidate with, or effect any business combination with, any Person, or acquire any material assets
of any Person, in each case whether by merger, purchase of stock, securities or assets, property transfers or otherwise, or enter
into any letter of intent (whether or not binding) with respect to any of the foregoing, in each case other than the M&A Purchases;


 


(xiii)                
adopt a plan of complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization with
respect to the Company or any of its Subsidiaries;


 


(xiv)                
(i) settle or compromise any Legal Proceeding that (x) involves any admission of wrongdoing or misconduct by the Company
or any of its Subsidiaries, (y) imposes any non-monetary injunctive or equitable relief against the Company or any of its Subsidiaries
(other than any immaterial injunctive or equitable relief that is merely incidental to a primary obligation for monetary damages)
or (z) requires payment of any amounts following the Closing by the Company or any of its Subsidiaries to the extent that such
amounts are not included in the Estimated Closing Statement as Estimated Closing Indebtedness or as a liability in Net Working
Capital; or (ii) initiate any material Legal Proceeding;


 






    66


     


    

 


(xv)                 
take any action which would have the effect of accelerating to pre-Closing periods collections of material receivables that
would otherwise be expected (based on past practice) to be made in post-Closing periods or the effect of postponing to post-Closing
periods payments to be made by the Company or any of its Subsidiaries that would otherwise be expected (based on past practice)
to be made in pre-Closing period;


 


(xvi)                 grant
any Lien (other than Permitted Liens) with respect to, or permit to be subject to any Lien (other than by a Permitted Lien),
the Company Capital Stock, Company Options, any other equity interest of the Company or, except as would not be material, any
of its Subsidiaries or any of the material properties or assets owned, used or occupied by the any of the Company or any of
its Subsidiaries and are released at or prior to the Closing;


 


(xvii)                discontinue
any material business of the Company or any of its Subsidiaries or enter into any material new line of business;


 


(xviii)               change, amend or restate the charter, certificate of formation or incorporation, operating agreement or bylaws (or other
comparable organizational or governing documents) of the Company and any of its Subsidiaries, other than corrections to inaccuracies
in the charter, certificate of formation or incorporation, operating agreement, bylaws or similar documents of any Subsidiaries
of the Company so long as such corrections are at no cost and without liability to any of Parent, Merger Sub or Merger Sub II;


 


(xix)                 
(i) declare, set aside or pay any non-cash dividends or make any other non-cash distributions with respect to any of its
equity interests, (ii) distribute any Restricted Cash, or (iii) between the Measurement Time and the Closing, declare, set aside
or pay any cash dividend or make any other cash distribution with respect to any of its equity interests;


 


(xx)                   (i)
make, change or revoke any material Tax election, in each case, inconsistent with past practice, (ii) settle or compromise any
claim, notice, audit report or assessment in respect of material Taxes, (iii) fail to pay material Taxes that would otherwise
be delinquent (including estimated Tax payments), (iv) change any annual Tax accounting period or change (or make a request
to any Governmental Entity to change) any material aspects of its method of accounting for Tax purposes, (v) consent to any extension
or waiver of the limitation period applicable to any material Tax claim or assessment, (vi) amend any income or other material
Tax Return that will have a material effect on Parent or either Surviving Company (or their respective Affiliates) in a Post-Closing
Tax Period, (vii) surrender any right to claim a material Tax refund, (viii) enter into any material Tax sharing, closing, or
similar agreement in respect of any Taxes (other than any agreement, arrangement or other Contract not principally related to
Taxes), or (ix) obtain or request any material Tax ruling; or


 






    67


     


    

 


(xxi)                  agree,
resolve, authorize or enter into any material written Contract, agreement, deed, mortgage, lease, license, indenture, note, bond,
or other material document or instrument to which or by which the Company or any of its Subsidiaries is legally bound to do any
of the actions referred to in this Section ‎6.1(a).


 


Nothing contained in this Agreement
shall give Parent, directly or indirectly, the right to control or direct the Company’s or any of its
Subsidiaries’ operations prior to the Closing, and the failure of the Company or any of its Subsidiaries to take any
action prohibited by this Section ‎6.1 shall not be a breach of this Section ‎6.1 or any other
provision of this Agreement. Further, notwithstanding any of the foregoing, the Company shall have the right to effect a
dividend recapitalization transaction (including the incurrence of additional Indebtedness and the payment of a cash dividend
or distribution to all of the Company Equityholders) prior to the Closing in an amount not to exceed $450 million (a
 “Dividend Recapitalization” ). Notwithstanding anything to the contrary contained in this Agreement,
nothing shall prevent the Company or any of its Subsidiaries from taking or failing to take any action, including the
establishment of any policy, procedure or protocol, in each case, in response to COVID-19 or any COVID-19 Measure, and none
of the foregoing shall be deemed to violate or breach this Section 6.1 in any way, be deemed to constitute an action
taken outside of the Ordinary Course of Business or serve as a basis for Parent to terminate this Agreement pursuant to Section
9.1(c) for a breach of this Section 6.1 or assert that the condition set forth in Section 7.1(b) has not been
satisfied due to a breach of this Section 6.1; provided, that in each case, such action or failure to act is (x) taken
or not taken, as applicable, in good faith, and (y) reasonable (as determined by the Company in good faith after consultation
with Parent unless such consultation is not practicable).


 


(b)              
From the date hereof through the earlier of the date this Agreement is terminated in accordance with its terms and the Closing,
except as otherwise expressly permitted, required or contemplated by this Agreement, or pursuant to any Legal Requirement (including
any COVID-19 Measures), Parent shall not, and it shall cause each of its Subsidiaries not to, do any of the following (except to
the extent expressly provided otherwise herein or as consented to in advance in writing by the Company):


 


(i)                     amend,
alter, repeal or otherwise modify (whether by merger, consolidation or otherwise) any provision of the Certificate of Incorporation
in a manner that would adversely effect the powers, preferences, rights or privileges of the Series C Preferred Stock or the Company
Equityholder’s investment therein; or


 


(ii)                    declare,
set aside or pay any cash or non-cash dividends or make any cash or other non-cash distributions with respect to any of its equity
interests (other than with respect to equity interests held by direct or indirect wholly-owned subsidiaries of Parent).


 


6.2            Public
Announcements. The Parties agree that at all times no Party hereto shall issue or make, and each Party shall cause its
Affiliates and representatives not to issue or make, any press releases or public announcements with respect to this
Agreement or the transactions contemplated by this Agreement without the prior written consent of the other Party hereto
(which consent shall not be unreasonably withheld, conditioned or delayed), except as may be required by applicable Legal
Requirement or the rules or regulations of any applicable United States securities exchange or other Governmental Entity to
which the relevant party is subject or submits, in which case the Party required to make the release or announcement shall
use its commercially reasonable efforts to allow the other Party reasonable time to comment on such release or announcement
in advance of such issuance. Each Party hereto will also obtain the prior written approval by the other Party hereto of any
press release to be issued announcing the consummation of the transactions contemplated by this Agreement. For the avoidance
of doubt, the foregoing shall not prevent: (a) disclosures by Parent or the Stockholder Representative or the Company’s
material stockholders (i) to their members, holders of its equity securities, limited partners and Affiliates and (ii) in
connection with any private equity, investment or similar fundraising activities by the direct or indirect, holders of their
equity securities or Affiliates, in each case so long as the recipients of such disclosure are bound by customary
confidentiality obligations; (b) disclosures by a Party to its respective legal counsel, accountants, financial advisors or
other advisors providing legal, tax, accounting, estate planning or investment advice; (c) customary post-closing tombstone
announcements that do not include price or other transaction terms; and (d) disclosures as are required to comply with the
obligations under this Agreement or any of the other Transaction Documents. Without the prior written consent of Parent not
to be unreasonably withheld, between the date hereof and the Closing Date, the Company shall not, and shall cause each of its
Subsidiaries to not, make any broad-based announcements or disclosures regarding the transactions contemplated hereby to any
customers, suppliers or other business partners of the Company or any of its Subsidiaries without the prior written consent
of Parent not to be unreasonably withheld, conditioned or delayed.


 






    68


     


    

 


6.3           
Indemnification and Insurance.


 


(a)              
Parent agrees that all rights to exculpation and indemnification now existing in favor of the Covered Persons, as provided
in the Charter Documents of the Company and its Subsidiaries or otherwise in effect as of the date hereof with respect to any matters
occurring prior to the Closing Date, shall survive the Closing and shall continue in full force and effect for the six-year period
beginning on the Closing Date, and that the Company will perform and discharge its obligations to provide such indemnity and exculpation
after the Closing. To the fullest extent required by the Charter Documents of the Company and each of its Subsidiaries as of the
date hereof or other applicable agreements as of the date hereof set forth on Section 6.3(b) of the Disclosure Schedule,
such indemnification shall be mandatory rather than permissive, and Parent shall cause the Company to advance expenses in connection
with such indemnification. For a period of six (6) years after the Closing, and at all times subject to applicable Legal Requirements,
Parent will not (and will not cause or permit the Company, its Subsidiaries or any of Parent’s other Subsidiaries or Affiliates
to) cancel, terminate, amend or otherwise modify in any way adverse to the Covered Persons, or to the other beneficiaries thereof
the exculpation and indemnification provisions set forth in the Charter Documents of the Company or its Subsidiaries with respect
to time periods at or prior to the Closing.


 


(b)              
Prior to the Closing, the Company will purchase a six (6) year “tail” prepaid directors’ and officers’
liability insurance policy covering the Covered Persons effective as of the Closing, and the premium, and any other costs, for
such policy will be borne 50% by the Company (as a Selling Expense) and 50% by Parent (the “Tail Policy”); provided,
however, in no event shall Parent be required to pay in excess of 200% of the premiums paid as of the date hereof by or
on behalf of the Company and its Subsidiaries for the current directors’ and officers’ liability insurance maintained
by or on behalf of the Company and its Subsidiaries as of the date hereof. From and after the Closing, Parent will (and/or will
cause the Company, its Subsidiaries or their Affiliates, as applicable, to) comply with the terms of any such insurance procured
pursuant to this Section ‎6.3(d), and will not cancel (or permit to be canceled) or take (or cause to be taken) any
other action or omission that would reasonably be expected to result in the cancellation, termination, amendment or modification
thereof.


 






    69


     


    

 


(c)              
If Parent, the Company or any of their respective successors or assigns proposes to (i) consolidate with or merge into any
other Person and Parent or the Company will not be the continuing or surviving corporation or entity in such consolidation or merger
or (ii) transfer all or substantially all of its properties and assets to any Person, then, and in each case, proper provision
will be made prior to or concurrently with the consummation of such transaction so that the successors and assigns of Parent or
the Company, as the case may be, will assume the indemnification and other obligations set forth in this Section ‎6.3.


 


(d)              
 The provisions of this Section ‎6.3 will survive the Closing and (i) are intended to be for the benefit of,
and will be enforceable by, each Covered Person and his or her successors, heirs and representatives and will be binding on all
successors and assigns of Parent and the Company and (ii) are in addition to, and not in substitution for, any other rights to
indemnification or contribution that any such Person may have by Contract or otherwise.


 


6.4           
Pre-Closing Access. From the date of this Agreement until the earlier of the termination of this Agreement in accordance
with its terms or the Closing, the Company shall, and shall cause its Subsidiaries to, permit Parent and its representatives (including
Debt Financing Sources) to have reasonable access (at reasonable times and upon reasonable notice during regular business hours)
to the books, records (including Tax records), employees, representatives, Contracts, financial and operating data and information
and documents pertaining to the Company and its Subsidiaries as Parent or its representatives may reasonably request; provided,
that in exercising access rights under this Section ‎6.4,
Parent shall not be permitted to interfere unreasonably with the conduct of the business of the Company or its Subsidiaries or
to unreasonably jeopardize the health and safety of any employee of the Company or any of its Subsidiaries in light of COVID-19
(provided, that if not in violation of any applicable Legal Requirements, reasonable accommodations shall be made to provide
such information by other means, including electronic video means); provided, further, that the foregoing shall not
require the Company to permit any inspection, or to disclose any information, that in the reasonable judgment of the Company, after
consultation with legal counsel, would reasonably be expected to result in (i) the disclosure of any trade secrets of third parties
or other competitively sensitive information, (ii) the waiver or jeopardizing of any information that is the subject to any applicable
confidentiality restrictions or of any applicable attorney-client, attorney work product or other privilege, or (iii) the violation
of any applicable Legal Requirement (including any COVID-19 Measures).  The Parties will, to the extent legally permissible
and practicable, provide notice to the other Party and make appropriate substitute arrangements under circumstances in which the
restrictions of the preceding sentence apply. None of the Company or any of its Subsidiaries or any other person(s) makes any representation
or warranty as to the accuracy of any information (if any) provided pursuant to this Section ‎6.4,
and none of Parent or any of its Subsidiaries may rely on the accuracy of any such information, in each case, other than to the
extent expressly provided in the representations and warranties expressly and specifically set forth in ‎ARTICLE
IV, as qualified by the Schedules.


 






    70


     


    

 


6.5           
Regulatory and Other Approvals.


 


(a)               Upon
the terms and subject to the conditions set forth in this Agreement, each Party shall use commercially reasonable efforts (at
its own expense, except as may be provided elsewhere in this Agreement) to take, or cause to be taken, all actions, and to
do, or cause to be done, and to assist and cooperate with the other Parties in doing, all things necessary, proper or
advisable to (i) obtain all necessary actions or non-actions, waivers, and consents from Governmental Entities and any other
Person and the making of all necessary registrations and filings (including filings with Governmental Entities, if any) and
the taking of all reasonable steps as may be necessary to obtain an approval or waiver from, or to avoid an action, objection
or Legal Proceeding by, any Governmental Entity or any other Person, (ii) defend any Legal Proceedings challenging this
Agreement or any of the other Transaction Documents or the consummation of the transactions contemplated hereby or thereby,
including seeking to have vacated or reversed any Order that could restrain, prevent or delay the Closing, (iii) promptly
comply with all Legal Requirements that may be imposed on such Party or any of its Affiliates with respect to the Closing or
any of the transactions contemplated by this Agreement or any other Transaction Document, (iv) execute and deliver any
additional instruments reasonably necessary to consummate the transactions contemplated by this Agreement or any other
Transaction Document in accordance with their respective terms and to fully carry out the purposes of this Agreement and any
other Transaction Documents to which it is a party and (v) deliver all required notices and obtain all required consents,
waivers or approvals, in each case under any contracts with third parties.


 


(b)              
Without limiting the generality of the foregoing, each of Parent and the Company shall (i) make or cause to be made all
filings required of each of them or any of their respective Subsidiaries or Affiliates under the HSR Act with respect to the transactions
contemplated by this Agreement or any other Transaction Document as promptly as practicable and, in any event, within five (5)
Business Days after the date of this Agreement, (ii) use reasonable best efforts to comply at the earliest practicable date with
any request under the HSR Act for additional information, documents, or other materials received by each of them or any of their
respective Subsidiaries from the Federal Trade Commission (“FTC”) or the Antitrust Division of the Department
of Justice (the “Antitrust Division”) in respect of such filings or such transactions, and (iii) cooperate
with each other in connection with any such filing (including, to the extent permitted by applicable Legal Requirements, providing
copies of all such documents to the non-filing Party prior to filing and considering all reasonable additions, deletions or changes
suggested in connection therewith) and in connection with resolving any investigation or other inquiry of any of the FTC, the Antitrust
Division or any other Governmental Entity with respect to any such filing or any such transaction.  Each such Party shall
use its reasonable best efforts to furnish to each other Party all information required for any application or other filing to
be made pursuant to any applicable Legal Requirement in connection with the transactions contemplated by this Agreement. 
Each such Party shall promptly inform the other Party hereto of any oral communication with, and provide copies of written communications
with, any Governmental Entity regarding any such filings or any such transaction.  No Party hereto shall independently initiate
or participate in any substantive meeting or discussion, either in person or by telephone, with any Governmental Entity in respect
of any such filings, investigation, or other inquiry without giving the other Party hereto prior notice of the meeting and, to
the extent permitted by such Governmental Entity, the opportunity to attend and/or participate.  Subject to applicable Legal
Requirements, the Parties hereto shall consult and cooperate with one another in connection with any analyses, appearances, presentations,
memoranda, briefs, arguments, opinions and proposals made or submitted by or on behalf of any Party hereto relating to proceedings
with any Governmental Entity; provided, however, that, the Parties shall not be required to share copies of filings
made under the HSR Act.


 






    71


     


    

 


(c)               Subject
to Section 6.5(d), each of Parent and the Company shall use reasonable best efforts to resolve such objections, if
any, as may be asserted by any Governmental Entity with respect to the transactions contemplated by this Agreement under the
HSR Act, the Sherman Act, as amended, the Clayton Act, as amended, the Federal Trade Commission Act, as amended, and any
other Legal Requirements or Orders that are designed to prohibit, restrict or regulate actions having the purpose or effect
of monopolization or restraint of trade (collectively, the “Antitrust Laws”).  Subject to Section
6.5(d), each of Parent and the Company shall use reasonable best efforts to take such action as may be required to cause
the expiration of the notice periods under the HSR Act or other Antitrust Laws with respect to such transactions as promptly
as possible after the execution of this Agreement.  Subject to Section 6.5(d), in connection with and without
limiting the foregoing, Parent agrees to use reasonable best efforts to take promptly any and all actions and steps necessary
to avoid or eliminate each and every impediment that may be asserted by any Governmental Entity, so as to enable the Parties
to consummate the transactions contemplated by this Agreement as expeditiously as possible.


 


(d)              
Notwithstanding anything herein to the contrary, including this Section ‎6.5 and the “reasonable best
efforts” standard, nothing in this Agreement shall require Parent or the Company to take or refrain from taking or to agree
to it or its Affiliates taking or refraining from taking any action, or to suffer to exist any restriction, condition or requirement:
(A) [INTENTIONALLY OMITTED], (B) that requires the taking of any action, including an amendment of any Transaction Document or
the sale, lease, license, disposal or holding separate by the Business or Parent or any of its Affiliates of any assets, rights,
product lines, licenses, categories of assets or business or other operations or interests therein that would, or would reasonably
be expected to, adversely affect in any material manner the economic benefits reasonably expected to be derived by Parent or the
Company Equityholders under the Transaction Documents or in connection with the consummation of the transactions contemplated thereunder,
(C) that requires Parent, the Company Equityholders or any of their respective Affiliates to terminate existing relationships,
ventures or arrangements or alter any agreement, change any agreement or enter into any agreement (including without limitation
any direct or indirect guarantee, capital maintenance agreement, keep-well or other requirement to fund money into the Company
or its Subsidiaries), in each such case, that materially alters or changes or has or would have the effect of changing or altering
the economic benefits derived or expected to be derived by Parent or the Company Equityholders and their respective Affiliates
under the Transaction Documents, (D) would, or would reasonably be expected to, materially adversely affect the ability of Parent
and its Affiliates, as the case may be, to conduct its business in the same manner as such business is being conducted, including
by materially adversely limiting its freedom of action or require the sale, lease, license, disposal or holding separate of any
material assets, rights, product lines, licenses, categories of assets or business or other operations or interests therein or
(E) would otherwise have a material adverse effect on the Business (each of the conditions or restrictions described in clauses
(A), (B), (C), (D) or (E) above, as applied to Parent (and not the Company Equityholders), a “Parent Burdensome Condition”,
and each of the conditions or restrictions described in clauses (A), (B) and (C) above, as applied to the Company Equityholders
(and not Parent), a “Company Burdensome Condition”); provided, however, that nothing contained
in this Agreement shall require Parent to agree to, or take, any action in connection with Section 6.5 unless such agreement
or action is conditioned upon the consummation of the transactions contemplated herein. For the purposes of this Section 6.5(d),
the term “material”, “materially” or “material adverse effect” shall be deemed to be based
on the size the Company and Parent, after taking into account the Closing, on a combined and consolidated basis.


 



    72


     


    





 


(e)          Prior
to the Closing, each of Parent and the Company shall not, and shall cause its Affiliates not to, acquire or agree to acquire
by merging or consolidating with, or by purchasing a substantial portion of the assets or Equity Interests of, or by any
other manner, any person or portion thereof, or otherwise acquire or agree to acquire any assets, if the entering into of a
definitive agreement relating to or the consummation of such acquisition, merger or consolidation would reasonably be
expected to (x) impose any material delay in the obtaining of, or materially increase the risk of not obtaining, any
authorizations, consents, orders, declarations or approvals or the expiration or termination of any applicable waiting
period, under any Antitrust Laws, (y) materially increase the risk of any Governmental Entity entering an order prohibiting
the consummation of the transactions contemplated by this Agreement or (z) delay the consummation of the transaction
contemplated by this Agreement; provided, however, that notwithstanding the restrictions set forth herein, the
Parties and their Subsidiaries shall be entitled to enter in and consummate the M&A Purchases (with respect to the
Company) and acquisitions of any Person, division or line of business set forth on Section 6.5(e)(ii) of the
Disclosure Schedule (with respect to Parent).


 


6.6           
Efforts to Consummate. Subject to the terms and conditions herein, the Parties shall use commercially reasonable
efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper or advisable
to consummate and make effective as promptly as practicable the transactions contemplated by this Agreement (including the satisfaction,
but not the waiver, of the closing conditions set forth in Article VII). Each Party shall promptly notify the other Party
of (i) the existence of any event or circumstance that could reasonably be expected to result in any condition to the obligations
of the other Parties to effect the transactions contemplated by this Agreement or any of the other Transaction Documents not to
be satisfied or (ii) the failure of such Party to comply with or satisfy any covenant, condition or agreement to be complied with
or satisfied by it pursuant to this Agreement which could reasonably be expected to result in any condition to the obligations
of the other Parties to effect the transactions contemplated by this Agreement not to be satisfied.


 


6.7            Preservation
of Records; Post-Closing Access. Parent shall, and shall cause the Company to, preserve and keep the books and records
held by them (including Tax records) relating to the respective businesses of each of the Company and its Subsidiaries prior
to the Closing for a period of six (6) years from and after the Closing Date (or longer if required by Legal Requirements)
and shall make such records (or copies) and officers, management, employees, advisors and representatives available, at
reasonable times and upon reasonable advance notice, to the Stockholder Representative, as may be reasonably required by such
Person in connection with any insurance claims by, Legal Proceedings or Tax audits against, investigations of Governmental
Entities of, compliance with Legal Requirements by, or the preparation of financial statements of, the equityholders (as of
the date hereof) of the Company or any of their respective Affiliates; provided, that in exercising access rights
under this Section ‎6.7, such Persons shall not
be permitted to interfere unreasonably with the conduct of the Business or to unreasonably jeopardize the health and safety
of any employee of the Company or any of its Subsidiaries in light of COVID-19 (provided, that if not in violation of
any applicable Legal Requirements, reasonable accommodations shall be made to provide such information by other means,
including electronic video means); provided, further, that the foregoing shall not require Parent or the
Company to make available any information, that in the reasonable judgment of Parent, after consultation with legal counsel,
would reasonably be expected to result in (i) the disclosure of any Trade Secrets of third parties, (ii) the waiver or
jeopardizing of any applicable confidentiality restrictions or of any applicable attorney-client or attorney work product
privilege, or (iii) the violation of any applicable Legal Requirement.  The Parties will, to the extent legally
permissible and practicable, make appropriate substitute arrangements under circumstances in which the restrictions of the
preceding sentence apply. In the event that Parent or the Company intends to destroy, alter or otherwise dispose of any such
books and records following the expiration of such six-year period, Parent must first provide reasonable prior notice of such
intended destruction to the Stockholder Representative and provide the Stockholder Representative the opportunity to instead
retrieve and/or copy such books and records from Parent.


 






    73


     


    

 


6.8           
Post-Closing Employee Matters.


 


(a)          
With respect to each Person who is an active employee of the Company or any of its Subsidiaries immediately prior to the
Closing (a “Continuing Employee”), for the period beginning on the Closing Date, and ending on the one-year
anniversary of the Closing Date, or, in each case, if earlier, on the date of the termination of employment of the relevant Continuing
Employee (the “Continuation Period”), Parent shall provide each such Continuing Employee, with (i) a base salary
or base wage rate that is no less than the base salary or base wage rate provided to such Continuing Employee by the Company or
its Subsidiaries as of the date hereof, (ii) annual cash based target incentive compensation and commission opportunities
that are comparable in the aggregate to the and annual cash based target incentive compensation and commission opportunities afforded
to such Continuing Employee by the Company and its Subsidiaries as of the date hereof, and (iii) employee retirement, health
and welfare benefits (but specifically excluding any defined benefit plan benefits, retiree health or welfare benefits, equity
based compensation or benefits or long-term incentive compensation), in each case, as determined by Parent after taking into consideration
the employee retirement, health and welfare benefits that are generally made available to similarly situated employees of Parent
and its Affiliates.


 


(b)          During
the Continuation Period, for purposes of eligibility to participate and vesting and, with respect to the determination of the
level or amount of vacation pay and benefits only, benefit accrual under the benefit and compensation plans, programs,
agreements and arrangements of Parent and its Subsidiaries in which Continuing Employees are eligible to participate
following the Closing (the “Parent Plans”), Parent shall, or shall cause its Subsidiaries to, credit each
Continuing Employee with his or her years of service with the Company and its Subsidiaries, to the same extent as such
Continuing Employee was entitled immediately prior to the Closing to credit for such service under any substantially similar
Employee Plan, except that Parent and its Subsidiaries shall not be required to provide credit for service prior to the
Closing (i) where such credit would result in a duplication of benefits, (ii) for benefit accruals under any
defined benefit pension or similar plan or any nonqualified deferred compensation plan, (iii) for purposes of any
retiree health or welfare plan, or (iv) where prior service is not recognized for similarly-situated employees of Parent
and its Affiliates. Parent shall, or shall cause its Subsidiaries to, use commercially reasonable efforts to cause each
Continuing Employee to be eligible to participate, without any waiting time, in any and all Parent Plans that are group
health plans to the extent coverage under such Parent Plan replaces coverage under a substantially similar Employee Plan in
which such Continuing Employee participated immediately before such replacement to extent such waiting time was met under
such Employee Plan. For purposes of each Parent Plan providing medical, dental, pharmaceutical and/or vision benefits to any
Continuing Employee, Parent shall, or shall cause its Subsidiaries to, use commercially reasonable efforts to cause all
pre-existing condition exclusions and actively-at-work requirements of such Parent Plan to be waived for such Continuing
Employee and his or her covered dependents to the extent such requirements were met or not applicable under the corresponding
Employee Plan.


 






    74


     


    

 


(c)          
The provisions of this Section ‎‎6.8 are solely for the benefit of the parties to this Agreement,
and no provision of this Section ‎‎6.8 shall constitute or be deemed to (i) guarantee employment for any
period of time for, or preclude the ability of Parent or the Company (or any of their Affiliates) to terminate, any Continuing
Employee, other employee or other service provider for any reason, (ii) confer upon any Person (including any current or former
director, officer or employee of, or consultant or independent contractor to, Parent or the Company) any third party beneficiary
or other rights or remedies, (iii) establish, amend or modify any Parent Plan, Employee Plan, or any or any other “employee
benefit plan” as defined in Section 3(3) of ERISA, or any other benefit plan, program, agreement or arrangement maintained
or sponsored by the Company, the Parent, or any of their respective Affiliates, or (iv) alter or limit the ability of the
Parent and its Subsidiaries (including, after the Closing Date, the Company and its Subsidiaries) to amend, modify or terminate
any Parent Plan, Employee Plan or any other benefit or employment plan, program, agreement or arrangement after the Closing Date.


 


6.9            Section
280G. To the extent necessary to avoid the application of Section 280G of the Code and the Treasury regulations
thereunder, (i) during the period commencing on the date hereof and ending on the date that is three (3) Business Days
prior to the Closing Date, the Company shall request waivers (the “Parachute Payment Waivers” ) from each
Person who has a right to any payments and/or benefits as a result of or in connection with the transactions contemplated by
this Agreement that would reasonably be expected to constitute “parachute payments” within the meaning of Section
280G of the Code and as to which such Person waives his or her rights to some or all of such payments and/or benefits (the
 “Waived 280G Benefits”) applicable to such Person so that all remaining payments and/or benefits
applicable to such Person shall not be deemed to be “excess parachute payments” (within the meaning of Section
280G of the Code), and (ii) following the execution of the waivers described in clause (i) and prior to the Closing
Date, solicit the approval of the stockholders of the Company of any Waived 280G Benefits pursuant to a vote intended to meet
the requirements of Section 280G(b)(5)(B) of the Code and the Treasury regulations thereunder. At least two (2) Business Days
prior to obtaining any waiver or soliciting stockholder approval, the Company shall provide Parent with copies of all Section
280G-related documents, including, without limitation, any Section 280G analysis prepared by the Company, the stockholder
disclosure document, waivers and stockholder consents, for Parent’s review and comment and shall consider all
reasonable comments made thereto by Parent. Prior to the Closing Date, the Company shall deliver to Parent evidence that a
vote of the stockholders of the Company was solicited in accordance with the foregoing provisions of this Section ‎6.9
and that either (A) the requisite number of votes were obtained with respect to the Waived 280G Benefits
(the “Section 280G Approval”), or (B) that the Section 280G Approval was not obtained, and, as a
consequence, the Waived 280G Benefits shall not be made or provided; provided, that the Parties agree that this Section
6.9 shall not be deemed breached, and no stockholder vote shall be required pursuant to Section 4.11(h), with respect to
(x) any 280G Payment to any such Person that refuses to execute a Parachute Payment Waiver or (y) the value of any
arrangement entered into by or at the direction of Parent or its Affiliates, the material terms (including value) of which
are not disclosed to the Company prior to the date that is at least five (5) Business Days prior to the Closing Date.


 






    75


     


    

 


6.10        
401(k) Plan. The Company shall take (or cause to be taken) all actions necessary or appropriate to terminate, effective
no later than the day immediately preceding the Closing Date, any Employee Plan that contains a cash or deferred arrangement intended
to qualify under Section 401(k) of the Code (the “401(k) Plans”), unless Parent or one of its Affiliates,
in its sole and absolute discretion, agrees to sponsor and maintain such 401(k) Plans by providing the Company with written notice
of such election at least ten (10) days before the Closing. Unless Parent or one of its Affiliates provides such notice to the
Company, Parent shall receive from the Company, prior to the Closing, evidence that the board of directors of the Company or its
applicable Affiliate has adopted resolutions to terminate the 401(k) Plans, effective no later than the date immediately preceding
the Closing Date (the form and substance of which resolutions shall be subject to review and comment and the Company shall consider
all reasonable comments made thereto by Parent). If Parent, in its sole and absolute discretion, agrees to sponsor and maintain
any 401(k) Plan and provides written notice of such election at least 15 (fifteen) days before the Closing, the Company shall use
commercially reasonable efforts to amend such 401(k) Plan, effective as of the Closing, to the extent necessary to limit participation
to employees of the Company and its Subsidiaries and to exclude all employees of Parent and its Subsidiaries (other than the Company
and its Subsidiaries) from participation in such 401(k) Plan.


 


6.11        
Parent’s Financing.


 


(a)          
Parent’s Actions.


 


(i)                    
Parent will use reasonable best efforts to, and will use reasonable best efforts to cause its Subsidiaries to, take, or
cause to be taken, all actions, and to do, or cause to be done, all things necessary to consummate on the terms and conditions
described in the Debt Financing Commitment, the Debt Financing, on or prior to the Closing Date. Such reasonable best efforts will
include taking the following actions: (A) complying with all obligations under, and maintaining in effect, the Debt Financing Commitment,
(B) arranging and obtaining the proceeds of the Debt Financing on the terms and conditions (including any “flex” provisions)
set forth in the Debt Financing Commitment or, if available, on other terms that are acceptable to Parent and as permitted under
this Agreement, (C) negotiating and entering into definitive agreements with respect to the Debt Financing, including the terms
and conditions contained in the Debt Financing Commitment (including any “flex” provisions) so that such agreements
are in effect no later than the Closing, (D) satisfying on a timely basis all the conditions to the Debt Financing and the definitive
agreements related thereto that are within its control and (E) drawing the full amount of the Debt Financing Proceeds to the extent
the funds are necessary at Closing to pay the Aggregate Merger Consideration (less the Aggregate Parent Stock Value and less the
Aggregate Exercise Price), the Payoff Amount and the Selling Expenses, and (F) enforcing its rights under the Debt Commitment Letter
and the Debt Financing Documents in order to consummate the Debt Financing at or prior to the Closing including in the event of
a breach by any lender providing such Debt Financing that impedes or delays the Closing.


 






    76


     


    

 


(ii)                   
 Parent will, as promptly as reasonably practicable after obtaining knowledge thereof, give the Company written notice of
any (A) actual material breach or default or termination by a Financing Party under the Debt Financing Commitment, (B) amendment
or modification of, or waiver under, the Debt Financing Commitment or (C) change or event which causes Parent to believe that it
will not be able to timely obtain all or any portion of the Debt Financing on the terms, in the manner or from the Financing Parties
contemplated by the definitive documents related to the Debt Financing. Parent and its Subsidiaries will not amend, modify or supplement
the Debt Financing Commitment or any related fee letters without the prior written approval of the Company (which shall not be
unreasonably conditioned, withheld or delayed), in each case, if such amendment, modification or supplement would (1) reduce the
aggregate amount of the Debt Financing below the amount required to consummate the transactions contemplated by this Agreement,
(2) impose new or additional conditions or otherwise expand, amend or modify any of the conditions that would reasonably be expected
to materially delay or prevent the funding of the Debt Financing on the Closing Date, or (3) adversely impact the ability of Parent
to enforce its rights against the Financing Parties; provided, that Parent may modify, amend or supplement the Debt Financing
Commitment to (A) correct typographical errors or mistakes, (B) add lenders, arrangers, bookrunners, agents or similar entities
or titles that have not executed the Debt Financing Commitment as of the date hereof or amend titles, allocations and fee sharing
arrangements in connection therewith or (C) increase the amount of the Debt Financing. Notwithstanding any of the foregoing, Parent
shall have the right to reduce the commitments under the Debt Financing Commitment on a dollar-for-dollar basis with the net proceeds
of consummated offerings or other incurrences of any debt for borrowed money incurred after the date of this Agreement for the
purpose of financing payment of the Aggregate Merger Consideration and other amounts payable by Parent or its Subsidiaries pursuant
to this Agreement and the other Transaction Documents to which Parent is a party. In the event that new commitment letters are
entered into in accordance with any amendment, replacement, supplement or other modification of the Debt Financing Commitment permitted
pursuant to this Section ‎6.11, such new commitment letters will be deemed to be a part of the “Debt
Financing” and deemed to be the “Debt Financing Commitment” for all purposes of this Agreement. Parent will promptly
deliver to the Company copies of any termination, amendment, modification, waiver or replacement of the Debt Financing Commitment.
In the event that funds in the amounts set forth in the Debt Financing Commitment, or any portion thereof, become unavailable to
it on the terms and conditions set forth therein (including, as necessary, any “flex” provisions), Parent will, as
promptly as practicable following the occurrence of such event, (x) notify the Company in writing thereof, (y) use its reasonable
best efforts to obtain substitute financing (i) in an amount sufficient to consummate the transactions contemplated hereunder,
(ii) that would not involve any conditions to funding the Debt Financing that are not contained in the Debt Financing Commitment
and (iii) that would not prevent, impede or delay the consummation of the transactions contemplated hereunder beyond the Closing
Date required to be effected under this Agreement (the “Substitute Financing”) and obtain a new financing commitment
letter that provides for such Substitute Financing and, promptly after execution thereof, deliver to the Company true, complete
and correct copies of the new commitment letter and the related fee letters (in redacted form removing commercially sensitive information
therein, including the fee information and “flex” provisions). Upon obtaining any commitment for any such Substitute
Financing, such financing will be deemed to be a part of the “Debt Financing” and any commitment letter for such Substitute
Financing will be deemed the “Debt Financing Commitment” for all purposes of this Agreement.


 






    77


     


    

 


(b)          
 Company’s Cooperation.


 


(i)                    From
the date hereof until Closing or the termination of this Agreement in accordance with its terms, subject to limitations set
forth in this Section ‎6.11(b) unless otherwise agreed by Parent, the Company will use its, and will
cause its Subsidiaries to use their, reasonable best efforts to cooperate with Parent, subject to Parent’s expense
reimbursement as set forth herein, as may be reasonably necessary in connection with the arrangement of the Debt Financing or
other financing of Parent or its Subsidiaries in connection with the transactions contemplated hereby (including any senior
notes offering) and in satisfying the conditions precedent set forth in the Debt Financing Commitment, including, in each
case, unless as otherwise as set forth herein, as promptly as practicable, (A) preparing and furnishing to Parent and the
Financing Parties (including for purposes of filing with the SEC) all Required Financial Information as promptly as
reasonably practicable (with respect to the information set forth in clauses (a) and ‎(b) of such definition, no
later than December 15, 2020, with respect to the information set forth in clause (c) of such definition, no later than March
31, 2021, and with respect to the information set forth in clause (d) of such definition, no later than 45 days after the end
of the applicable fiscal quarter) and, assisting in the preparation of any offering documents, private placement memoranda,
confidential information memoranda, rating agency presentations and any customary marketing and/or syndication materials
necessary in connection with the Debt Financing or other financing of Parent or its Subsidiaries in connection with the
transactions contemplated hereby (including any senior notes offering), including execution and delivery of customary
authorization letters related thereto (including customary representations with respect to the absence of material non-public
information in the public-side versions of documents and the absence of material misstatements) and customary chief financial
officer and similar certificates with respect to certain financial information in the offering documents not otherwise
covered by customary “comfort” letters, and cooperating with the due diligence efforts of the Debt Financing
Sources, in each case, to the extent reasonable and customary, (B) making appropriate officers or members of the management
team (with appropriate seniority and expertise) available for participation at reasonable times in a reasonable number of
virtual or telephonic meetings, lender presentations, due diligence sessions, drafting sessions, conference calls, meetings
with prospective lenders and ratings agencies and road shows, (C) assisting in the preparation of definitive financing
documents, including guarantee and collateral documents and customary closing certificates as may be required by the Debt
Financing or other financing of Parent or its Subsidiaries in connection with the transactions contemplated hereby (including
any senior notes offering) (it being agreed that neither the Company nor any of its Subsidiaries will be required to execute
and deliver financing agreements or certificates prior to the Closing), obtaining and/or assisting in obtaining Payoff
Letters and providing true and complete Charter Documents for each Subsidiary of the Company to the extent required under
such financing documentation, (D) facilitating the pledging of, granting a security interest in and obtaining perfection of
any liens on, collateral for the Debt Financing or other financing of Parent or its Subsidiaries in connection with the
transactions contemplated hereby (including any senior notes offering) upon consummation of the Closing, (E) assisting the
Financing Parties in benefiting from the existing lending relationships of the Company and its Subsidiaries, (F) providing as
promptly as reasonably practicable (and in any event, no less four (4) Business Days prior to the Closing Date provided,
that Parent has made such request at least nine (9) Business Days prior to the Closing Date) all documentation and other
information about the Company and its Subsidiaries as is reasonably requested by the Financing Parties with respect to
applicable “know your customer” and anti-money laundering rules and regulations, including the USA PATRIOT Act
and certifications regarding beneficial ownership, (G) causing the independent auditors of the Company and its Subsidiaries
to assist and cooperate with Parent in connection with the Debt Financing or other financing of Parent or its Subsidiaries in
connection with the transactions contemplated hereby (including any senior notes offering) or otherwise in connection with
filings with the SEC, including by (I) providing consent to registration statements (or SEC filings incorporated by reference
therein and) offering memoranda that include or incorporate the Company and its Subsidiaries’ financial information and
their reports thereon, and customary comfort letters (including “negative assurance” and change period comfort)
with respect to financial information relating to the Company and its Subsidiaries and (II) attending at reasonable times a
reasonable number of accounting due diligence sessions in connection with the Debt Financing or other financing of Parent or
its Subsidiaries in connection with the transactions contemplated hereby (including any senior notes offering) and (H)
causing the taking of corporate and other actions by the Company and its Subsidiaries reasonably necessary or customary to
permit the consummation of the Debt Financing or other financing of Parent or its Subsidiaries in connection with the
transactions contemplated hereby (including any senior notes offering) on the Closing Date, it being understood that except
as expressly provided above, no such corporate or other action will take effect prior to the Closing. Notwithstanding
anything to the contrary in this Agreement, (i) the Company and its Subsidiaries shall not be required to provide any
cooperation pursuant to this Section ‎ 6.11(b)(i)
to the extent it would unreasonably interfere with its ongoing business operations, taken as a whole, (ii) the Company and
its Subsidiaries shall not be required to pay any commitment or other similar fee or incur any other liability or expenses
(other than expenses reimbursed by Parent at or prior to Closing in accordance with the terms of Section ‎6.11(b)(ii)),
(iii) none of the Company or any of its Subsidiaries, or any Persons who are directors of the Company or any of its
Subsidiaries at any time prior to the Closing that do not continue in such role as of Closing shall be required to pass
resolutions or consents to approve or authorize the execution of the Debt Financing, (iv) the Company and its Subsidiaries
shall not be required to provide any cooperation pursuant to this Section‎
6.11(b)(i) to the extent it would (A) cause any covenant, representation or warranty in this Agreement to be breached
(unless otherwise agreed or waived by the parties hereto in accordance with this Agreement); (B) cause any closing condition
set forth in Article VII to fail to be satisfied or otherwise cause the breach of this Agreement; (C) require any officer,
director or other representative of the Company or any of its Subsidiaries to deliver any certificate that such officer,
director other representative believes, in good faith, contains any untrue certifications or requires the Company or its
Subsidiaries to give or deliver any legal opinion or other opinion of counsel; (D) require the Company or its Subsidiaries to
provide any information that is prohibited or restricted by applicable law or applicable confidentiality undertaking or that
constitutes privileged information or attorney-client work-product (provided, that in such instances the Company and
its Subsidiaries shall inform Parent and its Debt Financing Sources of the general nature of the information being withheld
and reasonably cooperate with Parent and its Debt Financing Sources to provide such information, in whole or in part, in the
manner that would not result in the loss of such privilege) or (E) require the Company or its Subsidiaries to take any action
that is prohibited or restricted by, or will conflict with or violate, its organizational documents, or would result in a
violation or breach of, or default under, any Material Contract to which the Company or any of its Subsidiaries is a party.
Parent and Merger Sub agree that any information regarding the Company or any of its Subsidiaries or Affiliates contained in
any offering document or other materials in connection with the Debt Financing shall be subject to the prior review of the
Company. In furtherance of the foregoing, the Company will use its, and will cause its Subsidiaries to use their, reasonable
best efforts to cooperate with Parent as may be reasonably necessary to assist in obtaining consents from lenders under the
Existing Credit Agreement to permit the transactions contemplated hereby and the incurrence of incremental term loans under
the Existing Credit Agreement in a similar manner and in similar time periods as agreed in causing the conditions in the Debt
Financing Commitment to be satisfied.


 






    78


     


    

 


(ii)                   
Parent will (A) promptly upon request by the Company, reimburse the Company for all of its reasonable and documented out-of-pocket
fees and expenses (including reasonable and documented out-of-pocket attorneys’ fees) incurred by the Company and its representatives
in connection with any cooperation contemplated by this Section ‎6.11; provided, that Parent shall not
be required to reimburse the Company for costs and expenses arising out of or related to (i) the preparing or delivery of the Required
Financial Information or (ii) providing true and complete Charter Documents for each Subsidiary of the Company to the extent required
to be provided under such financing documentation or for any items that the Company would have prepared in the ordinary course
of its business and (B) indemnify the Company, its Subsidiaries and its and their officers, directors and representatives
against any claim, loss, damage, injury, liability, judgment, award, penalty, fine, Tax, cost (including cost of investigation),
expense (including reasonable and documented out-of-pocket attorneys’ fees) or settlement payment incurred as a result of
such cooperation (other than historical information provided in writing by the Company, its Subsidiaries and its and their officers
and directors and representatives), except to the extent such indemnification arises out of gross negligence, breach or willful
misconduct of the Company, its Subsidiaries and its and their officers, directors and representatives.


 


(iii)                 
The Company hereby consents to the use of its and its Subsidiaries’ logos in connection with the Debt Financing; provided,
that such logos are used solely in a manner that is not intended to or reasonably likely to harm or disparage the Company or any
of its Subsidiaries or the reputation or goodwill of Company or any of its Subsidiaries.


 


(iv)                  
Parent may provide information of, and provided by, the Company and its Subsidiaries to potential sources of capital and
to rating agencies and prospective lenders and investors during syndication or placement of the Debt Financing (including any Substitute
Financing) subject to customary confidentiality arrangements with such Persons regarding such information, or during any offering
of debt securities contemplated by the Debt Financing.


 


(v)                  
Notwithstanding anything to the contrary, the condition precedent set forth in Section 7.1(b), as it applies to the Company’s
obligations under this Section 6.11, shall be deemed as satisfied unless (i) the Company’s material breach of its
obligations under this Section 6.11 is the proximate cause of Parent’s failure to obtain the Debt Financing (including
any Substitute Financing) or any financing contemplated by a senior notes offering and (ii) Parent has provided to the Company
written notice of such breach and, if such breach is curable, the Company fails to cure such breach by the earlier of (x) five
(5) Business Days after such notice is received by the Company and (y) the Outside Date.


 






    79


     


    

 


(vi)                   Parent
acknowledges and agrees that neither the obtaining of the Debt Financing or any Substitute Financing, nor the completion of
any issuance of securities contemplated by the Debt Financing or any Substitute Financing, is a condition to the Closing,
and, subject to Section 10.8(b), reaffirms its obligation to consummate the transactions contemplated by this Agreement
irrespective and independently of the availability of the Debt Financing or any Substitute Financing, or the completion of
any such issuance.


 


6.12        
Exclusivity. Between the date hereof and the earlier to occur of the Closing and the date that this Agreement is
terminated in accordance with its terms, the Company shall not, and shall cause its respective Affiliates, Subsidiaries, officers,
directors, employees, agents or representatives not to, (i) solicit, initiate or encourage any proposal or offer from any Person
(other than Parent, Merger Sub, Merger Sub II and their respective representatives), (ii) respond to any submissions, proposals
or offers relating to, (iii) engage in any negotiations or discussions with any person relating to, (iv) furnish or make available
any non-public information regarding the Company and its Subsidiaries or any of their respective assets or businesses in a manner
intended to facilitate, or (v) enter into any transaction, agreement, understanding or arrangement, whether binding or nonbinding,
providing for, or otherwise cooperate in any way with any person or entity relating to any part of the equity interests or all
or a material portion of the assets of the Company and its Subsidiaries (including any acquisition structured as a merger, consolidation,
share exchange or asset purchase) (each, an “Acquisition Proposal”). The Company will, and will cause its representatives
and Affiliates to, (x) cease and cause to be terminated any existing discussions, communications or negotiations with any Person
(other than Parent, Merger Sub, Merger Sub II and their respective representatives) conducted heretofore with respect to any Acquisition
Proposal, (y) revoke any such Person’s and its authorized representatives’ access to any electronic data room granted
in connection with any Acquisition Proposal and (z) reasonably promptly notify Parent of any bona fide inquiries, whether oral
or written, by any Person other than Parent, Merger Sub and Merger Sub II related to an Acquisition Proposal, whether or not such
inquiry was solicited by the Company or a representative thereof including notifying Parent of the material terms and conditions
of any such inquiries.


 


6.13         
Transfer Restrictions.


 


(a)           Other than Permitted Transfers, the Company agrees that the Company Equityholders receiving Share Consideration or the Substitute
Option Consideration shall not Transfer any Share Consideration, any Parent Option, any share of Class A Common Stock acquired
upon the exercise of Parent Options, or the other Securities into which the Share Consideration, any Parent Option or any share
of Class A Common Stock acquired upon the exercise of Parent Options are converted (together, the “Prohibited Shares”),
with respect to one-third (1/3rd) of the Share Consideration or the Substitute Option Consideration received by each such Company
Equityholder, during the period commencing on the Closing Date and continuing until the six-month anniversary after the Closing
Date, and with respect to the other two-thirds (2/3rds) of the Share Consideration or the Substitute Option Consideration received
by each such Company Equityholder, during the period commencing on the Closing Date and continuing until the one-year anniversary
after the Closing Date (such date, the “Restricted Period Termination Date”).


 






    80


     


    

 


(b)          
 “Permitted Transfer” means, in each case so long as such Transfer is in accordance with applicable Legal
Requirements:


 


(i)                     a
Transfer of Prohibited Shares to Affiliates of such Company Equityholder, so long as such transferee, to the extent it has
not already done so, executes a customary joinder to this Section ‎6.13, in form and substance reasonably
acceptable to Parent, in which such transferee agrees to be subject to the restrictions on Transfer in this Section ‎6.13;


 


(ii)                   
a Transfer of Prohibited Shares as a distribution in-kind to such Company Equityholder’s investors, and to their subsequent
investors, including limited partners, so long as all such transferees, to the extent it has not already done so, executes a customary
joinder to this Section ‎6.13, in form and substance reasonably acceptable to the Parent, in which such transferee
agrees to be subject to the restrictions on Transfer in this Section ‎6.13;


 


(iii)                 
a Transfer of Prohibited Shares in connection with the piggyback rights set forth in the Amended and Restated Registration
Rights Agreement;


 


(iv)                  
a Transfer of Prohibited Shares in connection with a sale of Parent approved by the Board of Directors or in connection
with a tender offer into which a majority of the Unaffiliated Shareholders of Parent have tendered their respective Common Stock;


 


(v)                    
a Transfer of Prohibited Shares to Parent;


 


(vi)                  
if the Company Equityholder is an individual, a Transfer of Prohibited Shares to an immediate family member or a trust for
the benefit of such Company Equityholder or one or more of such Company Equityholder’s immediate family members, so long
as such transferee, to the extent it has not already done so, executes a customary joinder to this Section ‎6.13,
in form and substance reasonably acceptable to Parent, in which such transferee agrees to be subject to the restrictions on Transfer
in this Section ‎6.13;


 


(vii)                 
a Transfer of Prohibited Shares pursuant to the laws of testamentary or intestate succession or otherwise involuntarily
transferred by operation of law so long as, subject to applicable law, such transferee, to the extent it has not already done so,
executes a customary joinder to this Section ‎6.13, in form and substance reasonably acceptable to Parent,
in which such transferee agrees to be subject to the restrictions on Transfer in this Section ‎6.13.


 


(viii)               
Transfer of Prohibited Shares to cover any amounts required to be withheld by Parent or any of its Affiliates in connection
with the exercise of a Parent Option; and


 


(ix)                  
a Transfer of Prohibited Shares following a voluntary filing by Parent of a petition for relief under the United States
Bankruptcy Code.


 


(x)                    Notwithstanding
anything to the contrary contained herein, including the occurrence of the Restricted Period Termination Date, the Company acknowledges
that, because the Prohibited Shares are “restricted securities” as such term is defined in Rule 144 under the Securities
Act, the Prohibited Shares may not be Transferred other than pursuant to a registered offering or in accordance with an exemption
from registration. No Transfers of Prohibited Shares shall be made to a person that, to such Company Equityholder’s knowledge,
is a competitor of Parent set forth on Exhibit P attached hereto or becomes a competitor of Parent after the date hereof,
as set forth on a quarterly or annual report filed by Parent with the SEC; provided, however, that nothing contained
in this Section 6.13(b)(x) shall prohibit any Transfer of Prohibited Shares on an exchange or otherwise in open market
transactions or non-privately negotiated transactions or to a hedge fund or other institutional investor, other than a hedge fund
or other institutional investor that is known by such Company Equityholder after reasonable inquiry to hold more than five percent
(5%) of the outstanding securities of any such competitor; provided, further, that nothing contained in this Section
‎6.13(b)(x) shall prohibit any Transfer of Prohibited Shares in accordance with any of the foregoing clauses
(ii), (iv) or (ix) of this Section ‎6.13(b) (unless such Transfer was structured in such manner for the purpose
of avoiding the provisions of this Section 6.13(b)(x)).


 






    81


     


    

 


6.14        
Parent Stockholder Approval.


 


(a)          
As promptly as reasonably practicable after the execution of this Agreement, and in any event no later than the later to
occur of sixty (60) days following the Closing Date, Parent shall prepare the Proxy Statement in preliminary form and file it with
the SEC. The Board of Directors of Parent shall recommend to Parent’s stockholders that the holders of the Common Stock vote
in favor of the Parent Stockholder Approval and shall include such recommendation in the Proxy Statement and shall not rescind,
modify or withdraw such recommendation except as required to comply with fiduciary duties. Prior to the Closing, the Company shall
provide to Parent all information reasonably available to it concerning the Company and its Affiliates as may be reasonably requested
by Parent in connection with the Proxy Statement and shall use its commercially reasonable efforts to otherwise assist and cooperate
with Parent in the preparation of the Proxy Statement and the resolution of any comments thereto received from the SEC if and to
the extent reasonably requested by Parent. Each of Parent, the Stockholder Representative and the Company shall promptly correct
any information provided by it for use in the Proxy Statement if and to the extent such information shall have become false or
misleading in any material respect. Parent shall notify the Stockholder Representative promptly upon the receipt of any comments
from the SEC and of any request by the SEC for amendments or supplements to the Proxy Statement and shall supply the Stockholder
Representative with copies of all written correspondence between Parent or any of its representatives, on the one hand, and the
SEC, on the other hand, with respect to the Proxy Statement. Parent shall use its reasonable best efforts to respond as promptly
as reasonably practicable to any comments received from the SEC concerning the Proxy Statement and to resolve such comments with
the SEC, and shall use its reasonable best efforts to cause the Proxy Statement to be disseminated to its stockholders as promptly
as reasonably practicable after the resolution of any such comments.  Prior to the filing of the Proxy Statement (or any amendment
or supplement thereto) or any dissemination thereof to the stockholders of Parent, or responding to any comments from the SEC with
respect thereto, Parent shall provide the Stockholder Representative with a reasonable opportunity to review and to propose comments
on such document or response, which Parent shall consider in good faith.


 


(b)           Subject
to Section ‎6.14(a), Parent shall take all necessary actions in accordance with applicable Legal Requirements
and the Charter Documents of Parent to duly call, give notice of, convene and hold a meeting of its stockholders (including
any adjournment, recess or postponement thereof, the “Parent Stockholders’ Meeting”) for the
purpose of obtaining the Parent Stockholder Approval, as soon as reasonably practicable after the SEC confirms that it has no
further comments on the Proxy Statement. Parent shall use its reasonable best efforts to obtain the Parent Stockholder
Approval. Notwithstanding anything to the contrary contained in this Agreement, Parent may, in its sole discretion,
temporarily adjourn, recess, or postpone the Parent Stockholders’ Meeting (i) after consultation with the Stockholder
Representative, to the extent necessary to ensure that any required supplement or amendment to the Proxy Statement is
provided to the stockholders of Parent within a reasonable amount of time in advance of the Parent Stockholders’
Meeting, (ii) if as of the time for which the Parent Stockholders’ Meeting is originally scheduled (as set forth in the
Proxy Statement) there are insufficient shares of Common Stock represented (either in person or by proxy) to constitute a
quorum necessary to conduct the business of the Parent Stockholders’ Meeting or (iii) to solicit additional proxies if
Parent reasonably believes it may be necessary to obtain the Parent Stockholder Approval. Parent will resume any adjourned,
recessed or postponed meeting as promptly as practicable.


 






    82


     


    

 


6.15        
Company Written Consent; Company Voting and Support Agreements; Stockholder Notice.


 


(a)         
As promptly as possible following the execution of this Agreement (but in any event within twenty four (24) hours), the
Company shall deliver to Parent (i) a written consent (or written consents) of the Stockholders holding (i) at least a majority
of the outstanding shares of Company Common Stock and Company Series C Preferred Stock (voting together as a single class) adopting
this Agreement and approving the First Merger in accordance with the DGCL and the Company’s Charter Documents in the form
attached hereto as Exhibit H (“Company Written Consent”) and (ii) the Voting and Support Agreements of
the Company in the form attached hereto as Exhibit I (the “Company Voting and Support Agreements”) executed
by Stockholders, including each holder of Company Series C Preferred Stock, holding sufficient type and number of shares of Company
Capital Stock to adopt this Agreement and approve the First Merger in accordance with the DGCL and the Company’s Charter
Documents.


 


(b)          
The Company shall promptly (and in any event prior to the Closing) deliver to any Stockholder who has not executed the Company
Written Consent a notice of the actions taken pursuant to the Company Written Consent that complies with the requirements of Section
228(e) of the DGCL, which notice shall also constitute and include the notice required by Section 262 of the DGCL that appraisal
or similar rights may be available to the Stockholders who did not execute the Company Written Consent (the “Stockholder
Notice”). The Stockholder Notice, as well as any information statement prepared by the Company in which the Stockholder
Notice shall be included, shall be subject to review and approval by Parent which shall not be unreasonably withheld or delayed
and the Company shall consider in good faith any comments proposed by Parent to the draft Stockholder Notice.


 


6.16         Accredited
Investor Certifications. Parent, Merger Sub, Merger Sub II and the Company acknowledge and agree that the Share
Consideration to be issued as consideration in the First Merger will not be registered under the Securities Act and will be
issued in reliance upon an exemption thereunder for transactions not involving a public offering. Notwithstanding anything to
the contrary in this Agreement, a Company Equityholder who is not a party to a Company Voting and Support Agreement shall be
entitled to receive Share Consideration in connection with the First Merger only if such Company Equityholder is (a) an
accredited investor within the meaning of SEC Rule 501 of Regulation D, as presently in effect, under the Securities Act and
(b) provides an executed accredited investor questionnaire in substantially the form attached hereto as Exhibit J (an
 “Accredited Investor Questionnaire”) no later than 6:00 pm Eastern Time on January 15, 2020 (the
 “Accredited Investor Questionnaire Deadline”), unless the Company otherwise determines that such Company
Equityholder is not an Accredited Investor. Each Accredited Investor Questionnaire shall also contain restrictions on the
resale of the Share Consideration consistent with the restrictions set forth in Section ‎6.13
hereof. In furtherance of the foregoing, the Company shall use commercially reasonable efforts to, as promptly as practicable
after the date of this Agreement (but in any event within ten (10) Business Days of the date hereof), deliver to each Company
Equityholder who is not a party to a Company Voting and Support Agreement an Accredited Investor Questionnaire and request
that each such Company Equityholder complete an Accredited Investor Questionnaire and return it to the Company by the
Accredited Investor Questionnaire Deadline. If any Company Equityholder delivers an Accredited Investor Questionnaire to the
Company, the Company shall promptly deliver a copy of such Accredited Investor Questionnaire to Parent. Any Company
Equityholder that does not execute and deliver a Company Voting and Support Agreement or an Accredited Investor Questionnaire
by the Accredited Investor Questionnaire Deadline certifying such Company Equityholder’s status as an Accredited
Investor shall, for all purposes of this Agreement, be deemed not to be an Accredited Investor.


 






    83


     


    

 


6.17        
Board Rights.


 


(a)           Promptly
following the Closing Date, and in any event within five (5) business days following the Closing Date, Parent shall increase
the size of the Board of Directors of Parent (the “Parent Board of Directors”) by two (2) members to
eleven (11) members and, promptly following such increase, and in any event within five (5) business days following the
Closing Date, shall cause Ted Lundberg to be elected or appointed to the Board of Directors (the “Nomination Right
Board Representative”), as a Class II director, and cause Stephen Griggs to be elected or appointed to the Board of
Directors (the “Other Board Representative” and together with the Nomination Right Board Representative,
the “Board Representatives”), as a Class I director. For so long as Peloton Equity AeroCare SPV I, L.P.
and SkyKnight Aero Holdings, LLC (the “Nomination Rights Holders”) or an Affiliate of the Nomination
Rights Holders hold in the aggregate among them at least 35% of the Share Consideration, on an as-converted basis, issued to
the Nomination Rights Holders hereunder, on an as-converted basis, the Nomination Rights Holders shall continue to have the
right to nominate the Nomination Rights Board Representative. The election or appointment of the Board Representatives will
be subject to satisfaction of all legal and governance requirements regarding service as a director of Parent and to the
reasonable approval of the Nominating and Governance Committee of the Board of Directors (such approval not to be
unreasonably withheld, conditioned or delayed); provided, that the parties hereto agree that election of Stephen
Griggs and Ted Lundberg to serve as the Board Representatives shall be acceptable and no such approval of the Nominating and
Governance Committee shall be required. Parent will reimburse the Board Representatives for their respective reasonable and
documented out-of-pocket expenses incurred in connection with travel to or from and attendance at each meeting of the Board
of Directors, in each case to the same extent provided to other non-employee directors. The Nomination Rights Board
Representative will receive the same director compensation as each other non-executive director of the Board of Directors.
The Nomination Rights Holders agree, upon Parent’s request, to timely provide Parent with accurate and complete
information relating to the Nomination Rights Board Representative as may be required to be disclosed by Parent under the
Exchange Act and the rules and regulations promulgated thereunder. The Board will not form any “executive” or
similar committees that do not include the Board Representatives. Notwithstanding any rights to be granted with respect to
the Board Representatives hereunder, the Board of Directors may exclude the Board Representatives from access to any Board of
Directors or committee materials or information or meeting or portion thereof or written consent if the Board of Directors
determines, in good faith, including the Board Representatives in discussions relating to such determination (but not
requiring the affirmative vote of such Board Representatives), that such access would reasonably be expected to result in a
conflict of interest with Parent; provided, that such exclusion shall be limited to the portion of the Board of
Directors or committee material or information and/or meeting or written consent that is the basis for such exclusion and
shall not extend to any portion of the Board of Directors or committee material and/or meeting that does not involve or
pertain to such exclusion.


 






    84


     


    

 


(b)         
Following the Closing Date and for so long as Peloton Equity AeroCare SPV I, L.P. and SkyKnight Aero Holdings, LLC (each
an “Observer Rights Holder”) or such Observer Rights Holder’s Affiliate holds at least 35% of the Share
Consideration, on an as-converted basis, issued to such Observer Rights Holder hereunder, on an as-converted basis, each such Observer
Rights Holder shall have the right to designate a non-voting observer of the Board of Directors, which observer shall be an employee,
investment professional or partner of such Observer Rights Holder or one of its Affiliates. The observer shall be entitled to receive
notice of and have the right to attend any and all meetings of the Board of Directors, and Parent shall provide the observer with
copies of all notices, minutes, consents and other material in connection therewith at the same time as such materials are distributed
to members of the Board of Directors; provided, that (A) such Observer Rights Holder shall cause the observer to agree to
hold in confidence all information provided to the observer pursuant hereto, (B) Parent and the Board of Directors shall have the
right to withhold any information and to exclude the observer from any meeting or portion thereof (1) if doing so is, in the opinion
of outside counsel to Parent, advisable or necessary to protect the attorney-client privilege between Parent and counsel or (2)
if the Board of Directors determines in good faith, after consultation with outside counsel, that fiduciary requirements under
applicable law would make attendance by the observer not advisable; provided, further, that, if Parent and/or the
Board of Directors withhold any information or exclude the observer from any meeting pursuant to the foregoing clause (B), to the
extent practicable they shall give such Observer Rights Holder notice of such withholding or exclusion and the parties shall cooperate
in seeking to allow disclosure of such information in a manner that is not reasonably likely (in the good faith belief of Parent
and the Board of Directors (after consultation with outside counsel)) to contravene such applicable law or cause such privilege
to be waived. The observer shall have no right to vote on any matters presented to the Board of Directors. All obligations of Parent
pursuant to this Section‎ 6.17(b) shall terminate with respect to an Observer Rights Holder upon such Observer Rights
Holder ceasing to have the right to designate the observer pursuant to this Section‎ 6.17(b). Parent will reimburse
any observer appointed pursuant to Section‎ 6.17(b) for their respective reasonable and documented out-of-pocket expenses
incurred in connection with travel to or from and attendance at each meeting of the Board of Directors, in each case to the same
extent provided to other non-employee directors.


 






    85


     


    

 


(c)          
 For so long as the Nomination Rights Holders have the right to designate or nominate the Nomination Rights Board Representative
pursuant to Section ‎6.17(a), Parent and the Nominating and Governance Committee of the Board of Directors shall take
such action as is required under applicable Legal Requirements or under the Charter Documents of Parent to include on the Board
of Directors or in the slate of nominees recommended by the Board of Directors such person designated or nominated, as the case
may be, by the Nomination Rights Holders pursuant to Section ‎6.17(a). Parent shall use its reasonable best efforts
to have the Nomination Rights Board Representative elected as a director of Parent and Parent shall solicit proxies for such person
to the same extent as it does for any of its other nominees to the Board of Directors. For so long as the Nomination Rights Holders
have the right to designate or nominate the Nomination Rights Board Representative, in the event that a vacancy is created at any
time by the death, disability, retirement, resignation or removal of the Nomination Rights Board Representative, the Nomination
Rights Holders may designate or nominate, as applicable, another individual to be elected to fill the vacancy created thereby,
and Parent hereby agrees to take, at any time and from time to time, all actions necessary to accomplish the same.


 


(d)        
Parent shall maintain in effect at all times directors’ and officers’ indemnity insurance covering the Nomination
Rights Board Representative to the same extent and on the same terms as any directors’ and officers’ indemnity insurance
maintained by Parent with respect to the other non-executive members of the Board of Directors. Any directors’ and officers’
indemnity insurance shall be primary to any insurance coverage for the Nomination Rights Board Representative maintained by any
other person. Upon the appointment of the Board Representatives to the Board of Directors, Parent and the Board Representatives
shall enter into an indemnification agreement substantially similar to the form included as Exhibit 10.4 to Parent’s Form
10-K for the fiscal year ended December 31, 2019 (the “Indemnification Agreement”).


 


(e)         
All obligations of Parent pursuant to this Section ‎6.17 relating to the Nomination Rights Board Representative
shall terminate, and, upon request by the Board of Directors, the Nomination Rights Holders shall cause the Nomination Rights Board
Representative to resign promptly from the Board of Directors, in each case upon the Nomination Rights Holders ceasing to have
the right to designate or nominate a director pursuant to Section ‎5.1. All obligations of Parent pursuant to this
Section ‎6.17 relating to the Other Board Representative shall terminate, and, upon request by the Board of Directors,
the Other Board Representative will resign promptly from the Board of Directors, in each case upon the Other Board Representative
ceasing to be employed by Parent or one of its Subsidiaries. Any vacancy created by such resignation may be filled by the Board
of Directors or the shareholders of Parent in accordance its Charter Documents and applicable Legal Requirements.


 


6.18        
Information Rights. From and after the date hereof and for so long as each Information Rights Holder or an Affiliate
of such Information Rights Holder holds at least 25% of the Share Consideration, on an as-converted basis, issued to such Information
Rights Holder hereunder, on an as-converted basis:


 


(a)           Parent
will provide to such Information Rights Holder the annual, quarterly and periodic reports of Parent in the time periods
required for the filing of such reports with the SEC as soon as reasonably practicable after they become available; provided, however,
that the filing of such reports with the SEC shall satisfy such delivery requirement.


 






    86


     


    

 



 


(b)           Parent
will permit such Information Rights Holder and its representatives, at such Information Rights Holder’s expense, to reasonable
and customary rights to the information of Parent and access to management of Parent, all at such reasonable times and as often
as may be reasonably requested.


 


6.19        
Tax Matters.


 


(a)          
Transfer Taxes. Except as otherwise provided herein, all transfer, stamp, documentary, registration, recording, value-added
and other similar Taxes (including all applicable real estate transfer Taxes) incurred in connection with this Agreement and the
transactions contemplated hereby (“Transfer Taxes”) and all expenses of filing Tax Returns with respect to such
Taxes will be borne one-half by Parent and one-half by the Company (as a Selling Expense). Each Person required by applicable law
agrees to file, or cause to be filed, in a timely manner all necessary documents (including, but not limited to, all Tax Returns)
with respect to such Transfer Taxes.


 


(b)          
Tax Opinions.


 


(i)                    
Each of Parent, Merger Sub I and Merger Sub II shall use its respective reasonable best efforts to, and cause each of their
respective Subsidiaries to, (i) cause the Mergers to qualify as a “reorganization” within the meaning of Section 368(a)
of the Code, and (ii) obtain the opinion of counsel referred to in Section 7.1(k). Neither Parent, Merger Sub I, nor Merger
Sub II shall take any action which (or fail to take any action, including failing to use its reasonable best efforts to proscribe
any of its respective Subsidiaries from taking any action, the failure of which) could reasonably be expected to prevent or impede
such qualification. In addition, at the request of the Company in connection with a Dividend Recapitalization, Parent shall cooperate
in good faith to consider alternative structures for the transactions contemplated by this Agreement in order for the transactions
to qualify as a reorganization described in Section 368(a)(1)(A) of the Code, including by converting Merger Sub II into a limited
liability company treated as a disregarded entity for U.S. federal income tax purposes.


 


(ii)                   
The Company shall use its reasonable best efforts to, and cause its Subsidiaries to, (i) cause the Mergers to qualify as
a “reorganization” within the meaning of Section 368(a) of the Code, and (ii) obtain the opinion of counsel referred
to in Section 7.2(j). The Company shall not take any action which (or fail to take any action, including failing to use
its reasonable best efforts to proscribe any of its Subsidiaries from taking any action, the failure of which) could reasonably
be expected to prevent or impede such qualification.


 


(iii)                   Unless
otherwise required pursuant to a “determination” within the meaning of Section 1313(a) of the Code, (i) each of
the Parties shall report the Mergers for U.S. federal income tax purposes as a “reorganization” within the
meaning of Section 368(a) of the Code in all Tax Returns, and (ii) none of the Parties shall take any Tax reporting position
inconsistent with the characterization of the transactions contemplated by this Agreement as a “reorganization”
under Section 368(a) of the Code. The Parties to this Agreement adopt this Agreement as a “plan of
reorganization” within the meaning of Treasury Regulations Section 1.368-2(g).


 






    87


     


    

 


(iv)                  
Each of the Company and Parent shall use its reasonable best efforts to deliver to Goodwin Procter LLP (“Company’s
Counsel”) and Willkie Farr and Gallagher LLP (“Parent’s Counsel”) (or to Company’s Replacement
Counsel or Parent’s Replacement Counsel, in each case, if applicable) at such time or times as requested by the Company’s
Counsel or Parent’s Counsel (or Company’s Replacement Counsel or Parent’s Replacement Counsel, in each case,
if applicable) letters signed by an officer thereof and containing representations reasonably requested by Company’s Counsel
and Parent’s Counsel for the purposes of obtaining (i) the tax opinion from Parent’s Counsel (or Parent’s Replacement
Counsel, if applicable) described in Section 7.1(l) and (ii) the tax opinion from the Company’s Counsel (or Company’s
Replacement Counsel, if applicable) described in Section 7.2(i) (such letters, the “Tax Representation Letters”).
Each of Parent and the Company shall cooperate with one another and provide such other information as reasonably requested by requested
by Parent’s Counsel or the Company’s Counsel (or Parent’s Replacement Counsel or Company’s Replacement
Counsel, in each case if applicable) for purposes of rendering the opinions described in Sections 7.1(l) and 7.2(i).


 


6.20        
VDR. No later than ten (10) Business Days following the date of this Agreement, the Company shall deliver to Parent
a CD-ROM or flash drive containing the contents of the VDR as of the date of this Agreement.


 


6.21        
Listing(a). As promptly as possible following the date hereof, Parent shall file a “Listing
of Additional Shares Notification Form” for listing of the Share Consideration to be issued to the Accredited
Investors pursuant to this Agreement and shall use its reasonable best efforts to cause Nasdaq to have completed its review of
a "Listing of Additional Shares Notification Form" prior to the Closing Date.


 


6.22        
 [INTENTIONALLY OMITTED].


 


6.23        
Form S-8. Parent will use commercially reasonable efforts
to cause the Class A Common Stock issuable upon exercise of the Parent Options issued in substitution of the assumed Vested Substitute
Options for which a Form S-8 registration statement is available to be registered with the SEC on Form S-8 in conjunction with
the filing of the Merger Resale Shelf Registration Statement (as such term is defined in the Amended and Restated Registration
Rights Agreement) (assuming timely receipt of all documentation relating to such Vested Substitute Options outstanding immediately
prior to the First Effective Time and all opinions and consents required for such registration statement) to be registered with
the SEC and will exercise commercially reasonable efforts to maintain the effectiveness of such registration statement for so long
as such substitute Parent Options remain outstanding and Parent has one or more other Registration Statements on Form S-8 on file
with the SEC and will reserve a sufficient number of shares of Class A Common Stock for issuance upon exercise or settlement thereof.
The Company and its counsel will reasonably cooperate with and assist Parent in the preparation of such registration statement.
The Form S-8 registration statement shall not cover the shares of Class A Common Stock subject to any Vested Substitute Options
that are not Employee Options.


 


6.24       
 Excess Capital Equipment. Between the date of the physical inventory pursuant to Section 2.8(a) and the Closing,
the Company shall not, and shall cause its Subsidiaries not to, sell, lease or otherwise dispose of or subject to any Lien any
Excess Capital Equipment or agree or enter into any Contract to take any such action.


 






    88


     


    

 


6.25        
Section 16 Matters. Prior to the First Effective Time, the Parent shall take all such steps as may be necessary or
appropriate to cause the transactions contemplated by this Agreement, including any dispositions of Company Common Stock (including
derivative securities with respect to such Company Common Stock) or acquisitions of Class A Common Stock (including derivative
securities with respect to such Class A Common Stock) resulting from the transactions contemplated by this Agreement by each individual
who will become subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to Parent to be exempt
under Rule 16b-3 promulgated under the Exchange Act, if applicable.


 


6.26        
Related Party Transactions. Prior to the First Effective Time, the Company shall take all such actions as are necessary
in order to terminate the Contracts set forth on or required to have been set forth on Section ‎4.18 of the Disclosure
Schedule, other than those Contracts denoted with an asterisk on Section 4.18 of the Disclosure Schedule.


 


ARTICLE
VII

CONDITIONS TO CLOSING


 


7.1          
Conditions Precedent to Obligations of Parent, Merger Sub and Merger Sub II. The obligation of Parent, Merger Sub
and Merger Sub II to consummate the transactions contemplated by this Agreement is subject to the fulfillment, on or prior to the
Closing Date, of each of the following conditions (any or all of which may be waived by Parent in whole or in part to the extent
permitted by applicable Legal Requirements):


 


(a)          
The Fundamental Representations of the Company shall be true and correct in all respects (except for Sections 4.2,
which Section shall be true and correct in all but de minimis respects) as of the date hereof and as of the Closing Date
as if made on and as of the Closing Date (or, if given as of a specific date, at and as of such date), and except for Section
4.5, which shall be true and correct in all but de minimis respects, other than with respect to any inaccuracies that
are corrected by the Company at no cost and without liability to any of Parent, Merger Sub or Merger Sub II prior to the Closing
and reflected in the final version of the Closing Consideration Schedule delivered to Parent prior to the Closing. The Ordinary
Reps made by the Company disregarding all qualifications and exceptions contained therein relating to “materiality”
or “Material Adverse Effect”, other than with respect to Section‎ 4.10(i), shall be true and correct as
of the date of this Agreement and as of the Closing Date as if made on and as of the Closing Date (or, if given as of a specific
date, at and as of such date), except for inaccuracies that, individually or in the aggregate, do not constitute a Material
Adverse Effect.


 


(b)          
Subject to Section 6.11(b)(v), the Company shall have performed and complied in all material respects with all covenants
required by this Agreement to be performed or complied with by it on or prior to the Closing Date.


 


(c)         
 There shall not be in effect any Order by a Governmental Entity of competent jurisdiction enjoining or otherwise prohibiting
the consummation of the transactions contemplated by this Agreement.


 


(d)           Any
applicable approval or waiting period (and any extension thereof) applicable to the consummation of the Mergers under the HSR
Act shall have been obtained or expired or been earlier terminated and any timing agreement delaying the Closing entered into
in connection therewith shall have expired.


 






    89


     


    

 


(e)           Since
the date hereof, there shall not have been a Material Adverse Effect.


 


(f)           
The Company Written Consent shall have been obtained.


 


(g)          
No more than 3.5% of the shares of Company Common Stock issued and outstanding immediately prior to the First Effective
Time shall consist of Dissenting Shares.


 


(h)          
The Company shall have delivered to Parent the items set forth in clauses (a), (b) and, if the Closing Date has not occurred
by March 31, 2021, clause (c) of the definition of Required Financial Information, and such Required Financial Information remains
Compliant as of the Closing Date.


 


(i)          
Nasdaq shall have completed its review of a “Listing of Additional Shares Notification Form” for listing of
the any Share Consideration on the Nasdaq CM; provided, that this condition will be disregarded if Parent has not fully
complied with Section 6.21 and made the filing described therein within five (5) days of the Closing.


 


(j)           
The Company Voting and Support Agreements listed in Section‎ 7.1(j) of the Disclosure Schedule shall be in
full force and effect at the Closing.


 


(k)          
The Company shall have obtained all Consents and given all notices listed on Section‎ 7.1(k) of the Disclosure
Schedule.


 


(l)          
Parent shall have received the written opinion of Parent’s Counsel (or if Parent’s Counsel is unable to issue
such an opinion, of another nationally recognized law firm proposed by the Company that is reasonably acceptable to Parent (“Parent’s
Replacement Counsel”)), dated as of the Closing Date, to the effect that the Merger will qualify as a “reorganization”
within the meaning of Section 368(a) of the Code; provided, that notwithstanding the foregoing, if Parent’s Counsel
or Parent’s Replacement Counsel is unable to render the opinion described in this Section 7.1(l) and but for a Dividend Recapitalization
would be able to render the opinion described in this Section 7.1(l), the receipt of such opinion shall not be a condition of Parent
to consummate the transactions contemplated by this Agreement. In rendering such opinion, Parent’s Counsel (or Parent’s
Replacement Counsel, if applicable) shall be entitled to rely upon the representations contained in the Tax Representation Letters
of Parent and the Company referred to in Section ‎6.19(b)(iv) hereto.


 


7.2           Conditions
Precedent to Obligations of the Company. The obligation of the Company to consummate the transactions contemplated by
this Agreement is subject to the fulfillment, prior to or on the Closing Date, of each of the following conditions (any or
all of which may be waived by the Company in whole or in part to the extent permitted by applicable Legal Requirements):


 


(a)          
The Fundamental Representations of Parent shall be true and correct (except for Sections 5.2 and 5.9, which Sections shall
be true and correct in all but de minimis respects) as of the date hereof as of the Closing Date as if made on and as of
the Closing Date (or, if given as of a specific date, at and as of such date). The Ordinary Reps made by Parent disregarding all
qualifications and exceptions contained therein relating to “materiality” or “Parent Material Adverse Effect”
shall be true and correct as of the date hereof and as of the Closing Date as if made on and as of the Closing Date (or, if given
as of a specific date, at and as of such date), except for changes that, individually or in the aggregate, do not constitute a
Parent Material Adverse Effect.


 






    90


     


    

 


(b)          
Parent shall have performed and complied in all material respects with all covenants required by this Agreement to be performed
or complied with by Parent on or prior to the Closing Date.


 


(c)          
There shall not be in effect any Order by a Governmental Entity of competent jurisdiction enjoining or otherwise prohibiting
the consummation of the transactions contemplated by this Agreement.


 


(d)           Any
applicable approval or waiting period (and any extension thereof) applicable to the consummation of the Mergers under the HSR
Act shall have been obtained or expired or been earlier terminated and any timing agreement delaying the Closing entered into
in connection therewith shall have expired.


 


(e)          
Since the date hereof, there shall not have been a Parent Material Adverse Effect.


 


(f)           
Parent shall have delivered to the Company a copy of the Certificate of Designations that has been filed with the Secretary
of State of the State of Delaware.


 


(g)        
Nasdaq shall have completed its review of a “Listing of Additional Shares Notification
Form” for listing of the any Share Consideration on the Nasdaq CM.


 


(h)         
The Parent Voting and Support Agreements shall be in full force and effect at the Closing or the Parent Stockholder Approval
shall have been obtained.


 


(i)            The
Company shall have received the written opinion of Company’s Counsel (or if Company’s Counsel is unable to issue
such an opinion, of another nationally recognized law firm proposed by Parent that is reasonably acceptable to the Company
(“Company’s Replacement Counsel”)), dated as of the Closing Date, to the effect that the Merger will
qualify as a “reorganization” within the meaning of Section 368(a) of the Code; provided, that
notwithstanding the foregoing, if Company’s Counsel or Company’s Replacement Counsel is unable to render the
opinion described in this Section 7.2(i) and but for a Dividend Recapitalization would be able to render the opinion
described in this Section 7.2(i), the receipt of such opinion shall not be a condition of the Company to consummate the
transactions contemplated by this Agreement. In rendering such opinion, Company’s Counsel (or Company’s
Replacement Counsel, if applicable) shall be entitled to rely upon the representations contained in the Tax Representation
Letters of Parent and the Company referred to in Section ‎6.19(b)(iv) hereto.


 






    91


     


    

 


ARTICLE
VIII

INDEMNIFICATION


 


8.1          
Representation and Warranty Insurance. Prior to the Closing, the Company shall use commercially reasonable
efforts to provide to Parent such cooperation reasonably requested by Parent that is customary to obtain a claims made representation
and warranty insurance policy (“Special Policy” ), including by reasonably assisting Parent in providing
customary information as may reasonably be requested by any insurance broker or insurance carrier in connection therewith.


 


8.2           Indemnification
by Company Equityholders. Subject to the provisions of this Article ‎VIII,
from and after the Closing, the Company Equityholders, solely from the Special Escrow Deposit, hereby agree to indemnify and hold
harmless Parent, its Affiliates and each of their respective directors, managers, officers and Affiliates (collectively, the “Parent
Indemnitees” or “Indemnified Parties”) from and against any and all Losses of such Parent Indemnitees
resulting from or arising out of the Special Matter.


 


8.3          
Survival. The representations and warranties in this Agreement and the covenants and agreements in this Agreement
that by their terms are to be performed or complied with at or prior to the Closing (the “Pre-Closing Covenants”
), in each case, shall terminate effective as of the Closing, shall not survive the Closing for any purpose, and neither Parent
or any of its Subsidiaries or any of its or their respective Affiliates nor the Company or any of its Subsidiaries or any Company
Equityholder or any of its or their respective Affiliates shall have any liability with respect to any such representations or
warranties or Pre-Closing Covenants, except in the case of Fraud. The Company Equityholders’ indemnification obligations
under Section ‎8.2 shall survive until the settlement
or other similar final resolution of the Special Matter (the “Special Matter Termination Date”). Any covenant
or agreement contained herein that by its terms is to be performed or complied with after the Closing (“Post-Closing Covenants”
) shall survive the Closing until fully performed or fulfilled unless and only to the extent that non-compliance with such covenant
or agreement is waived by the party entitled to such performance.


 


8.4          
Limitations on Indemnification; Procedures.


 


(a)           The
Special Escrow Deposit shall be the sole and exclusive source of recovery for any and all amounts payable to Parent or any of
the other Parent Indemnitees pursuant to Article ‎VIII, and then only for Losses resulting from or arising out
of the Special Matter pursuant to Section ‎8.2 and in accordance with this Article ‎VIII. Promptly
following the Special Matter Termination Date, Parent and the Stockholder Representative shall jointly instruct the Escrow
Agent to release and deliver from the Special Escrow Account, subject to the Escrow Agreement, any portion of the Special
Escrow Deposit in excess of any unresolved bona fide claim made pursuant to Section ‎8.2 within five (5)
Business Days after the Special Matter Termination Date, (i) to the Paying Agent, for further distribution to the Company
Equityholders (other than holders of Vested Company Options that are Employee Options) and (ii) to Parent (or its designee)
for further distribution to the holders of Vested Company Options that are Employee Options on the next regularly scheduled
payment date, through the payroll system of Parent or a Subsidiary of Parent subject to applicable Tax withholding, in each
case, in accordance with the percentage of such amount payable to each Company Equityholder based on their respective Pro
Rata Shares as set forth in the Closing Consideration Schedule.


 






    92


     


    

 


(b)         
The amount of any and all Losses will be determined net of any current liability in respect of the Special Matter included
in the calculation of Net Working Capital as of the Measurement Time as finally determined pursuant to Section ‎2.9(b).
The amount of any and all Losses will also be determined net of any amounts actually recovered by any Parent Indemnitees under
insurance policies or otherwise with respect to such Losses (and Parent will, and will cause its Subsidiaries to, use commercially
reasonable efforts to recover under any applicable insurance policies).


 


8.5          
Defense of the Special Matter. Following the Closing, the Indemnified Parties may assume defense of the Special Matter
(and will use commercially reasonable efforts to successfully conduct such defense and promptly resolve the Special Matter); provided,
however, that no Indemnified Party will agree to the entry of any judgment or enter into any settlement or compromise with
respect to the Special Matter without the prior written consent of the Stockholder Representative, on behalf of the Company Equityholders
(not to be unreasonably withheld, conditioned or delayed). The Stockholder Representative shall have the right to participate in
the defense of the Special Matter and to employ counsel of its own choosing, at its own cost, for such purpose, in each case on
behalf of the Company Equityholders.


 


8.6          
Sole and Exclusive Recourse.


 


(a)          
Each of Parent and the Company hereby acknowledge and agree that the Indemnified Parties’ sole and exclusive remedy
following the Closing against the Company Equityholders with respect to any breach of, or inaccuracy in, any representation or
warranty or the failure to perform under any Pre-Closing Covenant, and with respect to any and all claims relating to the subject
matter of this Agreement and the transactions contemplated by this Agreement, shall be the Special Policy and the Special Escrow
Deposit, except for Fraud or any breach of, or inaccuracy in, or failure to perform under any covenant or obligation, in each case,
set forth in any separate written agreement, document or instrument to which such Company Equityholder is a party or signatory
(including, for the avoidance of doubt, failure to comply with any requirement in such agreement to comply with any provision of
this Agreement).


 


(b)         
For the avoidance of doubt, any adjustments made to the Aggregate Merger Consideration pursuant to Section ‎2.9
shall not be considered “remedies” for purposes of this Section‎ 8.6 and shall not be limited by the terms
of this Section‎ 8.6.


 


8.7         
 [INTENTIONALLY OMITTED]


 


8.8          
Treatment for Tax Purposes. For all applicable Tax purposes, each party hereto and its respective Affiliates agree
to treat any indemnity payment under this Article ‎VIII
as an adjustment to the Aggregate Merger Consideration, unless otherwise required by applicable Legal Requirement.


 






    93


     


    

 


8.9          
Acknowledgement; Waiver.


 


(a)          
EXCEPT IN THE CASE OF FRAUD OR ANY BREACH OR DEFAULT IN PERFORMANCE OF ANY POST-CLOSING COVENANT, OTHER THAN THE REMEDIES
EXPRESSLY PROVIDED FOR IN THIS ‎ARTICLE VIII IN RESPECT OF THE SPECIAL MATTER, THE PURCHASE PRICE ADJUSTMENT PROVISIONS
OF SECTION ‎2.9, ANY AVAILABLE REMEDIES UNDER ANY OTHER TRANSACTION DOCUMENTS AND ITS RESPECTIVE RIGHTS OF SPECIFIC
PERFORMANCE UNDER SECTION ‎10.8, EACH OF PARENT, THE COMPANY (FROM AND AFTER THE CLOSING), MERGER SUB AND MERGER SUB
II, ON THEIR OWN BEHALF AND ON BEHALF OF THEIR AFFILIATES, HEREBY EXPRESSLY WAIVES AND RELEASES ANY REMEDY, LIABILITY AND ANY RIGHTS
IT MAY HAVE AGAINST ANY COMPANY EQUITYHOLDER OR ANY OF THEIR RESPECTIVE AFFILIATES ARISING OUT OF, RELATING TO OR RESULTING FROM
THIS AGREEMENT AND ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY PURSUANT TO LAW OR EQUITY OR OTHERWISE. FURTHERMORE, PARENT, THE
COMPANY (FROM AND AFTER THE CLOSING), MERGER SUB AND MERGER SUB II, ON THEIR OWN BEHALF AND ON BEHALF OF THEIR AFFILIATES, EACH
COVENANTS NOT TO SUE OR OTHERWISE THREATEN ANY CLAIM THAT INCLUDES ANY REMEDY WAIVED BY THE PRECEDING. PARENT, THE COMPANY (FROM
AND AFTER THE CLOSING) MERGER SUB AND MERGER SUB II, ON THEIR OWN BEHALF AND ON BEHALF OF THEIR AFFILIATES, EACH AGREES THAT, TO
THE EXTENT REQUIRED BY APPLICABLE LEGAL REQUIREMENT TO BE EFFECTIVE, THIS AGREEMENT AND THE WAIVERS AND RELEASES CONTAINED IN THIS
SECTION 8.9(a) ARE CONSPICUOUS.


 


(b)          Without
limiting the generality of Section ‎8.9(a), except for Fraud or for any breach or default of any Post-Closing
Covenant, other than the remedies expressly provided for in this Article ‎VIII, the purchase price adjustment
provisions of Section ‎2.9, any available remedies under any other Transaction Documents and its rights of
specific performance under Section ‎10.8, Parent, on its own behalf and on behalf of its Subsidiaries
(including, after the Closing, the Company and its Subsidiaries), and any of its and their respective agents, successors and
permitted assigns (including Parent, each, a “Waiving Party”), acknowledges and agrees that, from and
after the Closing, to the fullest extent permitted under applicable Legal Requirement, any and all rights, claims and causes
of action it may have against Company, any Company Equityholder or any of their respective Affiliates relating to the
business conducted by the Company or any of its Subsidiaries, the operation of the Company and any of its Subsidiaries, or
their respective businesses or relating to the subject matter of this Agreement or any of the transactions contemplated
hereby, whether arising under, or based upon, any Legal Requirement (including any right, whether arising at law or in
equity, to seek indemnification, contribution, cost recovery, damages or any other recourse or remedy, including as may arise
under common law) are hereby irrevocably waived by the Waiving Parties. Parent, on its own behalf and on behalf of each
Waiving Party, acknowledges and agrees that the Waiving Parties may not avoid such limitation on liability by seeking damages
for breach of contract, tort or pursuant to any other theory of liability, all of which are hereby waived. The Parties
acknowledge and agree that the limits imposed on the Waiving Parties’ remedies with respect to this Agreement and the
transactions contemplated hereby were bargained for between sophisticated parties and were specifically taken into account in
the determination of the amounts to be paid by Parent hereunder.


 






    94


     


    

 


(c)         
EXCEPT FOR FRAUD (AS DEFINED IN THIS AGREEMENT) OR ANY BREACH OR DEFAULT OF ANY POST-CLOSING COVENANT, AND OTHER THAN THE
REMEDIES PROVIDED FOR IN THIS ‎ARTICLE VIII, THE PURCHASE PRICE ADJUSTMENT PROVISIONS OF SECTION ‎2.9,
ANY AVAILABLE REMEDIES UNDER ANY OTHER TRANSACTION DOCUMENTS AND ITS RIGHTS OF SPECIFIC PERFORMANCE UNDER SECTION ‎10.8,
PARENT, ON ITS OWN BEHALF AND ON BEHALF OF EACH WAIVING PARTY, EXPRESSLY AND IRREVOCABLY WAIVES ALL RIGHTS AFFORDED BY ANY STATUTE
OR COMMON LAW PRINCIPLES WHICH LIMITS THE EFFECT OF A RELEASE WITH RESPECT TO UNKNOWN CLAIMS. PARENT, ON ITS OWN BEHALF AND ON
BEHALF OF EACH WAIVING PARTY, ACKNOWLEDGES THAT IT UNDERSTANDS THE SIGNIFICANCE OF THIS RELEASE OF UNKNOWN CLAIMS AND WAIVER OF
ANY STATUTORY PROTECTION AGAINST A RELEASE OF UNKNOWN CLAIMS. PARENT, ON BEHALF OF THE WAIVING PARTIES, ACKNOWLEDGES AND AGREES
THAT THIS WAIVER IS AN ESSENTIAL AND MATERIAL TERM OF THIS AGREEMENT.


 


8.10       
No Reliance. AS MODIFIED BY THE APPLICABLE DISCLOSURE SCHEDULE, THE REPRESENTATIONS AND WARRANTIES OF THE
COMPANY EXPRESSLY CONTAINED IN ARTICLE IV, AND OF PARENT, MERGER SUB AND MERGER SUB II IN ARTICLE V, OR IN ANY CERTIFICATE
DELIVERED BY SUCH PARTY PURSUANT TO SECTION 2.3, CONSTITUTE THE SOLE AND EXCLUSIVE REPRESENTATIONS AND WARRANTIES OF THE
PARTIES HERETO IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EXCEPT FOR SUCH REPRESENTATIONS AND WARRANTIES,
AND SUCH CERTIFICATES DELIVERED BY SUCH PARTY PURSUANT TO SECTION ‎2.3,
NEITHER COMPANY NOR PARENT MAKES ANY OTHER EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY OF ANY NATURE AND EACH OF COMPANY AND
PARENT HEREBY DISCLAIMS ANY SUCH REPRESENTATION OR WARRANTY WITH RESPECT TO THE EXECUTION AND DELIVERY OF THIS AGREEMENT AND THE
CONSUMMATION OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CONFIRMS THAT IT IS NOT RELYING ON ANY REPRESENTATION
OR WARRANTY OTHER THAN THOSE EXPRESSLY SET FORTH IN ARTICLE IV AND ARTICLE V AND EACH PARTY ACKNOWLEDGES THAT THIS
NO RELIANCE CONFIRMATION IS A MATERIAL INDUCEMENT TO THE OTHER PARTY’S WILLINGNESS TO ENTER INTO THIS AGREEMENT AND CONSUMMATE
THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED IN THIS SECTION ‎
8.10 OR OTHERWISE, NOTHING IN THIS SECTION ‎ 8.10
SHALL IN ANY MANNER (I) LIMIT EITHER PARTY’S RIGHTS UNDER ‎ARTICLE
VIII OR (II) LIMIT, OR BE TAKEN INTO ACCOUNT IN EVALUATING THE MERIT OF, ANY CLAIM OF FRAUD.


 


8.11       
 Non-Recourse. Any claims or causes of action (whether in contract or in tort, in law or in equity) that
may be based upon, arise out of or relate to this Agreement, or the negotiation, execution, performance or breach (whether willful,
intentional or otherwise) of this Agreement (including any representation or warranty made in or in connection with this Agreement
or as an inducement to enter into this Agreement), may be made only against the entities that are expressly identified as a Party.
No Person who is not a named Party to this Agreement, including without limitation any past, present or future director, officer,
employee, incorporator, member, partner, equityholder, Affiliate, agent, attorney or representative of any named Party to this
Agreement (“Non-Party Affiliates”), shall have any liability (whether in contract or in tort, in law or in
equity, or based upon any theory that seeks to impose liability of an entity party against its owners or Affiliates) for any obligations
or liabilities based upon, arising under, in connection with or related to this Agreement or for any claim based on, in respect
of, arising out of, related to or by reason of this Agreement or its negotiation, execution, performance or breach (whether willful,
intentional or otherwise); and each Party waives and releases all such liabilities, claims and obligations against any such Non-Party
Affiliate and expressly disclaims reliance on upon any Non-Party Affiliates with respect to the performance of this Agreement
or any representation or warranty made (or alleged to have been made) in, in connection with, or as an inducement to this Agreement.
Non-Party Affiliates are expressly intended as third party beneficiaries of this Section ‎8.11.
Notwithstanding the foregoing, this Section ‎8.11
shall in no way limit the liabilities of Company Equityholders expressly set forth in the Company Voting and Support Agreements
or Stock Letter of Transmittal.


 






    95


     


    

 


ARTICLE
IX

TERMINATION


 


9.1          
Termination of Agreement. This Agreement may be terminated prior to the Closing only as provided below:


 


(a)          
by Parent and Company if both agree to terminate this Agreement by mutual written consent at any time prior to the Closing;


 


(b)          
by either Parent or Company (with respect to each of the following, treating Parent, Merger Sub and Merger Sub II as one):


 


(i)                    
if any Order of a Governmental Entity having the effect set forth in Section ‎7.1(c) or Section ‎7.2(c)
shall be in effect and shall have become non-appealable, final and permanent at any time prior to the Closing and the terminating
Party delivered written notice of such event to the other Party; provided, that no Party may terminate this Agreement pursuant
to this Section ‎9.1(b)(i) if the Order described in this Section ‎9.1(b)(i) resulted primarily
from such Party’s breach of any representation or warranty made by it herein or the failure of such Party to fulfill any
of its covenants in this Agreement; and


 


(ii)                    at
any time on or after May 31, 2021 (such date, as extended pursuant to Section ‎10.8, the
 “Outside Date”) upon written notice to the other Party if the transactions contemplated by this Agreement
shall not have been consummated on or prior to such date; provided, that no Party may terminate this Agreement
pursuant to this Section ‎9.1(b)(ii) if such Party is in breach of any representation or warranty made by
it herein or has failed to fulfill any of its covenants in this Agreement, and such breach or failure has prevented the
satisfaction of the other Party’s conditions to Closing hereunder or was the primary cause of the failure to consummate
the Closing prior to the Outside Date.


 






    96


     


    

 


(c)          
by Parent, on the one hand, or Company, on the other hand, by written notice to the other, if the other shall have breached
or failed to perform any of its respective representations, warranties, covenants or other agreements contained in this Agreement,
and such breach or failure to perform: (i) would primarily give rise to the failure of a condition set forth in Section ‎7.1(a)
or Section ‎7.1(b) (in the case of a breach or failure to perform by Company) or Section ‎7.2(a) or Section
 ‎7.2(b) (in the case of a breach or failure to perform by Parent) and (ii) cannot be or has not been cured prior to the
earlier of: (A) the fifth (5th) Business Day prior to the Outside Date or (B) the date that is twenty (20) Business
Days from the date that Parent or Company, as applicable, is notified by the other in writing of such breach or failure to perform;
provided, that the right to terminate this Agreement under this Section ‎9.1(c) shall not be available to (x)
Parent if there has been a breach or failure to perform by Parent that would give the Company the right to terminate this Agreement
pursuant to this Section ‎9.1(c) or (y) Company if there has been a breach or failure to perform by Company that would
give Parent the right to terminate this Agreement pursuant to this Section ‎9.1(c) ;


 


(d)          
by the Company, if (i) all the conditions set forth in Section ‎7.1 (other than those conditions that by their
terms are required to be satisfied at the Closing, but all such conditions are then capable of being satisfied) shall have been
satisfied or waived, (ii) the Parent has failed to consummate the Closing on the date on which the Closing is required to occur
pursuant to Section ‎2.3, (iii) after the occurrence of the events described in the preceding clauses (i) and (ii),
the Company has irrevocably (for the two (2) Business Day period described in the following clause (iii)) confirmed to Parent in
writing that the Company is prepared and able to consummate the Closing in accordance with the terms of this Agreement, that if
the Debt Financing were to be funded, will consummate the Closing in accordance with the terms of this Agreement and that all of
the conditions to the Closing set forth in Section ‎7.2 have been satisfied or waived (other than conditions that,
by their nature are to be satisfied at the Closing), and (iii) the Parent has failed to consummate the Closing within two (2) Business
Days after such notification (it being understood that such confirmation remains in full force and effect at the close of business
on such second (2nd) Business Day);


 


(e)          
By Parent, if the Company shall have not delivered the executed Company Written Consent to Parent within twenty-four (24)
hours of the execution of this Agreement; provided, that the right to terminate this Agreement under this Section‎
9.1(e) shall only be available to Parent until the earlier of (y) the date and time that the Company delivers the executed
Company Written Consent to Parent and (z) the date that is five (5) Business Days after the execution of this Agreement; or


 


(f)           By
Parent, if the Company shall have not delivered or caused to be delivered to Parent the executed Company Voting and Support
Agreements listed on Section‎ 7.1(j) of the Disclosure Schedule within twenty-four (24) hours of the execution
of this Agreement; provided, that that the right to terminate this Agreement under this Section ‎9.1(f)
shall only be available to Parent until the earlier of (y) the date and time that the Company delivers all such executed
Company Voting and Support Agreements to Parent and (z) the date that is five (5) Business Days after the execution of this
Agreement.


 






    97


     


    

 


9.2           
Effect of Termination.


 


(a)          
In the event of the valid termination of this Agreement pursuant to Section ‎9.1, written notice thereof will
be given by the terminating Party to the other Party specifying the provision hereof pursuant to which such termination is made,
and all obligations of the Parties hereunder (other than obligations under Section ‎6.2, Section ‎6.11(b)(ii),
Section ‎ 6.24, this Section ‎9.2 and ‎ARTICLE X, and any related definitions contained
in any such Sections and Article, which shall survive termination) shall terminate without any liability of any Party to any other
Party; provided, that notwithstanding the foregoing, subject to the terms and conditions of this Agreement, liability may
exist for breach of, or otherwise with respect to, the provisions of this Agreement specified in the foregoing parenthetical (including,
for the avoidance of doubt, Parent’s liability for the Termination Fee and Collection Costs, if applicable). Nothing in this
Section 9.2 will be deemed to impair the right of any Party to compel specific performance by another Party of its obligations
under this Agreement, subject to the terms and conditions of this Agreement. In the event of the termination of this Agreement,
the Confidentiality Agreement will survive the termination of this Agreement for the period set forth therein.


 


(b)          
In the event that this Agreement is validly terminated by the Company pursuant to Section ‎9.1(c) or Section ‎9.1(d)
then Parent shall pay Sixty Million Dollars ($60,000,000) (the “Termination Fee”) to Company (or any designee
of Company) within five (5) Business Days following such termination, payable by wire transfer of same day funds (it being understood
that in no event shall Parent be required to pay the Termination Fee or any Collection Costs on more than one occasion). If Parent
fails to promptly pay the Termination Fee when due pursuant to this Section ‎9.2, and, in order to obtain such payment,
the Company commences a suit that results in a final and unappealable judgment against Parent for the payment of the Termination
Fee, Parent shall pay to the Company or its designee its reasonable and documented out-of-pocket costs and expenses paid to independent
third parties (including attorneys’ fees of outside counsel) in connection with any Action relating to the Termination Fee,
together with interest on the Termination Fee at a rate per annum equal to four percent (4%) plus the prime rate as published
in The Wall Street Journal, Eastern Edition, in effect on the date of termination beginning on the date such payment was required
to be made through the date of payment (such interest payment, together with the collection
costs, the “Collection Costs”).


 






    98


     


    

 


(c)          Notwithstanding
anything to the contrary contained herein, except for (i) the Company’s remedies under the Confidentiality Agreement or
in the event of Fraud, and (ii) the Company’s right to seek and obtain specific performance as to and to the extent
permitted by Section 8.10 and the amounts contemplated by Section 10.8(c), the right of Company (or any
designee of Company) to receive the Termination Fee (plus any Collection Costs, as applicable) pursuant to Section
9.2(b) (if payable pursuant to the terms thereof) shall be the sole and exclusive remedy (whether at law, in equity, in
contract, in tort, or otherwise) of Company or any of its Affiliates against Parent and any of its Affiliates’ former,
current or future direct or indirect equityholders, controlling persons, stockholders, directors, officers, employees,
agents, advisers, attorneys, representatives, members, managers, general or limited partners or assignees (collectively, the
 “Parent Related Parties” ) for any and all breaches (whether knowing, willful, intentional or otherwise),
losses, liabilities or damages, including, but not limited to, special, indirect or punitive damages, suffered or incurred by
Company or any other Person in connection with this Agreement, the transactions contemplated hereby (and the abandonment or
termination thereof) or any matter forming the basis for such termination, and neither Company nor any other Person shall
have any further or other recourse to, or rights or remedies against, or be entitled to bring or be entitled to assert, bring
or maintain, and Company on behalf of itself and each its respective Affiliates, former, current or future direct or indirect
equityholders, controlling persons, stockholders, directors, officers, employees, representatives, members, managers, general
or limited partners or assignees (collectively, the “Company Releasing Related Parties” ) hereby waives
any right to assert, bring or maintain, any claim, demand, suit, action or proceeding against Parent any other Parent Related
Party arising out of, under, or in connection with this Agreement, the negotiation, execution, performance, termination
hereof, or breach of any representation, warranty, covenant or agreement hereunder (whether intentional, willful, negligent
or otherwise) hereof, the transactions contemplated hereby (and the abandonment or termination thereof) or any matter forming
the basis for such termination, whether by or through (a) attempted piercing of the corporate veil, (b) a claim by or on
behalf of Parent or one of its Affiliates against another Parent Related Party or (c) any legal or equitable proceeding
whether at law, in equity, in contract, in tort or otherwise.  For the avoidance of doubt, under no circumstances will
Company or any other Company Releasing Related Party be entitled to any monetary amounts (whether money damages or any other
recovery, judgment, or damages of any kind, including consequential, indirect, or punitive damages) in excess of the amount
of the Termination Fee (plus any Collection Costs, as applicable).  In the event this Agreement is terminated and Parent
becomes obligated to pay the Termination Fee (plus any Collection Costs), no Company Releasing Related Party shall have the
right to seek, obtain or be entitled to money damages (whether at law or in equity, in contract, in tort or otherwise) from
any of Parent or Parent Related Parties in connection with this Agreement, the Debt Financing Commitment or in respect of any
other agreement, theory of law or otherwise including for any breach, loss or damage under or related to this Agreement other
than specifically set forth in this Section 9.2(c).   While the Company may pursue both (x) a grant of
specific performance prior to the Closing pursuant to Section 10.8 and the amounts contemplated by Section
10.8(c), on the one hand, and (y) the payment of the Termination Fee (plus any Collection Costs, as applicable) pursuant
to Section 9.2(b), on the other hand, under no circumstances shall the Company or any other Company Releasing Related
Party be entitled to receive both (1) a grant of specific performance and the amounts contemplated by Section 10.8(c)
and (2) all or any portion of the Termination Fee (plus any Collection Costs, as applicable); provided; however,
that, in the event Parent is compelled to effect the Closing pursuant to an Order granting specific performance in accordance
with the terms of this Agreement, and Parent fails to effect the Closing notwithstanding such Order, the Termination Fee
would remain available to the Company in lieu of specific performance and the consummation of the Closing.  In addition,
notwithstanding anything in this Agreement to the contrary, the Company, on behalf of itself and of its Company Releasing
Related Parties, hereby waives any claims against the Financing Parties and hereby agrees that in no event shall the
Financing Parties have any liability or obligation to the Stockholder Representative, the Company or any Company Releasing
Related Party relating to or arising out of this Agreement, the Debt Financing, the Debt Financing Commitments or the
transactions contemplated hereby; provided, that notwithstanding the foregoing, nothing in this Section 9.2(c) shall
in any way limit or modify the rights and obligations of Parent under the Debt Financing Commitments.


 


(d)         
Notwithstanding anything to the contrary in the foregoing, the Parties acknowledge and agree that (i) the agreements contained
in this Section ‎9.2 are an integral part of the transactions contemplated by this Agreement and (ii) any payment
of the Termination Fee (plus any Collection Costs, as applicable) is not a penalty but is liquidated damages in a reasonable amount
that will compensate Company in the circumstances in which such fees are payable for the efforts and resources expended and the
opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of the consummation
of the transactions contemplated by this Agreement, which amount would otherwise be impossible to calculate with precision and
that, without these agreements, the parties would not enter into this Agreement.


 






    99


     


    

 


(e)          
In the event that this Agreement is validly terminated by Parent pursuant to Section 9.1(e) or 9.1(f), the Company shall
pay to the Parent or its designee, or reimburse the Parent or its designee for, as applicable, the Purchasing Expenses. If Parent
fails to promptly pay the Purchasing Expenses when due pursuant to this Section 9.2, and, in order to obtain such payment, Parent
commences a suit that results in a final and unappealable judgment against the Company for the payment of the Purchasing Expenses,
the Company shall pay to Parent or its designee its reasonable and documented out-of-pocket costs and expenses paid to independent
third parties (including attorneys’ fees of outside counsel) in connection with any Action relating to the Purchasing Expenses,
together with interest on the Purchasing Expenses at a rate per annum equal to four percent (4%) plus the prime rate as published
in The Wall Street Journal, Eastern Edition, in effect on the date of termination beginning on the date such payment was required
to be made through the date of payment.


 


(f)           
Notwithstanding this Article ‎IX or anything in this Agreement to the contrary, subject to Section 10.8(b),
Parent affirms that it is not a condition to the Closing or to any of its obligations under this Agreement that Parent (or any
of the Company or any of its Subsidiaries) obtain financing for or related to any of the transactions contemplated by this Agreement.


 


ARTICLE
X

GENERAL


 


10.1       
Entire Agreement. This Agreement, together with the Disclosure Schedule, the Confidentiality Agreement and the other
Transaction Documents contain the sole and entire agreements between the Parties with respect to the subject matter hereof and
thereof and supersede all prior and contemporaneous discussions, understandings, negotiations, and agreements (whether written
or oral) among the Parties or between any of them with respect to the subject matter of this Agreement and the other Transaction
Documents.


 


10.2        Successor
and Assigns; Third-Party Beneficiaries. Neither this Agreement, the Transaction Documents nor the rights and obligations
hereunder or thereunder may be assigned, subcontracted or otherwise delegated or transferred without the prior written
consent of the Stockholder Representative, Parent and Company. All of the terms, covenants, representations, warranties and
conditions of this Agreement will be binding upon, and inure solely for the benefit of, and be enforceable by, the Parties
and their respective successors and permitted assigns (and in the case of indemnities, for the benefit of all Persons
indemnified). Nothing herein expressed or implied is intended or will be construed to confer upon or to give to any Person
that is not a Party any rights, claims or remedies under or by reason of this Agreement or the other Transaction Documents,
except as set forth in Section ‎6.3, Section ‎8.4, Section ‎8.11
and Section ‎10.10 and for parties expressly
entitled to the protection of any indemnification provision of this Agreement. Notwithstanding the foregoing, each Financing
Party is an express third party beneficiary of Sections ‎9.2, ‎10.3, ‎10.5 and
this Section ‎10.2 and may enforce such
provisions as if direct parties to this Agreement. Notwithstanding anything in this Agreement to the contrary, each Company
Equityholder is an express third party beneficiary of Sections 6.13, 6.14, 6.16, 6.17, 6.21, 8.9, 8.10,
and 8.11 and the Stockholder Representative may enforce such provisions on behalf of each Company Equityholder.


 






    100


     


    

 


10.3       
Amendments. This Agreement may be amended, modified or superseded, and any of the terms, covenants, representations,
warranties or conditions hereof may be waived, only by a written instrument executed by Parent, the Stockholder Representative
and Company. The failure of any Party at any time or times to require performance of any provisions hereof will in no manner affect
the right at a later time to enforce the same. No waiver by any Party of any condition, or of any breach of any term, covenant,
representation or warranty contained in this Agreement, in any one or more instances, will be deemed to be or construed as a further
or continuing waiver of any such condition or breach or a waiver of any other condition or of any breach of any other term, covenant,
representation or warranty. Notwithstanding the foregoing, Sections ‎9.2,
‎10.2, ‎10.5
and this Section ‎10.3 and the definitions related
thereto (solely as used in such sections) may not be amended in a manner materially adverse to any Financing Party without the
prior written consent of such Financing Party.


 


10.4       
Notices. Unless otherwise provided herein, all notices, requests, consents, approvals, demands and other communications
to be given hereunder (collectively, “Notices”) will be in writing and will be deemed given upon (a) email transmission
(so long as such transmission does not generate an error message or notice of non-delivery) to the extent transmitted by 5:00 p.m.
(local time of recipient) on a Business Day or if transmitted after such time on a Business Day or any other day, the Business
Day next following the day of the transmission of e-mail, (b) confirmed delivery by a reputable overnight carrier or when
delivered by hand, (c) actual receipt or (d) the expiration of four (4) Business Days after the day when mailed by registered
or certified mail (postage prepaid, return receipt requested), addressed to the respective Parties listed below at the following
addresses (or such other address for a Party hereto as will be specified by like notice):


 


If to Parent, to:


 


AdaptHealth Corp.


220 W. Germantown Pike, Suite 250


Plymouth Meeting, PA


Attn: General Counsel

Email: cjoyce@adapthealth.com


 






    101


     


    

 



 


with a copy (which shall not constitute
notice) to:


 


Willkie Farr & Gallagher
LLP


787 Seventh Avenue


New York, New York 10019


Attention: Michael E. Brandt
and Danielle Scalzo


Email: mbrandt@willkie.com and
dscalzo@willkie.com


 


If to Company, to:


 


AeroCare Holdings,
Inc.


3325 Bartlett Blvd.


Orlando, FL 32811


Attn: Stephen P. Griggs


Email: sgriggs@aerocareusa.com


 


with a copy (which
shall not constitute notice) to:


 


Goodwin Procter LLP


The New York Times Building


620 Eighth Avenue


New York, NY 10018-1405


Attention: Stuart L. Rosenthal and
Matthew M. Mauney


Email: srosenthal@goodwinlaw.com


     mmauney@goodwinlaw.com


 


If to the Stockholder Representative,
to:


 


Peloton Equity, LLC


c/o Peloton Equity


66 Field Point Road,
2nd Floor


Greenwich, CT 06830


Attention: General
Counsel & Ted Lundberg


Email: tlundberg@pelotonequity.com


 


with a copy (which
shall not constitute notice) to:


 


Goodwin Procter LLP

The New York Times Building

620 Eighth Avenue

New York, NY 10018-1405

Attention: Stuart L. Rosenthal and Matthew M. Mauney

Email: srosenthal@goodwinlaw.com

             mmauney@goodwinlaw.com


 






    102


     


    

 


10.5       
Governing Law; Venue; Service of Process; Waiver of Jury Trial.


 


(a)               This
Agreement and all matters arising out of or relating to this Agreement shall be governed by and construed in accordance with
the laws of the State of Delaware, without regard to any choice of law or conflict of law provision or rule (whether of the
State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the
State of Delaware.


 


(b)              
Each of the Parties hereto irrevocably and unconditionally agrees that any and all disputes, claims or proceedings arising
out of, relating to or in connection with this Agreement or its subject matter and the rights and obligations arising hereunder,
or for recognition and enforcement of any settlement or judgment in respect of this Agreement and the rights and obligations arising
hereunder brought by any other Party hereto or its successors or assigns, shall be brought and determined exclusively in the Chancery
Court of the State of Delaware and any state appellate court sitting in New Castle County in the State of Delaware (or, if the
Chancery Court of the State of Delaware declines to accept jurisdiction over a particular matter, a state or federal court sitting
in the State of Delaware). Each of the Parties hereto agrees that mailing of process or other papers in connection with any such
action or proceeding in the manner provided in Section ‎10.4 or in such other manner as may be permitted by applicable
laws, will be valid and sufficient service thereof. Each of the Parties hereto hereby irrevocably submits with regard to any such
action or proceeding for itself and in respect of its property, generally and unconditionally, to the personal jurisdiction of
the aforesaid courts and agrees that it will not bring any action relating to this Agreement or any of the transactions contemplated
by this Agreement in any court or tribunal other than the aforesaid courts. Each of the Parties hereto hereby irrevocably waives,
and agrees not to assert, by way of motion, as a defense, counterclaim or otherwise, in any action or proceeding with respect to
this Agreement and the rights and obligations arising hereunder, or for recognition and enforcement of any judgment in respect
of this Agreement and the rights and obligations arising hereunder, (i) any claim that it is not personally subject to the jurisdiction
of the above named courts for any reason other than the failure to serve process in accordance with this Agreement, (ii) any claim
that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts
(whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment
or otherwise) and (iii) to the fullest extent permitted by applicable law, any claim that (x) the suit, action or proceeding in
such court is brought in an inconvenient forum, (y) the venue of such suit, action or proceeding is improper or (z) this Agreement,
or the subject matter hereof, may not be enforced in or by such courts. Each Party agrees that a final, non-appealable judgment
in any action or proceeding so brought shall be conclusive and may be enforced by suit on the judgment or in any other manner provided
by law. Each Party agrees that service of summons and complaint or any other process that might be served in any action or proceeding
may be made on such Party by sending or delivering a copy of the process to the Party to be served at the address of the Party
and in the manner provided for the giving of Notices in Section ‎10.4. Nothing in this Section ‎10.5,
however, shall affect the right of any Party hereto to serve legal process in any other manner permitted by law.


 


(c)               EACH
PARTY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY
HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY
AGREEMENT CONTEMPLATED TO BE EXECUTED IN CONNECTION HEREWITH (INCLUDING THE DEBT FINANCING COMMITMENT), OR ANY COURSE OF
CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN), ACTIONS OR OMISSIONS OF ANY PARTY IN CONNECTION WITH ANY
SUCH AGREEMENTS, AND WHETHER MADE BY CLAIM, COUNTERCLAIM, THIRD-PARTY CLAIM OR OTHERWISE. EACH PARTY HERETO (i) CERTIFIES
THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY
WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE OTHER
PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION ‎10.5.


 






    103


     


    

 


(d)              
Notwithstanding anything herein to the contrary, each of the parties hereto agrees (i) that it will not bring or support,
or permit any its Affiliates to bring or support, any Legal Proceeding, whether in law or in equity, whether in contract or in
tort or otherwise, involving the Financing Parties arising out of, or relating to, the transactions contemplated hereby, the Debt
Financing Commitments, the Debt Financing or the performance of services thereunder or related thereto in any forum other than
the state or federal court sitting in the Borough of Manhattan, New York, New York, and any appellate court thereof and each party
hereto submits for itself and its property with respect to any such Legal Proceeding to the exclusive jurisdiction of such court,
(ii) to waive and hereby waives any right to trial by jury in respect of any such Legal Proceeding and (iii) that any such Legal
Proceeding shall be governed by, and construed in accordance with, the laws of the State of New York without regard to the conflicts
of law rules of such State that would result in the application of the laws of any other state.


 


10.6       
Severability. In the event that any of the provisions hereof is held to be invalid or unenforceable under applicable
Legal Requirements, the remaining provisions hereof will not be affected thereby. In such event, the Parties hereto agree and consent
that such provisions and this Agreement will be modified and reformed so as to effect the original intent of the Parties as closely
as possible with respect to those provisions which were held to be invalid or unenforceable.


 


10.7       
Transaction Costs and Expenses. Except as otherwise expressly provided in this Agreement, the Company and the Stockholder
Representative, on the one hand, and Parent, Merger Sub and Merger Sub II, on the other hand, shall bear all of their own costs,
fees and expenses, if any, incurred by or on their behalf in connection with this Agreement, the other Transaction Documents and
the transactions covered hereby; provided, that fees associated with the Paying Agent and the Escrow Agent, all filing fees
pursuant to the HSR Act, and the premiums of the Tail Policy (subject to the proviso in Section 6.3(b)) and the Special Policy
each shall be borne equally by the Company and Parent; provided, further, that any Transfer Taxes that arise from the consummation
of the transactions contemplated by this Agreement shall be borne as set forth in Section‎
6.19(a). The costs, fees and expenses to be paid by the Company may be (a) paid by the Company prior to the Closing or (b)
included in Selling Expenses and thus taken into consideration in the calculation of the Aggregate Merger Consideration.


 






    104


     


    

 


10.8       
Specific Enforcement.


 


(a)               Each
Party agrees that irreparable damage would occur and that the Parties would not have any adequate remedy at law in the event
that any of the provisions of this Agreement were not performed (including by failure to take such actions as are required of
it hereunder in order to consummate the transactions contemplated by this Agreement) in accordance with their specific terms
or were otherwise breached (including the obligation of the Parties to consummate such transactions contemplated by this
Agreement in accordance with the terms and subject to the conditions of this Agreement).  Accordingly, in addition to
any other remedies available under this Agreement, the Parties agree that, prior to the valid termination of this Agreement
and, as and when required pursuant to Section ‎9.2, payment of the Termination Fee (plus any Collection Costs,
as applicable) to the Company, each Party shall be entitled to an injunction or injunctions, specific performance and other
equitable relief to prevent the other Party’s breaches of this Agreement and to enforce specifically the terms and
provisions of this Agreement including Parent’s (subject to Section ‎10.8(b)) or the Company’s
obligation to consummate the transactions contemplated by this Agreement if required to do so hereunder. Each Party agrees
that it will not oppose the granting of an injunction, specific performance and other equitable relief when expressly
available pursuant to the terms of this Agreement, and hereby waives (x) any defenses in any action for an injunction,
specific performance or other equitable relief, including the defense that the other parties have an adequate remedy at law
or an award of specific performance is not an appropriate remedy for any reason at law or equity, and (y) any requirement
under Legal Requirement to post a bond, undertaking or other security as a prerequisite to obtaining equitable relief.


 


(b)               Notwithstanding
anything in this Agreement to the contrary, the Parties hereby acknowledge and agree that the Company shall not be entitled
to specific performance or other equitable remedies (or to seek specific performance or other equitable remedies) to cause
Parent to effect the Closing, unless (i) all conditions in Sections ‎7.1 have been satisfied or waived (other
than those conditions that by their terms are required to be satisfied at the Closing, but all such conditions are then
capable of being satisfied), (ii) the Debt Financing has been funded in accordance with the terms thereof or the Financing
Parties have confirmed in writing that such Debt Financing will be funded at the Closing, (iii) the Company irrevocably (for
the two (2) Business Day period described in the following clause (iv)) has notified Parent in writing that all of the
conditions in Section ‎7.2 have been satisfied or waived (other than those conditions that by their terms are
required to be satisfied at the Closing, but all such conditions are then capable of being satisfied) and that the Company is
ready, willing and able to consummate the Closing if specific performance is granted and the Debt Financing is funded, and
(iv) Parent failed to consummate the Closing within two (2) Business Days following the date the Closing was required to have
occurred pursuant to Section‎ 2.2. In the event this Agreement is terminated, other than the Termination Fee
(plus any Collection Costs) or any amounts contemplated by Section 10.8(c), no Company Releasing Related Party shall
have the right to seek, obtain or be entitled to money damages (whether at law or in equity, in contract, in tort or
otherwise) from any of Parent or Parent Related Parties in connection with this Agreement, the Debt Financing Commitment or
in respect of any other agreement, theory of law or otherwise including for any breach, loss or damage under or related to
this Agreement other than specifically set forth in Section 9.2(b).While the Company may pursue both (x) a grant of
specific performance prior to the Closing pursuant to Section 10.8 and the amounts contemplated by Section
10.8(c), on the one hand, and (y) the payment of the Termination Fee (plus any Collection Costs, as applicable) pursuant
to Section 9.2(b), on the other hand, under no circumstances shall the Company or any other Company Releasing Related
Party be entitled to receive both (1) a grant of specific performance and the amounts contemplated by Section 10.8(c)
and (2) all or any portion of the Termination Fee (plus any Collection Costs, as applicable); provided; however,
that, in the event Parent is compelled to consummate the Closing pursuant to a valid Order granting specific performance made
in accordance with the terms of this Agreement, and Parent fails to so consummate the Closing notwithstanding such Order,
then the Termination Fee would remain available to the Company in lieu of specific performance and the consummation of the
Closing. Notwithstanding anything in this Agreement to the contrary, the Parties hereby acknowledge and agree that (x) in
no event shall the Company or any other Person be entitled to enforce, seek to enforce, or seek the remedy of specific
performance with respect to Parent’s rights under the Debt Financing Commitments against the Debt Financing Sources or
(y) be entitled to specific performance or other equitable remedies (or to seek specific performance or other equitable
remedies) to cause Parent to effect the Closing if the Debt Financing has not been
funded (or will not be funded at the Closing if the transactions completed by this Agreement shall be consummated at the
Closing).


 






    105


     


    

 


(c)              
To the extent that any Party brings any Legal Proceeding to enforce specifically the performance of the terms and provisions
of this Agreement prior to the Closing, the Outside Date will automatically be extended to (i) the twentieth (20th)
Business Day after such Legal Proceeding is no longer pending or (ii) such other date established by the Governmental Entity presiding
over such Legal Proceeding. In the event that any aggrieved Party or Parties prevail in any final and unappealable judgment of
any Legal Proceeding commenced to enforce the terms of this Section ‎10.8 all fees, costs and expenses, including
reasonable attorneys’ fees and court costs, incurred by such aggrieved Party or Parties in such Legal Proceeding will be
reimbursed by the non-prevailing Party.


 


10.9        Disclosure
Schedule. The Disclosure Schedule is incorporated herein and expressly made a part of this Agreement as though completely
set forth herein. All references to this Agreement herein or in the Disclosure Schedule shall be deemed to refer to this
entire Agreement, including the Disclosure Schedule. The Disclosure Schedule has been arranged for purposes of convenience in
separately numbered sections corresponding to the sections of this Agreement; however any information set forth in or
incorporated into any section of the Disclosure Schedule shall be deemed to be disclosed in any other section of the
Disclosure Schedule to the extent that (i) it is reasonably apparent on the face of such disclosure that such
information is relevant to such other section thereof or (ii) such information is cross-referenced in such other section
thereof. Any item of information, matter or document disclosed or referenced in, or attached to, the Disclosure Schedule
shall not (a) be used as a basis for interpreting the terms “material”, “Material Adverse Effect” or
other similar terms in this Agreement or to establish a standard of materiality, (b) represent a determination that such item
or matter did not arise in the Ordinary Course of Business, (c) be deemed or interpreted to expand the scope of
Company’s representations and warranties, obligations, covenants, conditions or agreements contained herein, (d)
constitute, or be deemed to constitute, an admission to any third party of liability or obligation regarding such matter.
Matters reflected in the Disclosure Schedule are not necessarily limited to matters required by this Agreement to be
reflected in the Disclosure Schedule; such additional matters are set forth for informational purposes and do not necessarily
include other matters of a similar nature. The specification of any dollar amount in the representations or warranties
contained in this Agreement or included in the Disclosure Schedule is not intended to imply that such amounts, or higher or
lower amounts or other items, are or are not material, and no party hereto shall use the fact of the setting of such amounts
in any dispute or controversy as to whether any obligation, item or matter not described therein or included in the
Disclosure Schedule is or is not material for purposes of this Agreement. No disclosure in the Disclosure Schedule relating
to any possible breach or violation of any agreement or Legal Requirement shall be construed as an admission or indication
that any such breach or violation exists or has actually occurred. Capitalized terms used in the Disclosure Schedule and not
otherwise defined therein have the meanings given to them in this Agreement.


 






    106


     


    

 


10.10   
Appointment of the Stockholder Representative.


 


(a)              
By executing a Stock Letter of Transmittal or the Company Written Consent or, in the case of a Company Optionholder, participating
in the Mergers and receiving the benefits thereof, including the right to receive the consideration payable in connection with
the Mergers, each Company Equityholder shall be deemed to have irrevocably constituted and appointed, effective from and after
the date hereof, the Stockholder Representative as the representative, agent, proxy and attorney-in-fact for and on behalf of each
Stockholder to act as the Stockholder Representative for all purposes in connection with this Agreement and any agreements ancillary
hereto with full power and authority to take all actions under this Agreement and any other agreement entered into or document
delivered in connection with the transactions contemplated by this Agreement.


 


(b)              
The Stockholder Representative shall have the authority to take any and all actions it believes are required, permitted,
necessary, desirable or appropriate under this Agreement or any agreement ancillary hereto, including giving and receiving any
notice or instruction permitted or required under this Agreement, interpreting all of the terms and provisions of this Agreement,
authorizing payments to be made with respect hereto or thereto, conducting negotiations with Parent, Merger Sub or Merger Sub II
or any Surviving Company and their respective agents regarding such claims, dealing with Parent and any Surviving Company under
this Agreement, taking any other actions specified in or contemplated by this Agreement, and engaging counsel, accountants or other
representatives in connection with the foregoing matters. Without limiting the generality of the foregoing, the Company Equityholders
authorize the Stockholder Representative to act for and on behalf of the Company Equityholders as if the Company Equityholders
were acting on their own behalf, including:


 


(i)                       taking
any and all actions as the Stockholder Representative may, in its sole discretion, deem necessary or advisable in respect of:
(A) waiving any inaccuracies in the representations or warranties of Parent, Merger Sub I or Merger Sub II contained in this
Agreement or in any document delivered by Parent, Merger Sub I or Merger Sub II in connection with this Agreement or the
transactions contemplated hereby; (B) taking such other action as the Stockholder Representative is authorized to take
under this Agreement (including executing and delivering any documents and incurring any costs and expenses, in each case, on
behalf of the Company Equityholders); (C) receiving all documents or certificates and making all determinations required
under this Agreement; (D) making any and all determinations and taking all such actions which may be required or permitted in
connection with the implementation of this Agreement and the Transaction Documents and the transactions contemplated hereby
and thereby or to otherwise carry out the responsibilities of the Stockholder Representative contemplated by this Agreement
or any Transaction Documents, including any waiver of any obligation of Parent, Merger Sub I, Merger Sub II or any Surviving
Company;


 






    107


     


    

 


(ii)                   giving
and receiving notices, documents and communications given or to be given to or by the Company Equityholders under or in connection
with this Agreement and/or any of the Transaction Documents and accepting service of legal process in connection with any Legal
Proceeding arising in connection with this Agreement;


 


(iii)                 
negotiating, defending, settling, compromising and otherwise handling and resolving any and all claims and disputes with
Parent, Merger Sub, Merger Sub II, the Surviving Company (but only from and after the Closing) and any other Parent Indemnitees
arising out of or in connection with this Agreement or the Transaction Documents;


 


(iv)                  
retaining legal counsel, accountants, consultants and other experts and incurring other expenses in connection with all
matters and things set forth or necessary with respect to this Agreement or the Transaction Documents and the transactions contemplated
hereby and thereby as the Stockholder Representative may in its sole discretion deem necessary or advisable; and


 


(v)                   
making any other decision or election or exercising such rights, power and authority as are incidental to the foregoing.


 


(c)              
Upon execution of a Stock Letter of Transmittal or the Company Written Consent, each Company Equityholder acknowledges and
agrees (i) that upon any delivery by the Stockholder Representative of any waiver, amendment, agreement, opinion, certificate or
other document executed by the Stockholder Representative, such Company Equityholder shall be bound by such documents as fully
as if such Company Equityholder had executed and delivered such documents and (ii) to be bound by the provisions set forth in this
Section‎ 10.10 as if they were a party to this Agreement.


 


(d)              The
Stockholder Representative may resign at any time. Upon the resignation, death, disability or incapacity of the initial Stockholder
Representative, then such Person as is appointed by the Company Equityholders who held a majority of the voting power of the Company
Capital Stock immediately prior to the Closing shall become the Stockholder Representative; provided, that no appointment
of a successor shall be effective prior to the delivery to Parent of written notice thereof from such Company Equityholders.


 


(e)              In
the performance of its duties hereunder, the Stockholder Representative shall be entitled to (i) rely upon any document or
instrument reasonably believed by it to be genuine and (ii) assume that any Person purporting to give any notice in
accordance with the provisions hereof has been duly authorized to do so. Any and all actions taken or not taken, exercises of
rights, power or authority and any decision or determination made by the Stockholder Representative in connection herewith
shall be absolutely and irrevocably binding upon the Company Equityholders as if such Company Equityholder had taken such
action, exercised such rights, power or authority or made such decision or determination in its individual capacity, and
Parent may rely upon such action, exercise of right, power, or authority or such decision or determination of the Stockholder
Representative as the action, exercise, right, power, or authority, or decision or determination of such Company
Equityholders, and no Company Equityholder shall have the right to object, dissent, protest or otherwise contest the same.
Parent is hereby relieved from any liability to any Person for any acts done by the Stockholder Representative and any acts
done by Parent in accordance with any decision, act, consent or instruction of the Stockholder Representative.


 






    108


     


    

 


(f)               
The Stockholder Representative (including in respect of its holding and disbursement of the Representative Expense Amount)
will incur no liability of any kind with respect to any action or omission by the Stockholder Representative in connection with
the Stockholder Representative’s services pursuant to this Agreement and any agreements ancillary hereto, except in the event
of liability directly resulting from the Stockholder Representative’s fraud or willful misconduct in connection with this
Agreement; provided, that in no event shall the Stockholder Representative be liable hereunder or in connection herewith
for any indirect, punitive or special damages. The Stockholder Representative may, in all questions arising under this Agreement,
rely on the advice of counsel and other experts and advisers and shall not be liable for any action or omission pursuant to the
advice of counsel or any other experts or advisers. The Company Equityholders will indemnify, defend and hold harmless the Stockholder
Representative from and against any and all losses, liabilities, damages, claims, penalties, fines, forfeitures, actions, fees,
costs and expenses (including the fees and expenses of counsel and experts and their staffs and all expense of document location,
duplication and shipment) (collectively, “Representative Losses”) arising out of or in connection with the Stockholder
Representative’s execution and performance of this Agreement and any agreements ancillary hereto and for service as the Stockholder
Representative, in each case as such Representative Loss is suffered or incurred by the Stockholder Representative or any of its
Affiliates and any of their respective managers, directors, officers, employees, agents, members, partners, stockholders, consultants,
attorneys, accountants, advisors, brokers, representatives or controlling persons, in each case, relating to the Stockholder Representative’s
conduct as Stockholder Representative; provided, that in the event that any such Representative Loss is finally adjudicated
by a court of competent jurisdiction to have been directly caused by the fraud or willful misconduct of the Stockholder Representative,
the Stockholder Representative will reimburse the Company Equityholders the amount of such indemnified Representative Loss to the
extent attributable to such fraud or willful misconduct. Notwithstanding anything in this Agreement to the contrary, any restrictions
or limitations on liability or indemnification obligations of, or provisions limiting the recourse against non-parties otherwise
applicable to, the Company Equityholders set forth elsewhere in this Agreement are not intended to be applicable to the indemnities
provided to the Stockholder Representative under this Section. The foregoing indemnities will survive the Closing, the resignation
or removal of the Stockholder Representative or the termination of this Agreement.


 


(g)               The
Stockholder Representative will be entitled to full reimbursement for all expenses, disbursements and advances (including
service fees and disbursements of its counsel, experts, advisors, consultants, agents or other representatives, including
Affiliates of the Stockholder Representative) incurred by or on behalf of the Stockholder Representative in such capacity
from the Representative Expense Amount in accordance with the terms of this Agreement. If not paid directly to the
Stockholder Representative by the Company Equityholders, any such expenses, disbursements and advances or other
Representative Losses may be recovered by the Stockholder Representative from the Representative Expense Amount and/or the
amounts in the Adjustment Escrow Account at such time as remaining amounts would otherwise be distributable to the Company
Equityholders; provided, that while this section allows the Stockholder Representative to be paid from the
aforementioned sources of funds, this does not relieve the Company Equityholders from their obligation to promptly pay such
losses as they are suffered or incurred, nor does it prevent the Stockholder Representative from seeking any remedies
available to it at law or otherwise. In no event will the Stockholder Representative be required to advance its own funds on
behalf of the Company Equityholders or otherwise. Funds held as the Representative Expense Amount need not be invested and
shall accrue no interest. In furtherance of the foregoing, notwithstanding anything in this Agreement to the contrary, the
Stockholder Representative shall have the power and authority to set aside and retain additional funds paid to or received by
it, or direct payment of additional funds to be paid to the Company Equityholders (in the case of the Company Optionholders,
through any Surviving Company) pursuant to this Agreement at the Closing or thereafter (including to establish such reserves
as the Stockholder Representative determines in good faith to be appropriate for such costs and expenses that are not then
known or determinable). To the extent that the amount included in the Representative Expense Amount exceeds such expenses,
disbursements or advances, the Stockholder Representative will, at such time as it deems reasonable in its sole discretion,
pay such excess to the Company Equityholders in accordance with their respective percentages contributed to the
Representative Expense Amount set forth on the Closing Consideration Schedule; provided, that any of such amount
allocable to Company Optionholders shall be paid to the Second Surviving Company for further distribution to the Company
Optionholders in accordance with the Closing Consideration Schedule.


 






    109


     


    

 


(h)              
The appointment of the Stockholder Representative hereunder is duly made and irrevocable and any action taken by the Stockholder
Representative pursuant to the authority granted in this Section ‎10.10 shall be effective and binding as the action
of the Stockholder Representative under this Agreement.


 


10.11   
Counterparts. This Agreement may be executed simultaneously in one or more counterparts, each of which will be deemed
an original, but all of which will constitute one agreement. Execution and delivery of this Agreement by exchange of facsimile
or other electronically transmitted counterparts bearing the signature of a Party shall be equally as effective as delivery of
a manually executed counterpart of such Party.


 


10.12   
Further Assurance. If at any time after the Closing any further action is reasonably necessary or desirable to fully
effect the transactions contemplated by this Agreement, each of the Parties will, subject to the terms and conditions hereof, take
such further action (including the execution and delivery of such further instruments and documents) as any other party reasonably
may request in connection therewith.


 


10.13   
Legal Representation.


 


(a)              
Each of the Parties acknowledges and agrees that Goodwin Procter LLP (“Goodwin” ) has acted as counsel
to the Company, the Company’s Subsidiaries and the Stockholder Representative and certain of the Company Equityholders in
connection with the negotiation of this Agreement and the consummation of the transactions contemplated hereby.


 


(b)              
 Parent hereby consents and agrees to, and agrees to cause the Surviving Companies and their respective Subsidiaries to
consent and agree to, Goodwin representing the Stockholder Representative and/or any of the Company Equityholders after the Closing,
including with respect to disputes in which the interests of the Stockholder Representative or a Company Equityholder may be directly
adverse to Parent and its Subsidiaries (including the Surviving Companies and their respective Subsidiaries), and even though Goodwin
may have represented the Company its Subsidiaries and/or certain of the Company Equityholders in a matter substantially related
to any such dispute, or may be handling ongoing matters for the Company, its Subsidiaries and/or certain of the Company Equityholders.
Parent further consents and agrees to, and agrees to cause the Surviving Companies and their respective Subsidiaries to consent
and agree to, the communication by Goodwin to the Stockholder Representative and/or any Company Equityholder in connection with
any such representation of any fact known to Goodwin arising by reason of Goodwin’s prior representation of the Company,
Subsidiaries and/or certain of the Company Equityholders.


 






    110


     


    

 


(c)              
In connection with the foregoing, Parent hereby irrevocably waives and agrees not to assert, and agrees to cause the Surviving
Companies and their respective Subsidiaries to irrevocably waive and not to assert, any conflict of interest arising from or in
connection with (i) Goodwin’s prior representation of the Company, its Subsidiaries and/or certain of the Company Equityholders
in connection with the negotiation of this Agreement and consummation of the transactions contemplated hereby and (ii) Goodwin’s
representation of the Stockholder Representative and/or any Company Equityholder prior to and after the Closing.


 


(d)              
Parent further agrees, on behalf of itself and, after the Closing, on behalf of the Surviving Companies and their respective
Subsidiaries, that all communications in any form or format whatsoever between or among any of Goodwin, the Company, any of the
Company’s Subsidiaries, the Stockholder Representative, any Company Equityholder, or any of their respective directors, officers,
employees or other representatives to the extent related to the negotiation, documentation and consummation of the transactions
contemplated by this Agreement or any dispute arising under this Agreement (collectively, the “Deal Communications”)
shall be deemed to be retained and owned collectively by the Company Equityholders, shall be controlled by the Stockholder Representative
on behalf of the Company Equityholders and shall not pass to or be claimed by Parent, the Surviving Companies or any of their respective
Subsidiaries. All Deal Communications that are attorney-client privileged (the “Privileged Deal Communications”)
shall remain privileged after the Closing and the privilege and the expectation of client confidence relating thereto shall belong
solely to the Stockholder Representative and the Company Equityholders, shall be controlled by the Stockholder Representative on
behalf of the Company Equityholders and shall not pass to or be claimed by Parent, the Surviving Companies or any of their Subsidiaries.


 


(e)               Notwithstanding
the foregoing, in the event that a dispute arises between Parent, any Surviving Company or any of their Subsidiaries, on the
one hand, and a third party other than the Stockholder Representative, any Company Equityholder or any of their Affiliates,
on the other hand, Parent, such Surviving Company or its Subsidiaries may assert the attorney-client privilege to prevent the
disclosure of the Privileged Deal Communications to such third party; provided, however, that none of Parent,
any Surviving Company or its Subsidiaries may waive such privilege without the prior written consent of the Stockholder
Representative. In the event that Parent, any Surviving Company or any of their Subsidiaries is legally required by
governmental order or otherwise to access or obtain a copy of all or a portion of the Privileged Deal Communications, Parent
shall immediately (and, in any event, within two (2) Business Days) notify the Stockholder Representative in writing
(including by making specific reference to this Section ‎10.13(e)) so that the Stockholder Representative can
seek a protective order and Parent agrees to use all commercially reasonable efforts to assist therewith.


 






    111


     


    

 


(f)               
To the extent that Privileged Deal Communications maintained by Goodwin constitute property of its clients, only the Stockholder
Representative shall hold such property rights and Goodwin shall have no duty to reveal or disclose any such files or other materials
or any Privileged Deal Communications by reason of any attorney-client relationship between Goodwin, on the one hand, and Parent,
the Company or any of its Subsidiaries, on the other hand.


 


(g)              
Parent agrees that it will not, and that it will cause each Surviving Company and each of its Subsidiaries not to, (i) access
or use the Privileged Deal Communications, including by way of review of any electronic data, communications or other information,
or by seeking to have the Stockholder Representative waive the attorney-client or other privilege, or by otherwise asserting that
Parent, the Company or any Subsidiary thereof has the right to waive the attorney-client or other privilege or (ii) seek to obtain
the Deal Communications from Goodwin or any other Person. In furtherance of the foregoing, it shall not be a breach of any provision
of this Agreement if, prior to the Closing, the Company, any of the Company’s Subsidiaries, the Stockholder Representative
and/or any Company Equityholder, or any of their respective directors, officers, employees or other representatives, takes any
action to protect from access or remove from the premises of the Company or any of the Subsidiaries of the Company (or any offsite
back-up or other facilities) any Deal Communications, including without limitation by segregating, encrypting, copying, deleting,
erasing, exporting or otherwise taking possession of any Deal Communications.


 


[Signature Pages
Follow]


 






    112


     


    

 


IN WITNESS WHEREOF,
the Parties have duly executed this Agreement as of the date first written above.


 


	 	COMPANY:
	 	 
	 	AEROCARE HOLDINGS, INC.
	 	 
	 	By: 	/s/ Stephen P. Griggs
	 	Name: Stephen P. Griggs
	 	Title: Chief Executive Officer




 


[Signature page to Agreement
and Plan of Merger]


 






     


     


    

 



 


	 	STOCKHOLDER
    REPRESENTATIVE:
	 	 
	 	PELOTON EQUITY,
    LLC
	 	 
	 	By:	 /s/ Theodore B. Lundberg
	 	Name: Theodore B. Lundberg
	 	Title: Manager




 


[Signature page to Agreement
and Plan of Merger]


 






    


     


    

 


	 	PARENT:
	 	 
	 	ADAPTHEALTH CORP.
	 	 
	 	By: 	/s/ Luke McGee
	 	Name: Luke McGee
	 	Title: Chief Executive
    Officer
	 	 
	 	MERGER
    SUB:
	 	 
	 	AH APOLLO MERGER
    SUB INC.
	 	 
	 	By: 	/s/ Luke McGee
	 	Name: Luke McGee
	 	Title: Chief Executive
    Officer
	 	 
	 	MERGER
    SUB II:
	 	 
	 	AH APOLLO MERGER
    SUB II INC.
	 	 
	 	By: 	/s/ Luke McGee
	 	Name: Luke McGee
	 	Title: Chief Executive
    Officer



 


[Signature page to Agreement and Plan
of Merger]


 






     


     


    

 


Exhibit
A


 


DEFINITIONS


 


“Accredited
Investor” means a Person that (a) is, as of the First Effective Time, an “accredited investor” within the
meaning of SEC Rule 501 of Regulation D, as presently in effect, under the Securities Act and (b) delivers an executed Accredited
Investor Questionnaire to Parent by the Accredited Investor Questionnaire Deadline stating that such Person is an “accredited
investor” and agreeing to the transfer restrictions related to the Share Consideration contained therein, unless the Company
otherwise determines that such Company Equityholder is not an Accredited Investor


 


“Adjustment
Escrow Account” means the escrow account created pursuant to the Escrow Agreement in respect of the Adjustment Escrow
Deposit.


 


“Adjustment
Escrow Deposit” means $10,000,000.


 


“Affiliate”
means, with respect to an entity, any other entity controlling, controlled by or under common control with such entity. As used
in this definition, the term “control,” including the correlative terms “controlling,” “controlled
by” and “under common control with,” means the possession, directly or indirectly, of the power to direct or
cause the direction of the management or policies of an entity, whether through ownership of voting securities, by Contract or
otherwise.


 


“Affordable
Care Act” means the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation
Act of 2010.


 


“Aggregate
Exercise Amount” means the aggregate per share exercise price of all of the Vested Company Options (including, for the
avoidance of doubt, any Vested Company Options that are Vested Substitute Options), in each case outstanding immediately prior
to the First Effective Time.


 


“Aggregate
Merger Consideration” means an amount equal to (1) $1,100,000,000; plus (2) the Aggregate Parent Stock Value,
minus (3) the Selling Expenses; minus (4) the Closing Indebtedness; plus (5) the Closing Cash; plus
(6) the Net Working Capital Adjustment Amount as of the Measurement Time (which may be a positive or negative dollar amount); plus
(7) the Aggregate Exercise Amount plus (8) the Excess Capital Equipment Adjustment; minus (9) the Final Provider
Relief Adjustment; plus (10) the M&A Adjustment.


 


“Aggregate
Parent Stock Value” means an amount equal to the Share Consideration Amount multiplied by the Parent Stock Value.


 


“Aggregate
Shares” means the sum of (a) the number of shares of Company Common Stock issued and outstanding immediately prior
to the First Effective Time including, for the avoidance of doubt, without duplication, the aggregate number of shares of
Company Common Stock issuable upon conversion of shares of Company Series C Preferred Stock as contemplated by Section
 ‎2.4(b), plus (b), without duplication of any shares included in (a), the aggregate number of shares of Company
Common Stock issuable upon exercise of the Vested Company Options that are outstanding immediately prior to the First
Effective Time.


 






    116


     


    

 


“Aggregate
Stimulus Funds” means the aggregate amount of stimulus funds or other similar amounts received by the Company or any
of its Subsidiaries in connection with and pursuant to any COVID-19 related Legal Requirement, including programs created by the
CARES Act.


 


“AI
Aggregate Shares” means the number of Aggregate Shares held by Accredited Investors.


 


“Amended and
Restated Registration Rights Agreement” means the Amended and Restated Registration Rights Agreement, dated as of July
1, by and between the Company and certain of its equityholders, as amended by the Amendment to the Registration Rights Agreement,
dated as of the date hereof.


 


“Anti-Corruption
Laws” means U.S. Foreign Corrupt Practices Act of 1977, as amended, and similar Legal Requirements in any applicable
foreign jurisdiction.


 


“Borrowed
Money Debt” means, with respect to the Company and its Subsidiaries, any Indebtedness contemplated by clauses (a) or
(b) of the definition thereof, including any Indebtedness incurred in connection with a Dividend Recapitalization.


 


“Business”
means the business of the Company and its Subsidiaries as conducted during the twelve (12) months immediately preceding the Closing
Date.


 


“Business
Day” means any day other than a Saturday, a Sunday or a day on which banks in New York, New York are authorized or required
by law to be closed.


 


“CARES Act”
means the Coronavirus Aid, Relief, and Economic Security Act.


 


“Cash on Hand”
means all cash and cash equivalents of the Company and its Subsidiaries, in each case, determined in accordance with the Preparation
Methodology, but excluding (a) Restricted Cash, (b) any security deposits, (c) cash funded on the Closing Date by the Parent or
any of its Affiliates and (d) any amounts held for the benefit of a Person that is not the Company or its Subsidiaries, including
any security deposit or escrow. For the avoidance of doubt, Cash on Hand shall (i) be calculated net of issued but uncleared checks
and drafts written or issued by the Company or its Subsidiaries and (ii) include (A) checks, deposits in transit (to the extent
any corresponding asset was correspondingly reduced in Net Working Capital) and drafts deposited for the account of the Company
or any of its Subsidiaries and (B) any deposits and cash held as collateral in respect of outstanding letters of credit.


 


“Cash Option
Consideration” means, in respect of each Vested Cash-Out Option, an amount in cash equal to (a) (i) the Common Per Share
Amount, minus (ii) the applicable per share exercise price of such Vested Cash-Out Option multiplied by (b) the number
of shares of Company Common Stock issuable upon exercise of such Vested Cash-Out Option as of immediately prior to the First Effective
Time.


 


“Certificate
of Designations” means the Series C Certificate of Designation, Preferences and Rights, in substantially the form attached
hereto as Exhibit L.


 






    117


     


    

 


“Change in
Control Payment” means any transaction, retention, change in control or similar bonuses, severance payments and other
employee-related change of control payments payable by the Company or its Subsidiaries as of or after the Closing Date (including
the employer portion of any withholding, payroll, employment or similar Taxes, if any, associated therewith to the extent such
amounts are accrued (or required to be accrued) as of the Closing Date) solely as a result of the consummation of the transactions
contemplated by this Agreement. Notwithstanding anything herein to the contrary, a severance payment for an employee of the Company
or its Subsidiaries (including the employer portion of any withholding, payroll, employment or similar Taxes associated therewith)
that is triggered by the occurrence of (i) the transactions contemplated by this Agreement, followed by (ii) a subsequent termination
at or after the Closing Date of such employee’s employment with the Company or any of its Subsidiaries shall not be deemed
a Change in Control Payment, unless such employee has the right to resign and collect severance solely as a result of the transactions
contemplated by this Agreement without any additional act or omission by Parent or any of its Affiliates.


 


“Charter Documents”
means, with respect to any Person, the certificate of incorporation, articles of incorporation or association and by-laws, the
limited liability company agreement, or limited partnership agreement or other agreement or agreements that establish the legal
personality of such Person, together with any stockholders agreement by and between such Person and its equityholders, in each
case as amended to date.


 


“Claim”
means (a) any right to payment, whether or not such a right is reduced to judgment, liquidated, unliquidated, fixed, contingent,
matured, unmatured, disputed, undisputed, legal, equitable, secured or unsecured, or (b) the right to an equitable remedy for breach
of performance if such breach gives rise to a right to payment, whether or not such equitable remedy is reduced to judgment, liquidated,
unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, secured or unsecured.


 


“Closing Cash”
means the Cash on Hand held by the Company and its Subsidiaries as of the Measurement Time.


 


“Closing Indebtedness”
means the aggregate amount of Indebtedness as of immediately prior to the Closing.


 


“Code”
means the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder, or any amending or superseding
tax laws of the United States of America.


 


“Common Per
Share Amount” means the quotient of (a) the Estimated Aggregate Merger Consideration, divided by (b) the Aggregate
Shares.


 


“Common Per
Share Cash Amount” means an amount in cash equal to (a) the Common Per Share Amount minus (b) the Value of the
Common Per Share Stock Issuance Amount.


 


“Common Per
Share Stock Issuance Amount” means the number of shares equal to a fraction, the numerator of which is (a) the Share
Consideration Amount, and the denominator of which is (b) the AI Aggregate Shares.


 






    118


     


    

 


“Common Stock
Share Consideration” means a number of shares of Common Stock equal to the lesser of (i) the Share Consideration Amount
and (ii) the maximum number of shares of Common Stock as are issuable by the Company without obtaining prior shareholder approval
pursuant to Nasdaq listing rule 5635.


 


“Common Stockholder”
means any holder of Company Common Stock immediately prior to the First Effective Time.


 


“Company Capital
Stock” means the Company Common Stock and the Company Series C Preferred Stock taken together.


 


“Company Common
Stock” means shares of common stock, par value $0.001 per share, of the Company.


 


“Company Equity
Plan” means AeroCare Holdings, Inc. 2012 Stock Option and Grant Plan.


 


“Company Equityholders”
means the Stockholders and the Company Optionholders.


 


“Company Option”
means an option, whether vested or unvested, to purchase Company Common Stock issued under the Company Equity Plan.


 


“Company Optionholder”
means each holder of Company Options.


 


“Company Series
C Preferred Stock” means the Series C Preferred Stock, par value $0.001 per share, of the Company.


 


“Company Systems”
means all of the following owned, used by or for, or otherwise relied on by, the Company or any of its Subsidiaries: computers,
servers, hardware, software, firmware, middleware, databases, networks, routers, hubs, switches, data communication and telecommunication
equipment and lines, co-location facilities and equipment, and all other information technology equipment and related items of
automated, computerized or software systems, including any outsourced systems and processes (e.g., hosting locations).


 


“Compliant”
means, with respect to any Required Financial Information, that (a) such Required Financial Information, taken as a whole,
does not contain any untrue statement of a material fact regarding the Company and its Subsidiaries or omit to state any
material fact regarding the Company and its Subsidiaries necessary in order to make such Required Financial Information not
misleading, in light of the circumstances under which the statements contained in such Required Financial Information were
made, (b) such Required Financial Information complies with all applicable requirements of Regulation S-K and Regulation S-X
under the Securities Act for a registered public offering of debt securities on Form S-1 by a non-accelerated filer (or
non-large accelerated filer) (excluding the Excluded Information and other than such provisions for which compliance is not
customary in a Rule 144A offering of high yield debt securities), (c) the Company’s auditors have not objected to the
use of their audit opinion(s) related to any audited financial statements (of the Company and its Subsidiaries) included in
the Required Financial Information that is to be included in a customary offering memorandum for the offering of high yield
debt securities by Parent and (d) the financial statements and other financial information of the Company and its
Subsidiaries included in the Required Financial Information that is to be included in a customary offering memorandum for the
offering of high yield debt securities by Parent (or one of its Affiliates) are of a date and are otherwise sufficient, in
each case, to permit the Company’s independent accountants to issue customary “comfort” letters with
respect to such financial statements and financial information to the Debt Financing Sources providing the portion of the
Debt Financing consisting of high yield debt securities (including customary “negative assurance” comfort) in
order to consummate any offering by Parent (or one of its Subsidiaries) of non-convertible high yield debt securities under
Rule 144A.


 






    119


     


    

 


“Confidentiality
Agreement” means that certain Mutual Non-Disclosure Agreement, dated as of June 11, 2018, between QMES LLC and AeroCare
Holdings, Inc., as amended from time to time.


 


“Consent”
means, with respect to any Person, any consent, approval, authorization, permission or waiver of, or with or exemption by such
Person.


 


“Contract”
means any contract, commitment, lease, license, mortgage, bond, note or other instrument evidencing indebtedness, or other legally
binding commitment, arrangement or agreement, and all amendments, waivers or other changes thereto.


 


“Conversion
Rate” has the meaning set forth in the Certificate of Designations.


 


“Covered Person”
means each current or former director, manager, employee and officer of the Company or its Subsidiaries, and their respective Affiliates.


 


“COVID-19”
means SARS-CoV-2 or COVID-19, and any evolutions thereof or related or associated epidemics, pandemics or disease outbreaks.


 


“COVID-19
Measures” means any Law, order, directive or guideline by any Governmental Authority in connection with or in response
to COVID-19, including the CARES Act, that provides for any quarantine, “shelter in place,” “stay at home,”
workforce reduction, social distancing, shut down, closure, sequester or any similar restrictions


 


“Data Treatment”
means the access, collection, use, processing, storage, sharing, distribution, transfer, disclosure, sorting, treatment, manipulation,
performance of operations on, enhancement, aggregation, destruction, security or disposal of any data or information (including
Personal Data), databases, or collections of information.


 


“Debt Financing
Sources” means the financial institutions identified in the Debt Financing Commitment, together with each other Person
that commits to provide or otherwise provides the Debt Financing, whether by joinder to the Debt Financing Commitment or otherwise.


 


“Derivative
Instruments” means any and all derivative securities (as defined under Rule 16a-1 under the Exchange Act) that
increase in value as the value of any Equity Securities of Parent increases, including a long convertible security, a long call
option and a short put option position, in each case, regardless of whether (i) such derivative security conveys any voting
rights in any Equity Security, (ii) such derivative security is required to be, or is capable of being, settled through delivery
of any Equity Security or (iii) other transactions that hedge the value of such derivative security.


 






    120


     


    

 


“DGCL”
means the General Corporation Law of the State of Delaware, as amended.


 


“Employee
Option” means each Company Option that was granted to the holder in the holder’s capacity as an employee of the
Company or its Subsidiaries for applicable employment Tax purposes as specified in the Closing Consideration Schedule.


 


“Employee
Plan” means each “employee benefit plan” within the meaning of Section 3(3) of ERISA (whether or not subject
to ERISA) and all other compensation and benefits plans, policies, trust funds, programs, arrangements or payroll practices, including
Multiemployer Plans, and each other stock purchase, stock option, restricted stock, profit sharing, pension, savings, severance,
retention, employment, consulting, commission, change-of-control, collective bargaining, bonus, incentive, deferred compensation,
employee loan, fringe benefit, insurance, welfare, post-retirement health or welfare, health, life, tuition refund, service award,
company car, scholarship, relocation, disability, accident, sick pay, sick leave, accrued leave, vacation, holiday, termination,
unemployment, restrictive covenant, and other benefit plan, policy, trust fund, program, arrangement or payroll practice, whether
or not subject to ERISA (including any related funding mechanism now in effect or required in the future), whether formal or informal,
oral or written, funded, unfunded, insured or self-insured, in each case, that is sponsored, established, maintained, contributed
to or required to be contributed to by any of the Company or its Subsidiaries, or under which any of the Company or any of its
Subsidiaries has any current or potential liability.


 


“Environmental
Laws” means all Legal Requirements relating to pollution or the protection of the environment or the workplace, occupational
health and safety, or to human health as it relates to exposure to Hazardous Substances, or to the use, storage, handling, release,
disposal ore remediation of, or exposure to Hazardous Substances, in each case as in effect as of the relevant time.


 


“Equity
Securities” means any and all (a) shares, interests, participations or other equivalents (however designated) of
capital stock or other voting securities of a corporation, any and all equivalent or analogous ownership (or profit) or
voting interests in a person (other than a corporation), (b) securities convertible into or exchangeable for shares,
interests, participations or other equivalents (however designated) of capital stock or voting securities of a corporation,
and securities convertible into or exchangeable for any equivalent or analogous ownership (or profit) or voting interests in
a person (other than a corporation), and (c) any and all warrants, rights or options to purchase any of the foregoing,
whether voting or nonvoting, and, in each case, whether or not such shares, interests, participations, equivalents,
securities, warrants, options, rights or other interests are authorized or otherwise existing on any date of determination; provided,
that Equity Securities shall not include preferred stock that are not convertible or exchangeable for common stock in a
corporation.


 


“ERISA”
means the Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations promulgated thereunder.


 






    121


     


    

 


“ERISA Affiliate”
means each entity, trade or business that is, or was at the relevant time, a member of a group described in Section 414(b),
(c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA that includes or included the Company or any of its Subsidiaries,
or that is, or was at the relevant time, a member of the same “controlled group” as any of the Company or its Subsidiaries
pursuant to Section 4001(a)(14) of ERISA.


 


“Escrow Agent”
means Citibank, N.A.


 


“Escrow Agreement”
means the Escrow Agreement to be entered into at the Closing by Parent, Company and the Escrow Agent at the Closing, in customary
form as reasonably agreed by the Parties.


 


“Estimated
Aggregate Merger Consideration” means an amount equal to (1) $1,100,000,000; plus (2) the Aggregate Parent
Stock Value, minus (3) the Estimated Selling Expenses; minus (4) the Estimated Closing Indebtedness; plus
(5) the Estimated Closing Cash; plus (6) the Estimated Net Working Capital Adjustment Amount (which may be a positive or
negative dollar amount); plus (7) the Aggregate Exercise Amount; plus (8) the Excess Capital Equipment Adjustment;
minus (9) the Provider Relief Adjustment; plus (10) the Estimated M&A Adjustment.


 


“Ex-Im Laws”
means U.S. and non-U.S. Legal Requirements relating to export, reexport, transfer, and import controls, including, without limitation,
the Export Administration Regulations, the International Traffic in Arms Regulations, and the customs and import Legal Requirements
administered by U.S. Customs and Border Protection.


 


“Excess Capital
Equipment” means the capital equipment and inventory of the Company and its Subsidiaries set forth in Section 2.8(a)
of the Disclosure Schedule.


 


“Excluded
Information” means any (a) pro forma financial statements or adjustments (but excluding information (other than any
information regarding any post-Closing or pro forma cost savings, synergies, debt or equity capitalization, ownership or
other post-Closing pro forma adjustments) relating to the Company and its Subsidiaries necessary for Parent to prepare pro
forma financial statements), (b) description of all or any portion of the Debt Financing, including any “description of
notes” and “plan of distribution”, (c) risk factors relating to all or any component of the Debt Financing,
(d) stand-alone financial statements in respect of any of the Company’s subsidiaries or (e) financial statements or
other information (including segment reporting and consolidating and other financial statements and data) required by Rules
3-09, 3-10 and 3-16 of Regulation S-X and Item 402 of Regulation S-K, information regarding executive compensation related to
SEC Release Nos. 33-8732A, 34-54302A and IC-27444A, information required by Items 10 through 14 of Form 10-K or any other
information customarily excluded from an offering memorandum for private placements of non-convertible high-yield debt
securities under Rule 144A promulgated under the Securities Act.


 


“Existing
Credit Agreement” means that certain Credit Agreement, dated as of July 29, 2020 (as amended, restated, increased, extended,
supplemented or otherwise modified from time to time) among AdaptHealth LLC, the guarantors party thereto, the lenders from time
to time party thereto and Regions Bank, as administrative agent.


 






    122


     


    

 


“Final Provider
Relief Adjustment” means the Provider Relief Adjustment; provided, that if prior to the date which is ninety (90)
days after the Closing Date, Parent and its Subsidiaries actually repay or reimburse a Governmental Entity in respect of stimulus
funds they had previously received from programs created by the CARES Act that are the same programs from which the Company and
its Subsidiaries obtained Aggregate Stimulus Funds, then Parent and the Stockholder Representative shall mutually agree to adjust
the Provider Relief Adjustment amount, up or down, as applicable, by applying the same repayment or reimbursement methodology that
was used by Parent and its Subsidiaries in respect of its stimulus funds from the same programs.


 


“Financing
Parties” means the Debt Financing Sources, together with their respective Affiliates, and their respective Affiliates’
officers, directors, employees, agents and representatives and their respective successors and assigns.


 


“Fraud”
means common law fraud as defined under the laws of the State of Delaware, with respect to the making by such Person of the representations
and warranties (in each case, as modified by the Disclosure Schedule or Schedules hereto) pursuant ‎ARTICLE IV or
‎ARTICLE V or in any other Transaction Document or certificate delivered hereunder. For the avoidance of doubt, “Fraud”
does not include any claim to the extent it is solely based on equitable fraud, constrictive fraud or any torts based on negligence
or recklessness.


 


“Fundamental
Representations” means any of the representations and warranties set forth in any of Sections ‎4.1, ‎4.2,‎
4.5(a), 4.5(b), 4.5(c), 4.5(e), ‎4.21, ‎5.1, ‎5.2, ‎5.6
and ‎5.9.


 


“GAAP”
means generally accepted accounting principles in the United States as promulgated by the Financial Accounting Standards Board,
or its predecessors or successors, as of the date of the statement to which such term refers.


 


“Governmental
Entity” means any court, governmental department, commission, council, board, agency, bureau or other instrumentality
of the United States of America, any foreign jurisdiction, or any state, provincial, county, municipality or local governmental
unit thereof, including any Taxing Authority and any arbitrator.


 


“Hazardous
Substances” means any pollutants, contaminants, wastes, chemicals or other materials or substances that are
regulated by or for which liability or standards of conduct may be imposed under any Environmental Law, and shall include
without limitation oil, petroleum, petroleum-derived substances, radiation and radioactive materials, noise, odors, mold and
microbial matter, polychlorinated biphenyls, radon, urea formaldehyde, and asbestos or materials containing asbestos.


 


“Health Care
Laws” means all Legal Requirements pertaining to the healthcare regulatory matters applicable to the operations of the
Company or any of its Subsidiaries, including: (i) the Legal Requirements, licensure, certification, or registration requirements
of all Governmental Entities relating to the Business, including as applicable, the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
 § 301 et seq.), (ii) the Medicare statute (Title XVIII of the Social Security Act, 42 U.S.C. § 1395 et
seq.), the Medicaid statute (Title XIX of the Social Security Act, 42 U.S.C. § 1396 et seq.), including the Medicare
Part D program and the Medicare Advantage program, the federal TRICARE statute (10 U.S.C. § 1071 et seq.) and any other
federal, state or local governmental healthcare programs, including applicable program requirements; (iii) any criminal Legal Requirements
relating to health care, including all criminal false claims statutes (e.g., 18 U.S.C. Sections 287 and 1001); (iv) the Civil Monetary
Penalties Law, 42 U.S.C. §§ 1320a-7a and 1320a-7b; (v) all Legal Requirements relating to health care fraud and abuse,
including but not limited to the civil False Claims Act of 1863 (31 U.S.C. § 3729 et seq.), the federal Anti-Kickback
Statute (42 U.S.C. § 1320a-7b(b) et seq.), and the Stark Act (42 U.S.C. § 1395nn); (vi) all federal and state
self-referral prohibitions, state anti-kickback, illegal remuneration and provider conflict of interest Legal Requirements; (vii)
all applicable federal and state statutes and regulations relating to medical devices, durable medical equipment, home medical
equipment, or orthotics, or to the manufacturing, sale or distribution of such products; and (viii) all other applicable quality,
safety certification and accreditation standards and requirements applicable to the sale of relating to medical devices, durable
medical equipment, home medical equipment, or orthotics, or to the manufacturing, sale or distribution of such products.


 






    123


     


    

 



 


“HSR Act”
means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.


 


“Indebtedness”
means, with respect to the Company and its Subsidiaries, (a) all indebtedness for borrowed money, (b) all obligations
evidenced by bonds, debentures, notes or similar instruments, (c) all obligations in respect of any letter of credit, surety
bond, banker’s acceptance or similar reimbursement agreement or obligation, in each case, solely to the extent drawn,
(d) all obligations to pay the deferred purchase price of property, assets or services in respect of which the Company or any
of its Subsidiaries is liable (excluding trade accounts payable arising in the Ordinary Course of Business of the Company),
including any “earn-out”, contingency or royalty payments, and any unfunded or underfunded holdbacks or escrows,
(e) all obligations under leases required to be capitalized in accordance with GAAP as in effect as on the date hereof, (f)
all obligations under, any swap, hedging or derivative instruments, in each case assuming each such instrument were
terminated as of immediately prior to Closing, (g) except to the extent included as liabilities in the calculation of Selling
Expenses or Net Working Capital, any unfunded or underfunded liabilities pursuant to any pension or nonqualified deferred
compensation plan or arrangement, or any unpaid severance obligations with respect to employees (or other service providers)
terminated prior to the Closing, (h) all obligations under any direct or indirect guaranties in respect of, or obligations
(contingent or otherwise) to purchase or otherwise acquire, or otherwise to assure a creditor against loss in respect of,
indebtedness for borrowed money or obligations of others of the kinds referred to in clauses (a) through (g) above and (i)
all obligations of the kinds referred to in clauses (a) through (h) above of other Persons secured by any Lien on any
property or asset of the Company, (j) all accrued interest, prepayment premiums, fees (including loan management fees) or
penalties directly related to the payment of each of the foregoing items described in clauses (a) through (i) and (k) M&A
Costs other than to the extent paid in cash prior to the Closing. Notwithstanding the foregoing, “Indebtedness”
shall not include any (i) amounts included as Selling Expenses, (ii) any liability included in Net Working Capital, (iii) any
amounts in connection with any Aggregate Stimulus Funds or incurred in connection with the CARES Act, (iv) all prepaid
revenue (whether current or long-term) tied to the delivery of future services for which cash has already been received,
including deferred revenue (whether current or long-term), and (v) any liabilities, obligations or guarantees solely to the
extent related to any debt between the Company and its wholly-owned Subsidiaries or between the Company’s
wholly-Subsidiaries.


 






    124


     


    

 


“Information
Rights Holder” means Stephen Griggs, Peloton Equity AeroCare SPV I, L.P., SkyKnight Aero Holdings, LLC and SV Life Sciences
Fund VI, L.P.


 


“Intellectual
Property” means the following in any jurisdiction around the world: (a) patents, patent applications, and statutory invention
registrations, including reissues, divisionals, continuations, continuations in part, reexaminations, and extensions; (b) trademarks,
trademark applications, trademark registrations, trade names, service marks, service mark applications, service mark registrations,
brand names, trade dress, product designations, logos, designs, Internet domain names, and any other similar designations of source
or origin, together with all adaptations, derivations, abbreviations, acronyms, and combinations thereof, all applications, registrations,
and renewals in connection therewith, and all goodwill associated therewith; (c) copyrights and works of authorship, whether
or not registered, copyright registrations, and copyright applications, and moral rights; (d) trade secrets, know-how or other
proprietary or confidential information, inventions (whether or not patentable or reduced to practice), processes, techniques,
research and development, software, source code, formulae, algorithms, data, databases, collections of data, customer and supplier
lists, and business and marketing plans (collectively, “Trade Secrets”); (e) usernames, keywords, tags,
and other social media identifiers and accounts, for all third-party social media sites, as well as all content uploaded or posted
to such sites; and (f) all other intellectual property or proprietary rights or assets.


 


“IRS”
means the Internal Revenue Service.


 


“Knowledge”
means (a) with respect to the Company or its Subsidiaries, any fact, circumstance, event or other matter in question that is actually
known by Stephen Griggs, Albert Prast, Daniel Bunting, Joseph Russell, Joey Russell and Jacques Schira and (b) with respect to
Parent, any fact, circumstance, event or other matter in question that is actually known by Luke McGee, Joshua Parnes, Jason Clemens,
Christopher Joyce and Wendy Russalesi, in each case, after reasonable inquiry of their respective direct reports.


 


“Legal Proceeding”
means any judicial, administrative or arbitral claims, actions, suits, hearings, inquiries, challenges, investigations or other
proceedings (public or private) commenced, brought, conducted or heard before, or otherwise involving, any Governmental Entity
or arbitrator.


 


“Legal Requirement”
means all laws, common law, statutes, rules, regulations, codes, ordinances, permits, bylaws, variances, policies, judgments, injunctions,
orders, guidelines, conditions and licenses of a Governmental Entity, including the CARES Act, the Families First Coronavirus Response
Act of 2020 or any other law intended to address the consequences of COVID-19.


 


“Liabilities”
means all indebtedness, obligations and other liabilities of a Person, whether known or unknown, contingent or otherwise.


 


“Licenses
for Generally Commercially Available Software” means non-exclusive licenses granted to the Company or any of its Subsidiaries
in respect of commercially available, unmodified, prepackaged, off-the-shelf third-party software used by the Company or any of
its Subsidiaries solely for their own internal use with a replacement cost or aggregate fee, royalty, or other consideration for
any such software or group of related software licenses of no more than $150,000.


 






    125


     


    

 


“Lien”
means any lien, mortgage, pledge, condemnation award, expropriation award, encumbrance, lease, sublease, license, preferential
purchase right, option, conditional sales contract, ownership interest of another Person, security interest or encumbrance or other
similar third-party right of any nature whatsoever.


 


“Losses”
means, collectively, any loss, Liability, demand, claim, action, cause of action, cost, damage, deficiency, Tax, penalty, fine
or expense, whether or not arising out of any claims by or on behalf of any third party, including interest, penalties, reasonable
attorneys’ fees and expenses and all reasonable amounts paid in investigation, defense or settlement of any of the foregoing.
For the avoidance of doubt, “Losses” shall exclude special, exemplary or punitive damages except, in
each case, for any such damages that are actually awarded to and owed by an Indemnified Party to a third party.


 


“M&A Adjustment”
the M&A Costs less the M&A Target, which may be a positive or negative dollar amount.


 


“M&A Costs”
means the aggregate amount of all consideration paid and any funded holdbacks and escrows paid by the Company or any of its Subsidiaries
between the date hereof and the Closing Date (which the Company agrees will not exceed $21,000,000 for acquisitions consummated
prior to February 1, 2021, or $41,000,000 for all acquisitions between the date hereof and the Closing Date) in connection with
all actual M&A Purchase consummated following the date hereof and prior to the Closing; provided, that the Company may
increase such $41,000,000 ceiling with Parent’s consent, not to be unreasonably withheld, conditioned or delayed.


 


“M&A
Purchase” means each acquisition by the Company or any of its Subsidiaries of any Person, division or line of
business set forth on Section 6.5(e)(i) of the Disclosure Schedule plus any other division, company or line of
business which the Company determines to acquire after February 1, 2021.


 


“M&A Target”
means $15,857,500.


 






    126


     


    

 


“Marketing
Period” means the first period of 15 consecutive Business Days after the date hereof and throughout and on the last day
of which Parent shall have received the Required Financial Information from the Company, and such Required Financial Information
is and remains Compliant; provided the Marketing Period shall exclude December 19, 2020 through January 3, 2021 (each, a “Non-Marketing
Date”); it being understood that any Non-Marketing Date after the commencement of the Marketing Period shall be disregarded
for purposes of calculating the 15 consecutive Business Days constituting the Marketing Period except for Non-Marketing Dates between
December 19, 2020 through January 3, 2021, for which the Marketing Period shall be completed prior to such dates or commence after
such dates; provided, further, that if the Marketing Period shall not have ended by the later to occur of (A) February
11, 2021, and (B) the date on which the Company’s auditors will provide to the underwriters in an offering negative assurance
on the change period, the Marketing Period shall be deemed to have not commenced until the Company shall have delivered the information
set forth in clause (c) of the definition of Required Financial Information; provided, further, (i) the Marketing
Period shall not be deemed to have commenced if, prior to the completion of such 15 consecutive Business Day period, (1) the independent
public accountants of the Company shall have withdrawn its audit opinion with respect to any audited financial statements included
in the Required Financial Information, in which case such 15 consecutive Business Day period shall not commence unless and until
a new unqualified audit opinion is issued with respect to such audited financial statements by the independent public accountant
of the Company or another independent public accounting firm of recognized national standing or (2) the Company or its independent
public accountants shall have announced any intention to restate any financial statements included in the Required Financial Information,
in which case such 15 consecutive Business Day period shall not commence unless and until such restatement has been completed and
the applicable Required Financial Information has been amended or the Company or its independent public accountants, as applicable,
has announced that it has concluded that no restatement shall be required in accordance with GAAP. If at any time the Company believes
in good faith that it has delivered to Parent all Required Financial Information and such Required Financial Information is and
remains Compliant, it may deliver a written notice to Parent to such effect (stating when it believes it completed such delivery),
in which case the Required Financial Information shall be deemed to have been delivered and to be Compliant as of the date specified
in such notice and the “Marketing Period” shall be deemed to have commenced on the date specified in such notice (and
such Required Financial Information have been received on such date), unless Parent in good faith reasonably believes either any
Required Financial Information has not been received or is not Compliant and, within three (3) Business Days after the date of
Parent’s receipt of the aforementioned notice, delivers a written notice to the Company to that effect and stating with reasonable
specificity what Required Financial Information it believes it has not received or is not Compliant (it being understood and agreed
that the Marketing Period shall commence on the first (1st) Business Day following the date on which the Company delivers, or causes
to be delivered, the Required Financial Information specifically identified by Parent in such notice).


 






    127


     


    

 


“Material
Adverse Effect” means any change, effect, development, event, state of facts, or circumstance that (i) is, or would reasonably
be expected to be, individually or in the aggregate, materially adverse to the business, assets, liabilities, condition (financial
or otherwise), or results of operations of the Company and its Subsidiaries, taken as a whole, on the one hand, or, the Parent
and its Subsidiaries, taken as a whole, on the other hand (as applicable), or (ii) prevents the Company or Parent (as applicable)
from timely consummating the transactions contemplated by this Agreement; provided, that with respect to clause (i), any
change, effect, development, event, state of facts, or circumstance to the extent arising out of or relating to any of the following
will not be taken into account in determining whether there has been or may be a Material Adverse Effect: (a) general economic
conditions, including changes in the credit, debt or financial, capital markets (including changes in interest or exchange rates),
in each case, anywhere in the world, in the United States or in the regional economies or industries in which the Company or Parent
and their respective Subsidiaries (as applicable) operate; (b) conditions or fluctuations in the securities markets, capital markets,
any stock exchange, credit markets, currency markets or other financial markets in the United States or any other country or region
in the world, including (A) changes in interest rates in the United States or any other country or region in the world and changes
in exchange rates for the currencies of any countries and (B) any suspension of trading in securities (whether equity, debt, derivative
or hybrid securities) generally on any securities exchange or over-the-counter market operating in the United States or any other
country or region in the world; (c) any stoppage or shutdown of any Governmental Entity (including any default by a Governmental
Entity or delays in payments or delays or failures to act by any Governmental Entity); (d) global, national or regional political,
financial, economic or business conditions, including hostilities, acts of war, sabotage or terrorism or military actions or any
escalation, worsening or diminution of any such hostilities, acts of war, sabotage or terrorism or military actions existing or
underway; (e) hurricanes, earthquakes, floods, tsunamis, tornadoes, mudslides, wild fires, epidemics, pandemics, disease outbreak
(including COVID-19) or other natural disasters or any other act of God or force majeure events, in the United States or any other
country or region in the world; (f) changes in GAAP or other accounting requirements or principles; (g) changes in any Legal Requirements
or any change in the interpretation of such Legal Requirements (including in connection with COVID-19); (h) actions required to
be taken under Order or applicable Legal Requirements (including in connection with COVID-19); (i) the announcement or pendency
of this Agreement or the other transactions contemplated by this Agreement or the identity of Parent or the Company, as applicable;
(j) the failure of the Company or Parent (as applicable) or any of their respective Subsidiaries to meet or achieve the results
set forth in any internal budget, plan, projection or forecast (it being understood that the underlying causes of, or factors contributing
to, the failure to meet such results may be taken into account in determining whether a Material Adverse Effect has occurred or
would be expected to occur to the extent another exception set forth in this definition does not apply); (k) any increased cost,
or decreased availability, of capital or pricing or terms related to any financing for the transactions contemplated hereby or
any disruption thereof; except, in the case of the foregoing clauses (a) through (e) and (h), to the extent such changes
or effects referred to therein have a materially disproportionate impact on the Company or its Subsidiaries or Parent or its Subsidiaries
(as applicable) as compared to other companies with businesses that operate in the same industries in which the Company or Parent
(as applicable) or their respective Subsidiaries operate.


 


“Material
Subsidiaries” means each Subsidiary of the Company that would constitute a “significant subsidiary” (as defined
in Rule 1-02 of Regulation S-X).


 


“Measurement
Time” means 12:01 A.M. New York, New York time on the Closing Date.


 


“Multiemployer
Plan” means each Employee Plan that is a “multiemployer plan” as defined in Section 3(37) or 4001(a)(3) of
ERISA or Section 414(f) of the Code.


 


“NASDAQ”
means the Nasdaq Global Market.


 


“Net Working
Capital” means the current assets of the Company and the Subsidiaries of the Company (which Subsidiaries shall be determined
as of the date of this Agreement, i.e., excluding any Subsidiary acquired in connection with any M&A Purchase consummated
after the date hereof and prior to Closing) (excluding Cash on Hand, Restricted Cash, current and deferred Tax assets, Excess Capital
Equipment and all assets arising from any M&A Purchase structured as an asset purchase consummated after the date hereof and
prior to Closing) less current liabilities of the Company and the Subsidiaries of the Company (which Subsidiaries shall
be determined as of the date of this Agreement, i.e., excluding any Subsidiary acquired in connection with any M&A Purchase
consummated after the date hereof and prior to Closing) (excluding Indebtedness, Selling Expenses, current Tax liabilities, deferred
Tax liabilities, deferred revenue, Aggregate Stimulus Funds, M&A Costs and all liabilities assumed in any M&A Purchase
structured as an asset purchase consummated after the date hereof and prior to Closing (other than, for the avoidance of doubt,
any costs or expenses incurred by the Company or any of its Subsidiaries in connection with the authorization, preparation, negotiation,
execution or performance of such M&A Purchase, such as those paid to accountants, attorneys, bankers and other advisors)),
in each case, determined as of the Measurement Time in accordance with and including only those specific line items set forth in
the Preparation Methodology.


 






    128


     


    

 


“Net Working
Capital Adjustment Amount” means the Net Working Capital less the Net Working Capital Target, which may be a positive
or negative dollar amount.


 


“Net Working
Capital Target” means $22,222,307.


 


“Non-Employee
Option” means each Company Option that was granted to the holder in the holder’s capacity as a non-employee service
provider to the Company or its Subsidiaries for applicable employment Tax purposes as specified in the Closing Consideration Schedule.


 


“Option Consideration”
means the Cash Option Consideration and the Substitute Option Consideration, as applicable.


 


“Order”
means any order, injunction, judgment, decree, ruling, writ, assessment or arbitration award of a Governmental Entity.


 


“Ordinary
Course of Business” means, with respect to any Person, actions that are consistent in all material respects with the
past practices of such Person, taken in the ordinary course of the normal day-to-day operations of such Person.


 


“Ordinary
Rep” means any representation or warranty made by Company in ‎ARTICLE IV or the Parent in ‎ARTICLE
V, as applicable, other than the Fundamental Representations.


 


“Parent Material
Adverse Effect” means any change, effect, development, event, state of facts, or circumstance that, with respect to Parent
and its Subsidiaries, taken as a whole, constitutes a Material Adverse Effect.


 


“Parent Stock
Value” means the volume-weighted average price per share for Class A Common Stock as reported by Nasdaq for the 20 consecutive
Trading Days ending on (and including) the Trading Day that immediately precedes the fifth (5th) Business Day prior to the Closing
Date.


 


“Per Share
Cash Consideration” means an amount in cash equal to the Common Per Share Amount.


 


“Per Share
Mixed Consideration” means (a) the Common Per Share Cash Amount and (b) the Common Per Share Stock Issuance Amount.


 






    129


     


    

 


“Permitted
Liens” means (a) statutory Liens for current Taxes or assessments, or other similar governmental charges, not yet
due and payable or the amount or validity of which is being contested in good faith by appropriate proceedings and for which adequate
reserves have been established in the Company Financial Statements in accordance with GAAP, (b) carriers’, warehousemen’s,
mechanics’, materialmen’s, repairmen’s or other similar Liens arising or incurred in the Ordinary Course of Business
not yet delinquent or the amount or validity of which is being contested in good faith by appropriate proceedings and for which
adequate reserves have been established in accordance with GAAP, (c) zoning, entitlement and other land use or environmental
regulations regulating the use or occupancy of such Leased Real Property or the activities conducted thereon which are imposed
by any Governmental Entity having jurisdiction over such Leased Real Property which are not violated by the current use or occupancy
of such Leased Real Property or the operation of the Business thereon, (d) Liens created by or arising out of the express terms
of any Real Property Lease, (e) title to any portion of the premises lying within the right of way or boundary of any public road
or private road which, individually or in the aggregate, do not materially adversely affect the value or the continued use of the
Company Real Property; and (f) matters that would be disclosed by an accurate survey or inspection of the Leased Real Property.


 


“Person”
means any natural person, corporation, company, partnership (general or limited), limited liability company, trust, joint venture,
estate, association, organization, labor union or other entity or Governmental Entity.


 


“Personal
Data” means any data or other information (including “Protected Health Information” and
 “Individually Identifiable Health Information” as defined by HIPAA) about or from an individual, including any
personally identifiable data (e.g., name, street address, telephone number, e-mail address, photograph, social
security number, driver’s license number, credit card number, passport number, or customer or account number, and any
other piece of information that allows the identification of a natural person), or that is protected by or subject to any
Privacy Laws and Requirements.


 


“Post-Closing
Tax Period” means (a) any Tax period beginning after the Closing Date and (b) with respect to any Straddle Period, the
portion of such period beginning after the Closing Date.


 


“Preferred
Stock Share Consideration” means a number of shares of Series C Preferred Stock equal to the quotient obtained by dividing
(a) (i) the Share Consideration Amount, minus (ii) the number of Common Stock Share Consideration issued hereunder,
divided by (b) the Conversion Rate.


 


“Preparation
Methodology” means a preparation approach in accordance with GAAP (as consistently applied by the Company and its Subsidiaries
in the Company Financial Statements), but, in the case of Net Working Capital, using only those specific line items reflected in
Exhibit N, as modified by any inclusions or exclusions to those line items set forth in Exhibit N.


 


“Pro Rata
Share” means, with respect to each Company Equityholder (a) the sum of (i) the number of shares of Company Common Stock
(including the aggregate number of shares of Company Common Stock issuable upon conversion of shares of Company Series C Preferred
Stock) and (ii) the aggregate number of shares of Company Common Stock issuable upon exercise of the Vested Company Options held
by such Company Equityholder immediately prior to the First Effective Time held by such Company Equityholder, divided by
(b) the Aggregate Shares.


 






    130


     


    

 


“Provider
Relief Adjustment” means $8,758,130; provided, that if the Parties mutually agree prior to Closing, acting reasonably
and in good faith, that the portion of the Aggregate Stimulus Funds received by the Company and its Subsidiaries which the Parties
reasonably estimate will need to be repaid or reimbursed to the applicable Governmental Entity in accordance with the terms of
such programs is a different amount, the Provider Relief Adjustment will be such different amount.


 


“Purchasing
Expenses” means, whether or not incurred or paid prior to or after the termination, (a) all reasonable out-of-pocket
expenses (including all fees and expenses of counsel, accountants, financial advisors, investment bankers, experts and consultants
(including Willkie Farr & Gallagher LLP, Jefferies LLC, K&L Gates LLP, Berkeley Research Group, LLC and KPMG LLP)) incurred
by Parent or its Affiliates in connection with or related to the authorization, preparation, negotiation, execution or performance
of this Agreement and the transactions contemplated hereby, (b) one-half of the fees associated with the filings pursuant to the
HSR Act, (c) all fees, costs and expenses relating to the Parent’s portion of the Special Policy (including, to the extent
required to be paid notwithstanding the termination, the premium due therefor, the underwriting fee with respect thereto, and any
surplus lines Tax), (d) one-half of the fees and expenses of the Paying Agent to the extent required to be paid notwithstanding
the termination, (e) all reasonable fees, costs and expenses payable by Parent in authorization, preparation, negotiation, execution
or performance in seeking the Debt Financing.


 


“Real Property
Leases” means all leases, subleases, licenses, concessions and other Contracts applicable to the Leased Real Property,
and any ancillary documents pertaining thereto, including, for example, amendments, modifications, supplements, exhibits, schedules,
addenda and restatements thereto and thereof, including the right to all security deposits and other amounts and instruments deposited
by or on behalf of the Company or any of its Subsidiaries thereunder.


 


“Rental Equipment”
means the medical equipment in the Company’s or any of its Subsidiaries’ possession as of the date hereof of the type
provided to patients under rental arrangements in the Ordinary Course of Business.


 


“Representative
Expense Amount” means $500,000, as may be adjusted by the Stockholder Representative prior to the delivery of the Closing
Consideration Schedule.


 






    131


     


    

 


“Required
Financial Information” means (a) the audited consolidated balance sheets and statements of income and cash flows of
the Company and its consolidated Subsidiaries for the fiscal years ended December 31, 2018 and 2019, (b) the unaudited
consolidated balance sheet of the Company and its consolidated Subsidiaries as of September 30, 2020 and the unaudited
consolidated statements of income and cash flows of the Company and its consolidated Subsidiaries for the nine months ended
September 30, 2019 and September 30, 2020, upon which the Company’s auditors have performed an interim review in
accordance with the Statement of Accounting Standards 100, (c) to the extent the Closing Date occurs on or after 90 days
after December 31, 2020, the audited consolidated balance sheet of the Company and its consolidated Subsidiaries as of
December 31, 2020 and the consolidated statement of income and cash flows of the Company and its consolidated Subsidiaries
for the fiscal year ended December 31, 2020, (d)(1) an unaudited consolidated balance sheet of the Company and its
consolidated Subsidiaries as of the last day of the interim fiscal quarter of the Company subsequent to December 31, 2020
ended at least 45 days prior to the Closing Date and (2) unaudited consolidated income statements and cash flow statements of
the Company and its consolidated Subsidiaries for the interim period subsequent to December 31, 2020 and ended as of the date
of the unaudited consolidated balance sheet referred to in clause (d)(1) of this definition of Required Financial Information
(and, with respect to such unaudited consolidated income statement and cash flows statement of the Company and its
consolidated Subsidiaries, the corresponding period for the prior fiscal year), in each case, upon which the Company’s
auditors have performed an interim review in accordance with the Statement of Accounting Standards 100, (e) all other
financial data regarding the Company and its Subsidiaries reasonably requested by Parent and required to permit Parent to
prepare pro forma financial statements in accordance with Article XI of Regulation S-X and (f) such other customary financial
information regarding the Company and its Subsidiaries as may be reasonably requested by Parent to the extent such
information is of the type and form customarily included in a customary bank information memorandum or an offering memorandum
for private placements of non-convertible high yield bonds pursuant to Rule 144A promulgated under the Securities Act or
customarily included in a registrant statement on Form S-1 under the Securities Act. The financial statements referenced in
clauses (a)-(d) above shall be in conformity with GAAP applied on a consistent basis during and across the periods involved
and shall satisfy the requirements of Rule 3-05 or 8-04 of Regulation S-X. Notwithstanding anything to the contrary in this
definition, nothing in this Agreement will require the Company or any of its Subsidiaries to provide (or be deemed to require
the Company or any of its Subsidiaries to prepare) any Excluded Information.


 


“Restricted
Cash” means any cash and cash equivalents (a) the use of which is restricted by law or Contract, including any deposits
with third parties and (b) that are insurance proceeds in respect of a condemnation, casualty, loss or other material damage to
any of the assets of the Company or any of its Subsidiaries prior to the Closing Date that have not been used to repair or replace
such condemned or damaged property as permitted or required pursuant to the terms hereof.


 


“Sanctions
Laws” means Legal Requirements administered or enforced by the United States (including by the United States Department
of Treasury, Office of Foreign Assets Control or the U.S. Department of State), and the United Nations Security Council.


 


“Securities”
means the Share Consideration and any Securities into which the Share Consideration is convertible.


 


“Security
Breach” means actions that result in an actual, suspected, alleged or potentially likely cyber or security incident that
could have an adverse effect on any Company System or any information or data stored or contained therein, including an occurrence
that actually or potentially likely jeopardizes the confidentiality, integrity, or availability of such system or the data or information
the system processes, stores, or transmits. A Security Breach includes incidents of security breaches or intrusions, denial of
service, or unauthorized entry, access, collection, use, processing, storage, sharing, distribution, transfer, disclosure, or destruction
of, any data, Company System, or Trade Secrets, or any loss, distribution, compromise or unauthorized disclosure of any of the
foregoing.


 






    132


     


    

 


“Selling Expenses”
means (a) to the extent not paid prior to the Closing, all out-of-pocket expenses (including all fees and expenses of counsel,
accountants, financial advisors, investment bankers, experts and consultants (including Goodwin Procter LLP and Brown & Fortunato))
incurred on or prior to the Closing Date (whether or not payable on, at or prior to the Closing) by the Company and its Subsidiaries
in connection with or related to the authorization, preparation, negotiation, execution or performance of this Agreement and the
transactions contemplated hereby, including a Dividend Recapitalization, (b) the Change in Control Payments, (c) the
employer portion of any withholding, payroll, employment or similar Taxes payable with respect to each Company Option, and (d)
to the extent not paid prior to the Closing, (i) one-half of the fees associated with the filings pursuant to the HSR Act, (ii) one-half
of the premium, underwriting fee and surplus lines Tax relating to the Tail Policy (subject to Section 6.3(b)), (iii) one-half
of the premium for up to $75,000,000 of coverage under the Special Policy, (iv) one-half of the amount of any Transfer Taxes, (v)
one-half of the fees and expenses of the Paying Agent in accordance with Section ‎2.5(a) and (vi) one-half of the
fees and expenses of the Escrow Agent in accordance with Section ‎3.1.


 


“Series C
Preferred Stock” means Series C Convertible Preferred Stock, par value $0.0001 per share, of Parent.


 


“Series C
Preferred Stockholders” means any holder of Company Series C Preferred Stock immediately prior to the First Effective
Time.


 


“Share Consideration”
means the Common Stock Share Consideration and the Preferred Stock Share Consideration.


 


“Share Consideration
Amount” means 31,000,000 shares of Common Stock (as equitably adjusted for any stock split, dividend, recapitalization
and similar transaction or reorganization on or after the date hereof pursuant to Section 2.13).


 


“Special Escrow
Account” means the escrow account created pursuant to the Escrow Agreement in respect of the Special Escrow Deposit.


 


“Special Escrow
Deposit” means $7,000,000.


 


“Special Matter”
means the matter described in item 3 of Section 4.6(a) of the Disclosure Schedule.


 


“Stockholder”
means any holder of Company Capital Stock, as determined immediately prior to the First Effective Time.


 


“Straddle
Period” means any taxable period that includes but does not end on the Closing Date.


 


“Subsidiary”
or “Subsidiaries” means, as to any Person, any other Person of which a majority of the outstanding voting
securities or other voting equity interests, or a majority of any other interests having the power to direct or cause the direction
of the management and policies of such other Person, are owned, directly or indirectly, by such first Person.


 






    133


     


    

 


“Substitute
Option Consideration” means, in respect of each Company Optionholder that is an Accredited Investor, the right to receive
the Parent Options in respect of each Vested Substitute Option held by such Company Optionholder pursuant to Section‎
2.7(a) and ‎2.7(b).


 


“Surviving
Companies” means, collectively, the First Surviving Company and the Second Surviving Company.


 


“Tax”
or “Taxes” means any taxes and similar assessments imposed by any Taxing Authority, including income, profits,
gross receipts, net proceeds, alternative or add-on minimum, ad valorem, value added, sales, use, real property, personal property
(tangible and intangible), stamp, leasing, lease, user, excise, duty, franchise, capital stock, transfer, registration, withholding,
social security (or similar), unemployment, disability, payroll, employment, fuel, excess profits, occupational, premium, windfall
profit, severance, escheat or unclaimed property, actual or estimated, tax, levy, assessment, duty, custom or similar governmental
charge including any interest, penalty, or addition thereto, whether disputed or not.


 


“Tax Return”
means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule
or attachment thereto, and including any amendment thereof.


 


“Taxing Authority”
means, with respect to any Tax, the Governmental Entity or political subdivision thereof that imposes such Tax, and the agency
(if any) charged with the collection of such Tax for such entity or subdivision, including any governmental or quasi-governmental
entity or agency that imposes, or is charged with collecting, social security or similar charges or premiums.


 


“Third Party
Payor Programs” means all payment or reimbursement programs (including but not limited to those programs that are sponsored
or maintained by any Third Party Payor and/or those programs under which a Third Party Payor bills and collects), in which the
Company or any of its Subsidiaries participate and/or the Company or any of its Subsidiaries provide products or services, regardless
of whether the Company or its Subsidiaries are an in-network or out-of-network provider/supplier.


 


“Third Party
Payors” means state or local governmental insurance programs, private, non-governmental insurance and managed care programs,
employers, unions, trusts, or third party administrators, including, but not limited to, any Governmental Entity that sponsors
a health benefit program, including Medicare, Medicaid, CHAMPUS/TRICARE or any federal health care program, with which the Company
or any Subsidiary contracts to provide goods and services or through which the Company or any Subsidiary receives payments or reimbursements
for goods and services provided.


 


“Trade Control
Laws” means, collectively, the Sanctions Laws, Ex-Im Laws, or the anti-boycott Legal Requirements administered by the
U.S. Department of Commerce and the U.S. Department of Treasury’s Internal Revenue Service.


 


“Trading Day”
means, with respect to a security, a day on which the principal national securities exchange on which such security is listed or
admitted to trading is open for the transaction of business or, if such security is not listed or admitted to trading on any national
securities exchange, a Business Day.


 






    134


     


    

 


“Transaction
Documents” means, collectively, this Agreement, the Escrow Agreement, the Voting and Support Agreements, the Stock Letters
of Transmittal and all of the certificates, instruments and agreements required to be delivered by any of the Parties at the Closing.


 


“Transfer”
means (a) any direct or indirect sale, lease, assignment, Lien, disposition or other transfer (by operation of law or otherwise),
either voluntary or involuntary, or entry into any Contract, option or other arrangement or understanding with respect to any
sale, lease, assignment, Lien, disposition or other transfer (by operation of law or otherwise), of any Equity Security or (b) to
enter into any Derivative Instrument, swap or any other Contract, agreement, transaction or series of transactions that hedges
or transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of any Equity Security, whether
any such Derivative Instrument, swap, Contract, agreement, transaction or series of transactions is to be settled by delivery
of securities, in cash or otherwise; provided, however, that, notwithstanding anything to the contrary in this Agreement,
a Transfer shall not include the conversion of one or more shares of Series C Preferred Stock into shares of Class A Common Stock
pursuant to the Certificate of Designations.


 


“Unaffiliated
Shareholders” means the shareholders of Parent, other than (a) the Company, (b) any Affiliates or representatives
of the Company or any person acting for or on behalf of the Company or (c) any shareholder that is a member of a “group”
(within the meaning of Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder) with the Company.


 


“Value of
the Common Per Share Stock Issuance Amount” means the Common Per Share Stock Issuance Amount multiplied by the
Parent Stock Value.


 


“Vested Cash-Out
Options” means, (i) in respect of each Company Optionholder that is an Accredited Investor, a number of Vested Company
Options, rounded down to the nearest share of Company Common Stock underlying such Vested Company Option, equal to (a) the
total number of Vested Company Options held by such Company Optionholder as of immediately prior to the First Effective Time, multiplied
by (b) a ratio, the numerator of which is the Common Per Share Cash Amount and the denominator of which is the Common
Per Share Amount, and (ii) in respect of each Company Optionholder that is not an Accredited Investor, the total number of
Vested Company Options held by such Company Optionholder as of immediately prior to the First Effective Time.


 


“Vested Company
Option” means each Company Option that (i) is outstanding and unexercised as of immediately prior to the First Effective
Time, (ii) is vested as of immediately prior to or at the First Effective Time pursuant to the terms of the Company Equity
Plan and the applicable agreement(s) governing such Company Option (after giving effect to any accelerated vesting that occurs
at or immediately prior to the First Effective Time or otherwise in connection with, or as a result of, the consummation of the
First Merger), and (iii) has an exercise price per share of Company Common Stock subject thereto that is less than the Common
Per Share Amount.


 


“Vested Substitute
Options” means, in respect of each Company Optionholder that is an Accredited Investor, a number of Vested Company Options
equal to (i) the total number of Vested Company Options held by such Company Optionholder as of immediately prior to the First
Effective Time, minus (ii) the number of Vested Cash-Out Options held by such Company Optionholder.


 


******


 






    135